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CHAPTER I 
INTRODUCTION* 
 
 The task of developing from a single cell into a multicellular organism is 
remarkable. It requires ultimate precision every time a cell commits to duplicate 
its genetic material, the genome. In human cells, this means making copies of 
more than 6,000,000,000 base pairs of DNA during each DNA replication cycle. 
These copies have to be accurately divided between two daughter cells during 
mitosis. Mistakes made in the cell cycle cause mutations and chromosomal 
aberrations that eventually lead to diseases such as cancer. 
 However, to become a multicellular organism, it is insufficient to just 
replicate DNA. Cells must also differentiate to form tissues. Although all cells 
contain the same DNA, some cells differentiate into muscle cells while others 
differentiate into bone cells. This tissue-specific differentiation is driven in part by 
changes that occur ʻon top ofʼ the genome. This is called the ʻepigenomeʼ and it 
must also be inherited accurately for daughter cells to express the same genes 
and differentiate into the same tissue as the parental cell. Mistakes in copying the 
parental epigenome results in aberrant gene expression and human disease.  
 
 
*Excerpts of this chapter are published in reference [1]. Sirbu BM, Couch FB and Cortez D, 
Genes & Development 2011 and are in press Sirbu BM and Cortez D, CSHL Perspectives in 
Biology 2013. 
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And yet, maintaining genomic and epigenomic integrity during the cell 
cycle is still insufficient to become a healthy multicellular organism. Cells must 
also coordinate genome and epigenome inheritance with the given daily dose of 
damage. For example, exposure to UV light or the reactive byproducts of our 
metabolism stops cell growth to check the severity of the damage. Such a 
ʻcheckpointʼ in the cell cycle allows time for DNA repair to occur. If left 
unrepaired, these types of damages accumulate, cause mutations, chromosomal 
abnormalities and eventually lead to severe human syndromes such as cancer. 
How does a cell maintain integrity throughout the cell cycle and after DNA 
damage? By activating the DNA damage response system. This alert pathway 
preserves the genetic and epigenetic material to promote the development of one 
cell into a specific tissue that forms a healthy multicellular organism.  
In this chapter, I will discuss the events of chromatin and DNA replication, 
epigenomic inheritance during replication, and how cells confront and repair DNA 
damage that disrupts these events. Exploring how these events are coordinated 
in a timely manner relative to one another has been difficult to study and is the 
topic of my thesis project.  
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Chromatin replication 
 Within the nucleus, DNA is tightly packaged into chromatin fibers that are 
assembled from repeating units of nucleosomes. Each nucleosome contains 147 
base pairs of DNA wrapped around eight histone proteins (Fig. 1.1). This highly 
organized chromatin structure poses a physical barrier to duplication of the 
underlying DNA and must be disassembled. This process of chromatin 
decondensation begins with unraveling of histones from parental DNA at the end 
of the G1 (gap 1) phase of the cell cycle and continues throughout S phase when 
the underlying DNA is replicated.  
DNA replication causes a large disturbance in chromatin structure and 
must be properly restored after passage of the replication fork [2]. After 
completion of DNA replication, DNA is repackaged into nucleosomes and higher 
order chromatin structure is reestablished. The duplicated genetic material is 
then segregated to two daughter cells during mitosis (Fig. 1.1).  
The dynamic process of chromatin disassembly and reassembly is tightly 
coupled to DNA replication to ensure the accurate inheritance of the genome [3]. 
Histones are removed from their location on parental DNA ʻin frontʼ of the 
replication fork and captured by the histone chaperone CAF1 (Fig. 1.2). CAF1 
interacts with the proliferating nuclear antigen (PCNA) protein, which serves as 
the processivity factor for DNA polymerases. This physical coupling to PCNA 
ensures that chromatin assembly is coordinated with DNA replication [4].  
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Figure 1.1. Maintaining genome integrity through the cell cycle. Decondensation of the chromatin 
fiber within the nucleus starts at the end of G1 phase. Nucleosomes (DNA wrapped around 
histones) are removed from parental DNA during S phase to allow the replication fork machinery 
to duplicate DNA. Chromatin is reestablished behind the replication fork into chromatin fibers and 
the duplicated genome is distributed to two daughter cells during mitosis.  
  
G1 G2 Mitosis S phase 
(DNA replication) 
Replication fork Nucleosome Chromatin fiber 
DNA Histone 
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Figure 1.2. Chromatin replication. Parental histones on parental DNA in front of the replication 
fork (RF) are disassembled and recycled by histone chaperones onto nascent DNA behind the 
replication fork. Chromatin disassembly and reassembly are coordinated with replication fork 
passage and only a few histones are removed at any one time ahead of the replication fork. 
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CAF1 facilitates assembly of nascent chromatin behind the replication fork by 
recycling histones for deposition onto the nascent DNA (Fig. 1.2) 
Since the amount of DNA is doubled during replication, twice the number 
of histones is needed to assemble nascent chromatin. Newly synthesized 
histones are imported from the cytosol into the nucleus as an H3-H4 dimer in 
complex with the histone chaperone ASF1. Nascent histones are distinguished 
from parental histones by the presence of an evolutionarily conserved di-
acetylation mark on lysines 5 and 12 of histone H4 (H4K5ac/K12ac) [5] (Fig. 1.3). 
How the nascent and parental histones mix prior to being deposited onto nascent 
DNA remains unclear, but is hypothesized to be an asymmetric process, 
although some level of semi-conservative and random mixing may occur [6].  
 
Epigenomic integrity during chromatin replication 
Epigenetic inheritance refers to the faithful maintenance of parental 
modifications present on histones and DNA. For example, the removal of specific 
post-translational modifications on histones through DNA replication is essential 
for progression from nascent to parental histone, a process termed chromatin 
maturation. The prominent example involves the removal of the pre-deposition di-
acetyl marks from H4K5/K12, which facilitates chromatin assembly and the 
formation of higher order chromatin structures [3, 7].  
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Figure 1.3. Chromatin maturation. Newly synthesized histones imported from the cytosol into the 
nucleus contain pre-deposition marks. Following assembly into nascent chromatin, histone 
acetyltransferases remove pre-deposition marks to faithfully transmit epigenetic information to the 
next cell cycle.  
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Chromatin maturation is a dynamic balance between histone deacetylases 
(HDACs) and histone acetyltransferases (HATs) that catalyze removal and 
addition of acetyl groups on histones, respectively. In yeast, the HAT1 
acetyltransferase modifies H4 on K5/K12 in the cytosol where nascent histones 
are synthesized. Following catalysis, HAT1 remains bound to nascent histones 
that are imported into the nucleus for deposition onto nascent chromatin [8].  How 
this dynamic event is coupled to progression through replication has remained 
poorly characterized in higher organisms and is a topic explored in this thesis. 
Epigenetic inheritance involves not only propagating the parental histone 
marks during chromatin assembly and maturation, but also transmitting the 
marks on DNA to the next generation. Parental DNA is methylated and serves as 
the template for the faithful transmission of methylation to newly replicated DNA. 
PCNA links semi-conservative DNA methylation to replication by recruiting the 
DNA methyltrasferase DNMT1 to replication forks [9]. Proper methylation of 
nascent DNA occurs at CpG sites (cytosine followed by guanine) also requires 
the ubiquitin ligase UHRF1 (Ubiquitin-like, containing PHD and RING finger 
domains 1), a coordinating factor for DNA methylation and histone deacetylation 
[2, 10]. Hypermethylation of CpG sites in the promoter regions of genes is a 
hallmark of the epigenetic instability underlying several cancer types and has 
contributed to the methylator phenotype hypothesis for tumorigenesis [11]. 
In addition to DNA methylation and chromatin maturation, chromatin 
remodeling enzymes catalyze nucleosome sliding, histone eviction and histone 
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exchange to restore higher order chromatin structure after disruption during DNA 
replication [2]. It remains largely unresolved how these enzymatic activities are 
coordinated at replication forks due to the lack of tools to study replication-
coupled chromatin assembly and maturation, particularly in mammalian cells. 
 
DNA replication 
 Following removal of histones from parental DNA during chromatin 
disassembly, the underlying DNA is exposed and ready to be copied. The 
process of DNA replication is tightly controlled to ensure the genetic material is 
duplicated once and only once per cell cycle. DNA replication begins at origins of 
replication that are present throughout the genome of eukaryotic cells. Unlike in 
yeast (e.g. S. cerevisiae), origins of replication are poorly defined regions of the 
genome in higher organisms [12]. 
Beginning in late mitosis and early G1 phases of the cell cycle, protein 
complexes are recruited to origins of replication to form the pre-replication 
complex (pre-RC) (Fig. 1.4).  The pre-RC consists of several proteins including 
the origin recognition complex (ORC), Cdt1, Cdc6 and the MCM helicase that 
unwinds the two parental DNA strands. This unwinding begins in S phase, 
depends on the enzymatic activities of the CDK (cyclin dependent kinase) and 
DDK (Cdc7/Dbf4-dependent kinase) kinases, and provides the DNA template 
used for bi-directional DNA replication [13]. 
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Figure 1.4. Initiation of DNA replication. ORC loading begins at the end of mitosis, followed by 
recruitment of Cdc6 and Cdt1. In G1, the pre-replication complex is formed and the double 
hexamer MCM2-7 helicase is loaded head-to-head onto DNA. The kinases CDK and DDK are 
needed for firing of origins of replication upon entry into S phase. DNA replication proceeds bi-
directionally from a fired origin.  
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Binding of the Replication Protein A (RPA) to parental DNA maintains the 
parental strands separated to allow the loading of the replicative polymerases 
and initiation of leading and lagging strand DNA synthesis. Since DNA 
polymerases delta and epsilon cannot initiate DNA synthesis de novo, an RNA 
primer is first provided by DNA primase/polymerase alpha. Once DNA synthesis 
begins, an origin is said to have ʻfired.ʼ 
DNA synthesis occurs asymmetrically with continuous polymerization on 
the leading strand and in a discontinuous manner on the lagging strand. The 
replication factor C (RFC) 1-5 complex loads the replicative polymerases epsilon 
and delta on the leading and lagging strands, respectively. RFC1-5 likely 
facilitates the recycling of the DNA polymerase processivity factor PCNA once 
synthesis of the Okazaki fragment (nascent DNA fragment on the lagging strand) 
is completed. Thus, constant loading and unloading of PCNA and polymerase 
delta occurs on the lagging strand. DNA replication continues until the parental 
DNA is completely duplicated exactly once and replication is then terminated.  
DNA replication occurs in the context of chromatin, yet how histone and 
DNA replication are coordinated at the elongating replication fork has remained 
poorly understood. This unanswered question is addressed in this thesis.  
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DNA damage response 
DNA damage occurs in each and every cell cycle and threatens the 
integrity of the genome and epigenome. Fortunately, cells have evolved an 
evolutionarily conserved mechanism to deal with DNA damage called the DNA 
damage response (DDR). 
The major coordinators of the DDR are a family of related 
phosphatidylinositol 3-kinase-related kinases (PIKK). These kinases include DNA 
dependent protein kinase (DNA-PKcs), ataxia telangiectasia-mutated (ATM), and 
ATM and Rad3-related (ATR). DNA-PKcs and ATM are primarily involved in DSB 
repair, whereas ATR responds to a wide range of DNA lesions, especially those 
associated with DNA replication [14] (Fig. 1.5). ATRʼs versatility makes it 
essential for the viability of replicating cells in mice and humans [15-17]. Rare 
hypomorphic ATR mutations are found in some cases of Seckel Syndrome, 
which is characterized by growth and mental retardation, and short stature [18, 
19]. In the case of ATM, inherited biallelic mutations cause ataxia-telangiectasia, 
characterized by neurodegeneration, immunodeficiency, and cancer [20, 21]. 
ATM mutations are also frequently found in several types of tumors [22]. 
The DDR kinases share several common regulatory mechanisms of 
activation [23]. All three DDR kinases sense damage through protein–protein 
interactions that serve to recruit the kinases to damage sites. Once localized, 
post-translational modifications and other protein–protein interactions fully 
activate the kinases to initiate a cascade of phosphorylation events.  
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Figure 1.5. DNA damage response. The ATM and ATR kinases are two of the apical 
coordinators of the DNA damage response and are recruited to so sites of double-strand breaks 
(in the case of ATM) and damaged replication forks (in the case of ATR). Together, the DNA 
damage response halts the cell cycle to allow time for repair and initiates senescence or 
apoptosis of heavily damaged cells.  
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ATM and ATR have both unique and shared substrates that participate in DNA 
repair, checkpoint signaling, and determining cell fate decisions such as 
apoptosis and senescence. 
 
Responding to DNA damage at the replication fork 
Where does damage come from and how does it affect the crucial events 
coordinated at the replication fork? Thousands of DNA lesions, the lack of 
nucleotides, and other types of stress are encountered during every round of 
DNA replication and cause what is collectively termed replication stress.  
The majority of lesions are removed and repaired before the replication 
fork encounters the damage site using one of several choices of repair 
mechanism. Base excision repair (BER) removes damaged bases, mismatch 
repair (MMR) recognizes base incorporation errors and base damage, nucleotide 
excision repair (NER) removes bulky DNA adducts, and crosslink repair (ICL) 
removes interstrand crosslinks. In addition, breaks in the DNA backbone are 
repaired via double-strand break (DSB) repair pathways including homologous 
recombination (HR) and nonhomologous end joining (NHEJ). Some of these 
mechanisms can operate independently to repair simple lesions. However, the 
repair of more complex lesions involving multiple DNA processing steps is 
regulated by the DNA damage response (DDR). For the most difficult to repair 
lesions, the DDR can be essential for successful repair. 
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When damage is not repaired before the replication fork reaches the 
damage site or when a lesion is encountered directly at the replication fork, the 
replication fork stalls until the damage is removed. A stalled fork itself may not be 
a particularly devastating event to a cell because DNA replication will usually be 
completed from an adjacent origin of replication. In such cases, the DDR 
stabilizes the damaged fork to prevent aberrant DNA processing. In other cases, 
such as in replication of fragile sites that contain few replication origins, fork 
stabilization may be insufficient and DDR-kinase dependent restart of the stalled 
fork becomes essential [24]. 
How are stalled forks repaired? Depending on the DNA strand affected 
(leading or lagging), the type of damage, and the severity of damage, cells 
employ different DNA repair mechanisms to allow DNA polymerases to 
accurately read and duplicate the information in the genome. Damage 
encountered on the leading strand that halts movement of the replicative 
polymerase but allows DNA unwinding by the helicase creates large stretches of 
RPA-coated ssDNA [14]. This is the signaling platform that recruits the ATR 
kinase through its obligatory interacting partner ATRIP that binds RPA- ssDNA 
(Fig. 1.6). Other fork stalling mechanisms include the bypass of damage using 
low fidelity polymerases or switching DNA template strands for translesion 
synthesis. If the damage is observed on the lagging strand, it is typically easier to 
bypass since repriming occurs naturally to synthesize Okazaki fragments [25].  
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Figure 1.6. ATR kinase responds to damage at replication forks. Stalling of the replicative 
polymerase and continued unwinding by the replicative helicase generates parental ssDNA. The 
replication protein A (RPA, depicted as yellow dots) has high affinity for ssDNA and forms a 
recruiting platform for the ATR-ATRIP complex that initiates the DNA damage response to stalled 
replication forks.   
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Lesions that halt movement of both helicase and polymerases elicit a specialized 
repair type called interstrand crosslink repair (ICL). ICL repair provides the best 
mechanistic understanding of repair of damaged replication forks (see below). 
 
Interstrand crosslink repair during DNA replication 
 
Engineering of site-specific DNA crosslink lesions in Xenopus egg extracts 
has provided an excellent tool for studies of fork repair [26, 27]. Such lesions are 
highly effective in stalling both the replicative polymerase and helicase. 
Interstrand crosslinks are perhaps the most difficult lesions to repair, requiring 
specialized repair mechanisms governed by genes mutated in patients with 
Fanconi anemia (FA), as well as components of nucleotide excision and DSB 
repair [28]. In the context of DNA replication, interstrand crosslinks are potent 
fork stalling lesions that activate ATR. Perhaps for these reasons, the ATR 
kinase has critical function in ICL repair. 
When the ICL stalls a replication fork, the DNA structure signals the 
recruitment of several Fanconi proteins beginning with the FANCM translocase 
[26, 29]. FANCM may remodel the damaged fork to help recruit the FA core 
complex, a multisubunit ubiquitin ligase (Fig. 1.7). An essential activity of the core 
complex is monoubiquitination of FANCD2 and FANCI within the FANCI-
FANCD2 (ID) complex [30]. Repair then initiates with synchronized incision on 
both sides of the crosslink and may be mediated by the flap endonuclease FAN1 
or SLX4-associated nucleases.  
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Figure 1.7. Replication fork repair of interstrand crosslink damage. Interstrand crosslinks prevent 
both helicase and polymerase activities and stall replication forks. FANCM remodels the stalled 
fork and results in recruitment of the FA core complex and activation of the ATR pathway. Repair 
involves nucleolytic cleavage to unhook the ICL and allow for translesion synthesis past the 
damaged base to restore the replication fork. These steps involve components of the nucleotide 
excision repair and homologous recombination pathways and ATR-mediated phosphorylation. 
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The ubiquitin-binding UBZ motif of FAN1 is essential for ICL repair as it 
recognizes mono-ub FANCD2 [31-33]. Fork cleavage results in “unhooking” of 
the crosslink allowing error-prone polymerases to extend past the lesion and 
NER to remove the crosslinked base. The unhooking reaction also generates a 
DSB intermediate that is processed by HR to restore the fork [34]. These 
complex steps of fork repair are coordinated by the ATR kinase, which stabilizes 
damaged replication forks. 
 
ATR stabilizes stalled replication forks to prevent fork collapse  
The fork stabilization activity of ATR is functionally defined either in terms 
of the ability to restart replication once a blockage is removed or by the changes 
in DNA or protein composition at the fork. Yeast mutants deficient in the ATR 
pathway lose the replicative polymerases from the fork [35-37] and accumulate 
abnormal DNA structures including long stretches of ssDNA and reversed fork 
structures [38, 39]. Polymerase epsilon is lost from replicating chromatin in 
Xenopus egg extracts when ATR is depleted. This results in replication fork 
collapse into a DSB [40]. Therefore, ATR may promote genome integrity by 
stabilizing replisomes and limiting nucleolytic processing of replication forks. 
In addition, other replication fork proteins including RPA, CLASPIN, and 
members of the replication fork pausing complex like TIMELESS, TIPIN, and 
AND1 are ATR substrates [41]. Deficiencies in these proteins cause 
hypersensitivity to replication stress agents [42-45]. The significance of the DDR 
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to replication stress is highlighted by the fact that numerous ATR substrates are 
mutated in human diseases [46]. 
ATR directly targets several repair enzymes that remodel damaged forks 
including WRN, FANCM, and SMARCAL1. The WRN helicase and FANCM 
translocase proteins can unwind a variety of complex DNA structures. 
SMARCAL1 is a SNF2 family ATPase that is activated by complex DNA 
structures and uses the energy of ATP hydrolysis to re-anneal DNA strands and 
branch migrate model fork structures [47, 48]. RPA directly influences these 
SMARCAL1-dependent fork remodeling activities. For example, when damage is 
encountered on the leading strand, RPA stimulates regression of the replication 
fork into a complex chicken foot structure that may be a necessary intermediate 
structure for repair of forks [48]. The presence of RPA subsequently promotes 
restoration of the chicken foot structure into a normal fork structure containing a 
gap on the lagging strand. These mechanisms are essential to promote the 
accurate repair of damaged replication forks and provide valuable insights into 
how the ATR pathway maintains fork stability.  
Unfortunately, such studies provide only glimpses of the numerous 
proteins implicated in replication fork stability, replication-associated DNA repair 
and fork restart. Identifying the proteins implicated in these functions has been 
difficult due to the inability to purify stalled and damaged replication forks from 
mammalian systems. How ATR maintains genome stability at stalled replication 
forks is explored in this thesis. 
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Studying genome and epigenome maintenance at replication forks 
 
Overall, the response and repair of damaged replication forks remains 
poorly understood in comparison with the response to double-strand breaks 
(DSBs). Several investigators have used site specific DSBs combined with 
chromatin immunoprecipitation (ChIP) to examine proteins localizing to breaks 
with high resolution [49-52]. These studies have revealed that chromatin 
surrounding a DSB is extensively modified, that nucleosomes are destabilized, 
chromatin is remodeled, and histones are modified with post-translational marks 
[53-56]. These changes increase access to the repair machinery and recruit 
proteins involved in repair and DDR signaling. The extent to which chromatin 
changes at a stalled fork mimic those at a DSB is unknown because site-specific 
analyses of active and stalled replisomes have not been achieved in mammalian 
systems. 
 
Thesis project 
My thesis project has focused on gaining insights into how the genome 
and epigenome are inherited during DNA replication. Specifically, the spatial and 
temporal regulation of replication-coupled chromatin assembly and maturation 
have been poorly understood due to the technical limitations of studying 
elongating replication forks in vivo in mammalian cells. Additionally, how stalled 
replication forks transition to a state of irreversible collapse has been unclear.   
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To address these questions, in Chapter III, I describe the development of 
the iPOND (isolation of proteins on nascent DNA) methodology for studies of the 
dynamic mechanisms at replication forks. In Chapter IV, I used iPOND to 
examine the changes that accompany chromatin deposition and maturation 
following DNA synthesis. I also defined the timing and several genetic 
requirements involved in switching from a stalled to a collapsed replication fork. 
In Chapter V, I coupled iPOND to proteomics approaches to demonstrate the 
capacity of iPOND-MS as a discovery technology for studies of the mechanisms 
that preserve normal, stalled and collapsed replication forks. In Chapter VI, I 
further discuss the implications of my findings for comprehending how the 
genome and epigenome are inherited during DNA replication and following DNA 
damage. Overall, my thesis findings are significant for understanding the 
dynamic processes coordinated at replication forks and furthermore provide a 
tool for studying genomic and epigenomic instability, which are hallmarks of 
human diseases such as cancer. 
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CHAPTER II 
 
MATERIALS AND METHODS* 
 
Cell culture 
HEK293T cells were cultured in DMEM supplemented with 7.5% FBS and 
maintained at 37°C and 5% CO2. Stable cell lines expressing POLE2-HA and 
POLE3-HA were generated by retroviral infection and selection in puromycin-
containing medium. HAT1-/- and HAT1+/+ MEF cells were cultured in DMEM 
supplemented with 15% FBS. HEK293T suspension cells were cultured in 
Freestyle medium (Invitrogen) supplemented with 1%FBS, 1% glutamine and 1% 
penicillin/streptomycin and maintained at 37°C, 5% CO2, 80 humidity setting, and 
spinning at 130rpm in a shaking incubator. 
Plasmid constructs 
POLE2-HA and POLE3-HA retroviral vectors were generated by gateway 
cloning. pENTR POLE2 and pENTR POLE3 were recombined with pLPCX-GW-
HA3X (pDC1127) to generate a C-terminal HA-tagged POLE2 and POLE3 
retroviral vectors. pDC1127 was created by subcloning a 3XHA epitope into 
pLPCX between the Not1 and Cla1 restriction sites, then subcloning the gateway 
cassette containing attR1, ccdB gene, and attR2 as an EcoRV fragment between 
EcoR1 and Not1 sites. 
 
*This Chapter contains the iPOND protocol from reference [57] and experimental 
details from reference [1]. 
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Antibodies 
Antibody incubations were performed in 1% milk in TBST buffer for 1-2 
hours at room temperature for all of the following antibodies 
Table 2.1. Antibody list and dilutions. 
 
 
 
Protein Source Catalog Number Dilution
CAF1/p60 Bethyl Laboratories A301-085A 1:1,000
H1 Millipore 05-457 1 to 200
H2A Abcam ab18255 1:1,000
H2AX Bethyl Laboratories A300-082A 1:1,000
H2B Abcam ab1790 1:5,000
H3 Abcam ab46765 1:5,000
H4 Abcam ab31830 1:1,000
H4K12ac Active Motif 39166 1:2,000
H4K20me1 Active Motif 39176 1:1,000
H4K5ac Abcam ab51997 1:1,000
HA.11 Covance MMS-101P 1:1,000
HDAC1 Abcam ab7028 1 to 500
HDAC2 Abcam ab7029 1 to 500
HDAC3 Abcam ab16047 1 to 500
KU70 Abcam ab3114 1 to 500
KU80 Abcam ab33242 1 to 500
MRE11 (12D7) GeneTex, Inc. GTX70212 1 to 500
PCNA Santa Cruz Biotechnology SC-56 1 to 200
pRPA S33 Bethyl Laboratories A300-246A 1:1,000
pRPA32 S4/S8 Bethyl Laboratories A300-245A 1:1,000
pSMC1 S966 Bethyl Laboratories A300-050A 1:1,000
RAD51 Santa Cruz Biotechnology SC-8349 1 to 200
RPA32 Bethyl Laboratories A300-244A 1:1,000
SMARCA1/SNF2L Cell Signaling 9450 1 to 500
SMARCA5/SNF2H Abcam ab3749 1 to 500
yH2AX (S139), 
clone JBW302 Upstate Biotechnology 05-636 1:1,000
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iPOND materials  
The following materials were used for iPOND experiments:  
EdU (Invitrogen, cat. no. E10187 to be used at 10 μM or synthesized at 
Vanderbilt Core to be used at 12 μM); thymidine (Sigma, cat. no. T1895); 
formaldehyde solution (37% (wt/vol); Sigma, cat. no. F1635); PBS, pH 7.2 (10x; 
Gibco, cat. no. 70013); glycine (Fisher, cat. no. BP 381); cell lifter (Corning, cat. 
no. 3008); Triton X-100 (Sigma, cat. no. T8787); BSA (Sigma, cat. no. A7030); 
dimethyl sulfoxide (DMSO; Fisher, cat. no. A4034); copper (II) sulfate 
pentahydrate (CuSO4·5H2O; Fisher, cat. no. C489); (+) sodium l-ascorbate 
(Sigma, cat. no. A4034); biotin azide (Invitrogen, cat. no. B10184, photocleavable 
biotin azide synthesized in Professor Ned Porterʼs laboratory at Vanderbilt, or 
TEV cleavable biotin azide synthesized in Vanderbilt Sythesis Core); SDS 
(Sigma, cat. no. L4390); Tris, pH 8.0 and 6.7; sodium chloride (NaCl); RNase A 
solution (Sigma, cat. no. R6148); proteinase K (Sigma, cat. no. P5568); glycerol; 
bromophenol blue; EDTA; agarose (Bio-Rad Laboratories, cat. no. 161-3101); 
dithioerythritol (DTT; Sigma, cat. no. D-8255); aprotinin (Sigma, cat. no. A6279); 
leupeptin (Sigma, cat. no. L2884); streptavidin agarose (Novagen, cat. no. 
69203-3); magnetic streptavidin beads used for iPOND-MS (Novagen, cat. no. 
21344); trichloroacetic acid (TCA); acetone; Western Lightning Plus enhanced 
chemilluminescence substrate; Igepal CA-630; Odyssey infrared imaging system 
(Li-Cor Biosciences); click reaction stock solutions (biotin azide, CuSO4 and 
sodium l-ascorbate; see below for iPOND reagent setup). 
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iPOND equipment  
The following equipment was used for iPOND experiments:  
Nylon mesh (90 μm; Small Parts, cat. no. B000FN0PGQ); glass vial screw thread 
with cap attached for UV photocleavage (Fisher, cat. no. 03-338AA); magnetic 
micro-stirring bar (2 mm diameter x 7 mm length; Fisher, cat. no. 1451363); 
microtip sonicator for cell lysis and chromatin fragmentation (Misonix 4000 or 
Fisher Scientific Sonic Dismembrator, model 500); rotating platform for biotin 
captures; UV lamp (UVP, cat. no. UVLMS-38 EL Series 3UV lamp, 365/302/254 
nm UV 8 Watt); magnetic stir plate; microcentrifuge for 1.5-ml microcentrifuge 
tubes; tabletop centrifuge for 15-ml and 50-ml conical tubes 
 
iPOND reagent setup  
The reagents for iPOND were prepared as follows: 
EdU: Dissolve EdU in DMSO to obtain a final concentration of 10 mM. Protect 
from light. Store in aliquots at − 20 °C for up to 1 year. Before use, thaw at 37 °C. 
To EdU-label cells, pipette 1:1,000 of EdU directly into medium for a final 
concentration of 10 μM. 
Thymidine: Dissolve in water to a final concentration of 10 mM. Store in aliquots 
at –20 °C for up to 1 year. Thaw the solution before use. Use at a final 
concentration of 10 μM. 
PBS, 1x: Prepare 1x PBS from 10• PBS stock by diluting 1:10 with water; store 
at room temperature (RT, 25 °C) for up to 1 year. 
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Formaldehyde/PBS, 1% (wt/vol): Dilute 37% (wt/vol) formaldehyde 1:37 with 
PBS. Freshly prepare this reagent and keep it at RT until cell fixation (see 
detailed iPOND procedure, Step 12). 
Glycine, 1.25 M: Prepare 1.25 M glycine stock in water and store at RT for up to 
1 year. Use at 1:10 dilution for a final concentration of 0.125 M glycine. 
Permeabilization buffer: Prepare a 20% (vol/vol) stock of Triton X-100 in water 
and keep it at RT. Dilute to 0.25% (vol/vol) Triton X-100 in PBS. Store at 4 °C for 
several months. 
BSA in PBS wash buffer, 0.5% (wt/vol): Prepare 0.5% (wt/vol) BSA in PBS. 
Filter-sterilize the solution and store it at 4 °C for a couple of weeks. 
Biotin azide (1 mM): Dissolve biotin azide in DMSO to a final concentration of 1 
mM. Aliquot and store at − 20 °C for up to 1 year. 
CuSO4 (100 mM): Prepare a stock of 100 mM CuSO4 in H2O; store at RT for 
several months. 
Sodium l-ascorbate: Freshly prepare 20 mg/ ml of ( + ) sodium l-ascorbate 
(reducing agent) in H2O; limit exposure to air and store on ice until needed. 
Click reaction mixes: To prepare click reaction cocktails, please see Table 2.1 
for details. Cocktails are freshly prepared for each experiment before the click 
reaction (see detailed iPOND procedure, Step 28). 
Lysis buffer: Prepare 1% (wt/vol) SDS in 50 mM Tris (pH 8.0). Store at RT for 
several months. Before use, add protease inhibitors aprotinin and leupeptin to a 
final concentration of 1 μg ml − 1. 
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Salt wash: Prepare 5 M NaCl in water. Dilute to 1 M NaCl with water before use. 
Store at RT for 1 year. 
SDS Laemmli sample buffer (2xSB): Mix 0.4 g of SDS, 2 ml of 100% glycerol, 
1.25 ml of 1 M Tris (pH 6.8), and 0.01 g of bromophenol blue in 8 ml of H2O. 
Store at − 20 °C for up to 1 year. Before use, add 1 M DTT to a final 
concentration of 0.2 M. 
Cross-link reversal solution: Mix 2 μl of 0.5 M EDTA, 4 μl of 1 M Tris (pH 6.7) 
and 1 μl of Proteinase K. Freshly prepare this solution.	  Prepare sufficient cross-
link reversal solution mix to add 7 μl to each sample (in step 8 of Crosslink 
reversal and DNA analysis). 
Cell lysis buffer: Mix 10 mM Tris (pH 8.0), 2 mM MgCl2 and 1% (vol/vol) Igepal 
CA-630. Before use, add protease inhibitors aprotinin and leupeptin to a final 
concentration of 1 μg ml − 1. Freshly prepare this buffer. 
Nuclei buffer: Mix 15 mM Tris (pH 8.0), 0.125 M sucrose, 15 mM NaCl, 40 mM 
KCl, 0.5 mM spermidine and 0.15 M spermine. Freshly prepare this buffer. 
Extraction buffer: Mix 1x PBS with 350 mM NaCl, 2 mM EDTA and 0.1% 
(vol/vol) Triton X-100. Freshly prepare this buffer. 
 
Detailed iPOND Procedure 
Below is the detailed iPOND protocol that includes CRITICAL STEPS, 
PAUSE POINTS and a TROUBLESHOOTING guide provided in table format that 
addresses the most pertinent issues encountered in the iPOND procedure [57].  
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Cell culture preparation ● TIMING 1–7 d 
1| Calculate the number of dishes of cells needed for the experiment. Each 
sample requires at least 1.0 x108 cells at the time of the EdU pulse. I typically use 
three 150 mm dishes of HEK293T cells per sample. The number of cells may 
need to be increased depending on the application and cell type. 
2| Expand cell cultures 1 d before EdU incubation (Step 3) to ensure that the 
cells are growing optimally. Include one extra dish of cells for counting the cell 
number in Step 3. 
  CRITICAL STEP For HEK293T cells, the experiment works best when cell 
confluence is between 4 and 6 x107cells per dish on the day of the EdU pulse. 
Cells must be in log phase of growth and should not be overgrown. Monitor 
proper incubator temperature and CO2 content. EdU incorporation is not maximal 
unless these crucial parameters are met. If you are performing chases, 
equilibrate the medium to 37 °C and the proper CO2 content overnight. 
 
EdU labeling of nascent DNA● TIMING 10 min–8 h 
3| Determine the cell number in the extra dish of cells from Step 2. This cell 
number will be used to calculate the amount of the reagents used for each 
sample in Step 29. 
4| Plan out times to pulse, chase, fix, quench, collect and wash the samples. 
  CRITICAL STEP Stagger the samples to ensure that each is treated equally 
throughout the processing steps. 
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5| To pulse cells with EdU, remove the dishes from the incubator and place them 
in a biological safety cabinet. 
6| Add 23 μl of the 10 mM EdU stock into 23 ml of cell culture medium in each 
dish to achieve a final EdU concentration of 10 μM. Return the dishes to the 
incubator for the desired pulse time (e.g., 10 min). 
7| If thymidine chases or drug treatments are not being performed, skip to Step 
11. 
8| To perform thymidine chase or addition of drug, remove the dishes from the 
incubator and decant the medium. 
9| Carefully wash the cells with 5 ml of chase medium and decant. The chase 
medium should have been pre-equilibrated to 37 °C and the proper CO2 content. 
10| Add 20 ml of chase medium containing 10 μM thymidine or the desired 
concentration of DNA damaging drug. Return the dishes to the incubator for the 
desired length of time. 
  CRITICAL STEP It is important to perform Steps 5–10 as quickly as possible to 
prevent pH and temperature changes in the medium, which can affect replication 
rates. 
 
Formaldehyde cross-linking and collection of cells ● TIMING 1 h 
11| After EdU pulse and/or chase, decant the medium. 
12| Immediately fix the cells on a dish by adding 10 ml of 1% (wt/vol) 
formaldehyde in PBS and incubating for 20 min at RT. 
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13| Quench cross-linking by adding 1 ml of 1.25 M glycine. 
14| Collect the sample by scraping with a cell lifter and transfer it to a 50-ml 
conical tube. Note the volume. This is the same volume that should be used for 
PBS washes in Step 17. 
15| Centrifuge for 5 min at 900g, 4 °C. 
16| Decant the supernatant. 
17| Wash pellets three times with 1x PBS and centrifuge for 5 min at 900g, 4 °C. 
PBS wash volume is same as fixation volume noted in Step 14. Vortex to 
resuspend pellets in PBS. 
18| After the last wash, decant PBS. 
  PAUSE POINT The samples can be flash-frozen and stored at − 80 °C for 
several weeks. 
 
Cell permeabilization ● TIMING 1 h 
19| Resuspend the cells in permeabilization buffer at a concentration of 1 x107 
cells per ml. 
20| Incubate the cells at RT for 30 min. During incubation, thaw and prepare the 
reagents necessary for the click reaction cocktail (see Steps 28 and 29). 
21| Spin down for 5 min at 900g, 4 °C. 
22| Carefully decant the supernatant. 
23| Wash the cells once with cold 0.5% (wt/vol) BSA in PBS, using the same 
volume as used for permeabilization in Step 19. 
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  CRITICAL STEP BSA prevents the cell pellet from detaching from the wall of a 
50-ml conical flask. A loose pellet will lead to the loss of cells in this step. 
24| Centrifuge the cells for 5 min at 900g, 4 °C, and then decant the supernatant. 
TROUBLESHOOTING 
25| Wash the cells once with PBS using the same volume as used for 
permeabilization in Step 19. 
26| Spin down for 5 min at 900g, 4 °C. 
27| Decant the supernatant and place the pellets on ice while completing the 
preparation for the click reaction cocktail. 
 
Click reaction ● TIMING 2 h 
28| Thaw an aliquot of stock biotin azide by placing it on a 37 °C heat block. 
  CRITICAL STEP If you are using photocleavable biotin azide, keep the reagent 
protected from light and prepare the click reaction cocktail in the dark. 
29| To calculate click reaction cocktail volumes, Table 2.1 lists the amounts of 
each reagent needed per reaction with an example sample size of 1 x108 cells. 
The actual volumes should be adjusted on the basis of the cell number measured 
per sample (Step 3). Note that two click reaction cocktails need to be prepared: 
one for the control, which contains DMSO, and one for the experimental samples, 
which contains the biotin azide. 
30| Combine the click reaction cocktail reagents on ice in the order listed in Table 
2.1. 
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Table 2.1. Click reaction cocktails for a sample with 1 x 108 cells. 	  
Reagent	   [stock]	   [final]	   Control	  reaction	  
volume	  (ml)	  
Experimental	  
reaction	  
volume	  (ml)	  1×PBS	   	   	   4.35	   4.35	  DMSO	   	   	   0.05	   	  Biotin-­‐azide	   1mM	   10µM	   	   0.05	  Sodium	  ascorbate	   100mM	   10mM	   0.5	   0.5	  CuSO4	   100mM	   2mM	   0.1	   0.1	  Total	  Volume	   	   	   5.0	   5.0	  
 
31| Resuspend the cell pellets from Step 27 in the click reaction cocktail from 
Step 30 by vortexing. 
32| Rotate the reactions at RT for 1–2 h. 
33| Centrifuge the samples for 5 min at 900g, 4 °C, and decant the supernatants. 
34| Wash the cells once with cold 0.5% (wt/vol) BSA in PBS, using the same 
volume as used in click reaction for one sample. 
35| Centrifuge for 5 min at 900g, 4 °C and decant supernatant. 
36| Wash the cells once with PBS, using the same volume as used in click 
reaction for one sample. 
37| Decant the PBS and invert the tubes on a paper towel to remove all PBS. 
  PAUSE POINT The samples can be flash-frozen and stored at − 80 °C for a 
few days. 
 
Cell lysis and sonication ● TIMING 1 h 
38| Prepare the lysis buffer by adding aprotinin and leupeptin before use (see 
REAGENT SETUP) and place on ice. 
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39| Resuspend the samples from Step 37 at a concentration of 1.5 x 107 cells per 
100 μl of lysis buffer and transfer them to 1.5-ml centrifuge tubes on ice. To 
examine DNA fragment size at this step (see Crosslink reversal and DNA 
analysis). 
40| Sonicate the cells by using a microtip sonicator and the following settings: 
pulse: 20 s constant pulse, 40 s pause; power: 13–16 Watts; repeat pulse 1x for 
every 200 μl of cell lysate; total pulse time: 4–5 min per sample. 
  CRITICAL STEP Lysates should appear translucent after sonication and not 
cloudy. Cloudiness is an indicator of an improper ratio of SDS to protein in the 
lysate or of insufficient sonication. Keep the samples on an ice slurry during 
sonication to prevent overheating. 
TROUBLESHOOTING 
41| Centrifuge the samples for 10 min at 16,100g, RT in a tabletop centrifuge. 
  CRITICAL STEP Lysate should appear clear after centrifugation. The presence 
of a white precipitate or a white film on top of the lysate is indicative of insufficient 
clearing of the lysate. 
42| Filter the supernatant through a 90-μm nylon mesh into a new tube. Place the 
tube on ice. 
43| Note the lysate volume. 
44| To examine DNA fragment size at this step (see Cross-link reversal and DNA 
analysis). 
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45| Dilute the lysate 1:1 (vol/vol) with cold PBS containing 1 μg ml − 1 of aprotinin 
and leupeptin. 
  CRITICAL STEP Samples have been diluted to contain 0.5% (wt/vol) SDS and 
25 mM Tris because less efficient biotin capture is observed in lysates containing 
1% (wt/vol) SDS. 
46| Note the final capture volume. 
47| Remove 15 μl of the lysate to save as the input sample for use in Step 64 
and place it on ice. Immediately add 15 μl of 2x SB to this input sample and store 
at − 80 °C. The remaining lysate is used for the streptavidin capture, which is 
described below. 
 
Streptavidin capture of biotin-tagged nascent DNA and associated proteins 
● TIMING 16–20 h 
48| To capture biotin-tagged nascent DNA, each sample from Step 47 is 
incubated with streptavidin-agarose beads at a concentration of 100 μl of bead 
slurry (50 μl packed volume) per 1x108 cells. First, wash sufficient beads for all 
samples together by centrifuging the bead slurry at 1,800g for 1 min at RT. 
49| Slowly and carefully aspirate the storage buffer from the beads. 
50| Wash the beads twice with 1:1 (vol/vol) lysis buffer containing protease 
inhibitors. 
51| Carefully and slowly aspirate the supernatant after each wash in Step 50. 
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52| Wash the beads once with 1:1 (vol/vol) PBS containing aprotinin and 
leupeptin; carefully aspirate the supernatant. 
53| Resuspend the beads in 1:1 (vol/vol) PBS containing protease inhibitors. 
54| Add an equal volume of beads to each sample from Step 47 with a pipette tip 
that is cut at the end. 
55| Rotate the biotin captures in a cold room for 16–20 h (in the dark if 
photocleavable biotin azide is used). 
56| Centrifuge the streptavidin-agarose beads with the captured DNA and 
associated proteins for 3 min at 1,800g, RT. 
57| Very slowly and carefully aspirate most of the supernatant. 
  CRITICAL STEP The supernatant should be light blue/clear with no precipitate. 
TROUBLESHOOTING 
58| Add 1 ml of cold lysis buffer (no additives needed) to wash the beads. 
59| Rotate at RT for 5 min. 
60| Centrifuge for 1 min at 1,800g at RT and carefully aspirate and discard the 
supernatant. 
61| Wash the beads once with 1 ml of 1 M NaCl. 
62| Rotate and pellet the beads by repeating Steps 59 and 60. 
63| Repeat the lysis buffer washes (Steps 58–60) two more times. 
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Elution of proteins bound to nascent DNA● TIMING 1–4 h 
64| Protein elution can be performed using option A (boiling in 2x SB) or option B 
(UV photocleavage), depending on the amount of background observed in the 
negative control. Option B is best suited for proteins that show substantial 
background and require larger amounts of starting material for detection. 
(Elution option A) Boiling in 2x SB  
(i) After the last wash in Step 63, aspirate all of the supernatant. Protein-DNA 
complexes isolated on the beads are called the capture sample.  
(ii) To elute proteins bound to nascent DNA, add 2x SB to packed beads from 
Step 64A(i) (1:1, vol/vol of packed beads; e.g., 100 μl 2xSB/100μl packed 
beads).  
(iii) Incubate the capture sample from Step 64A(ii) and the input sample from 
Step 47 for 25 min at 95 °C to reverse cross-links. 
  CRITICAL STEP Typically, both the input and iPOND-purified capture samples 
should be examined concurrently.  
(iv) Centrifuge the boiled samples for 1 min at 1,800g, RT. The supernatant is the 
ʻ2x eluted captureʼ sample and is ready to use in standard SDS-PAGE and 
immunoblotting procedures (see Step 65). 
(Elution option B) UV photocleavage, TCA concentration and boiling in 2x 
SB  
(i) After the last wash in Step 63, wash one additional time with 1x PBS 
containing leupeptin and aprotinin as in Steps 59 and 60. 
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(ii) Centrifuge for 1 min at 1,800g, RT, and carefully aspirate the supernatant.  
(iii) Add 1:1 (vol/vol) of 1x PBS containing protease inhibitors to the packed 
beads and resuspend by pipetting.  
(iv) Transfer the resuspended beads into a glass vial with a mini magnetic stir 
bar.  
(v) Place the glass vial containing the sample on a magnetic stir plate and adjust 
to stir on the lowest possible speed.  
(vi) Position a UV lamp as close to the glass vial as possible. UV-photoelute at 
365 nm for 2 h at RT.  
(vii) Transfer the bead slurry from the glass vial into a 1.5-ml centrifuge tube.  
(viii) Centrifuge the tube for 1 min at 1,800g, RT to pellet the beads.  
(ix) Carefully remove the supernatant into a fresh tube. This is the ʻUV-
photoeluted captureʼ sample in PBS.  
(x) Optionally, to concentrate the sample using TCA precipitation, proceed to the 
next step. Otherwise, add 1:1 (vol/vol) of 2x SB to the UV-photoeluted capture 
sample, boil at 95 °C for 25 min to reverse cross-links, and then proceed to 
analysis of proteins (Step 65).  
(xi) Add ice-cold 100% TCA to the UV photoeluted capture sample from Step 
64B(ix) to achieve a final concentration of 15% (vol/vol) TCA.  
(xii) Incubate the sample on ice for 30 min.  
(xiii) Centrifuge at 16,100g for 30 min in a cold room.  
(xiv) Carefully remove the supernatant and save it for troubleshooting.  
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(xv) Wash the pellet with 1 ml of ice-cold acetone.  
(xvi) Centrifuge for 10 min at 16,100g in cold room.  
(xvii) Carefully remove the supernatant and save it for troubleshooting.  
(xviii) Air-dry the pellet for 2–3 min until the smell of acetone is undetectable. 
  CRITICAL STEP If the pellet is not visible at this step, spin down the 
supernatant saved from Step 64B(xiv), and then repeat Step 64B(xv–xviii). If no 
pellet is observed, spin down the supernatant previously saved from Step 
64B(xvii) and repeat Step 64B(xviii). 
TROUBLESHOOTING  
(xix) Add 30 μl of 2x SB to the protein pellet to resuspend the sample.  
(xx) Incubate the capture sample (from Step 64B(x) if it is not TCA precipitated or 
from Step 64B(xix) if it is TCA precipitated) and the input sample (from Step 47) 
for 25 min at 95 °C. The samples are ready for use in standard SDS-PAGE and 
immunoblotting procedures. 
 
Analysis of eluted proteins using western blotting ● TIMING 2–3 d 
65| Prepare a standard SDS-PAGE gel [58]. To examine purification of positive 
controls concurrently (a replication protein and a histone, e.g., PCNA and H3, 
respectively), it is useful to prepare a 15% (wt/vol) gel. 
66| To detect purified proteins from input and capture samples (from Step 64A(iv) 
or Step 64B(xx)), load the equivalent of 3 to 6 x 107 cells per well from the total 
protein capture (e.g., 3 to 6 x 107 of 1 x 108). This means that each sample of 1 x 
	   40	  
108 cells yields sufficient sample for analysis of 2–3 immunoblots. For input 
samples, load the equivalent of 0.1% (vol/vol) input per well. 
  CRITICAL STEP Depending on antibody quality, different proteins may require 
more cells for detection than others. This will require empirical determination. 
67| Perform electrophoresis to resolve proteins on the basis of molecular weight, 
and then proceed with standard immunoblotting with desired antibodies 
according to supplier instructions or with MS analysis [59]. 
68| Proteins can be detected by using chemiluminescence (e.g., Western 
Lightning Plus) or quantitative immunoblotting with the Odyssey infrared imaging 
system. 
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Table 2.2. iPOND troubleshooting table. 	  Step	   Problem	   Reason	   Solution	  24	   Poor	  cell	  recovery	   The	  cells	  were	  not	  pelleted	  sufficiently	  during	  the	  centrifugation.	  
Increase	  the	  time	  or	  speed	  of	  the	  centrifugation.	  Be	  sure	  wash	  solution	  contains	  BSA.	  40	   Cell	  lysate	  is	  cloudy	  after	  sonication	   Sonication	  did	  not	  completely	  lyse	  cells	  or	  SDS-­‐protein	  complexes	  precipitate	  from	  solution.	  
Increase	  sonication	  times	  and	  be	  sure	  to	  avoid	  foaming	  of	  samples.	  Ensure	  the	  proper	  volume	  of	  lysis	  buffer	  was	  used	  in	  Step	  39.	  	  56	   White	  precipitate	  layer	  observed	  above	  beads	  after	  centrifugation	  of	  biotin	  captures	  
Lipids	  from	  cell	  membranes	  were	  not	  properly	  pelleted	  after	  sonication	  
Make	  certain	  that	  lysate	  is	  clear	  after	  sonication	  and	  centrifugation.	  	  If	  white	  layer	  is	  observed	  on	  top	  of	  cell	  lysate,	  remove	  lysate,	  and	  clear	  again	  by	  centrifugation.	  64,	  Elution	  Option	  B,	  xviii	   No	  pellet	  is	  observed	  after	  air	  drying	  the	  TCA	  concentrated	  iPOND	  eluate	  	  
Sample	  was	  lost	  during	  TCA	  precipitation	  	   Centrifuge	  the	  supernatant	  saved	  in	  Step	  xiv.	  	  Proceed	  with	  steps	  xv-­‐xviii.	  If	  no	  pellet	  is	  observed,	  centrifuge	  supernatant	  previously	  saved	  in	  Step	  xvii.	  	  Continue	  with	  step	  xix.	  	  68	   High	  background	  signal	  in	  the	  control	  sample	   Protein	  binds	  to	  streptavidin	  beads	  non-­‐specifically.	   Use	  elution	  option	  B,	  increase	  the	  number	  of	  washes	  in	  Steps	  62-­‐63.	  68	   Poor	  signal	  for	  control	  proteins	  like	  PCNA	  in	  the	  experimental	  sample	   Poor	  EdU	  incorporation.	   Increase	  the	  number	  of	  cells	  used	  in	  each	  sample	  and	  ensure	  the	  cells	  are	  growing	  well	  prior	  to	  experiment.	  68	   Poor	  detection	  of	  protein	  of	  interest	  in	  the	  input	  samples	  	   Poor	  antibody	  or	  formaldehyde	  crosslinking	  interferes	  with	  epitope	  detection.	  
Optimize	  immunoblotting	  conditions	  or	  change	  antibody.	  Consider	  increasing	  the	  boiling	  time	  in	  Step	  65Aiii	  or	  Step	  65Bxx	  to	  completely	  reverse	  the	  formaldehyde	  crosslinks.	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Crosslink reversal and DNA analysis 
To examine DNA fragmentation size, cross-links are reversed from lysates 
collected before and after DNA sonication, bound proteins are digested, DNA 
fragments are separated on an agarose gel and analyzed under UV light. 
1. Before sonication (iPOND protocol above Step 39), remove 5 μl of lysate and 
place it on ice. This is the presonication sample. 
2. After sonication and sample filtration (Step 44), remove 5 μl of lysate and 
place it on ice. This represents the postsonication sample. 
3. To all samples, add 90 μl of H2O and 4 μl of 5 M NaCl. 
4. Incubate the samples at 65 °C for 4–16 h. 
5. Add 1 μl of RNase A (20 mg/ ml) to each sample. 
6. Incubate the samples in a 37 °C water bath for 30 min. 
7. Prepare the cross-link reversal solution (see Reagent Setup). 
8. Add 7 μl of cross-link reversal solution to each sample. 
9. Incubate the samples at 45 °C for 1–2 h. 
10. During the incubation time, pour a 1.5% (wt/vol) agarose/TAE gel without 
ethidium bromide. 
11. Add DNA loading dye to 20 μl of sample and load it on a 1.5% (wt/vol) 
agarose gel. 
12. Perform electrophoresis at 75 V for 3 h in 1x TAE buffer to resolve DNA 
fragments. 
13. Stain the gel with ethidium bromide. 
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14. Visualize DNA fragments under UV light. 
 
Native iPOND (developed by Jami Couch) 
iPOND performed without formaldehyde cross-linking (native iPOND) may 
simplify mass spectrometry analyses of purified histones. 
1. Culture 5 x 107 cells in one 150 mm dish per sample. 
2. Label the samples with 10 μM EdU for 60 min. 
3. Collect the cells by scraping on ice. 
4. Collect the pellets by centrifuging at 100g for 5 min at 4 °C. 
5. Discard the supernatant and wash the cells with 5 ml of ice-cold PBS. Collect 
the cells by centrifuging at 100g for 5 min at 4 °C. 
6. Discard the supernatant and lyse the cells by resuspension in ice-cold cell 
lysis buffer with Igepal CA-630 at 1 x 107 cells per ml. 
7. Vortex five times for 5 s with 5 s between pulses. 
8. Collect nuclei by centrifugation at 100g for 5 min at 4 °C. 
9. Discard the supernatant and wash twice in 5 ml cell lysis buffer without Igepal 
CA-630. 
10. Collect nuclei by centrifugation at 100g for 5 min at 4 °C. 
11. Discard the supernatant and resuspend the cells in ice-cold nuclei buffer at 
2.5 x107cells per ml. 
12. Set up click reactions using the formula in Table 2.1. 
13. Incubate for 1 h on a shaker at 4 °C and protect from light. 
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14. Collect the nuclei by centrifugation at 100g for 5 min at 4 °C. 
15. Discard the supernatant and resuspend in ice-cold nuclei buffer at 2 x 107 
cells per ml. 
16. Add EDTA to a final concentration of 1 mM and CaCl2 to 2 mM. 
17. Warm to 37 °C in a water bath and add micrococcal nuclease to 20 Kurntz 
units per 1 x 107 cells. 
18. Incubate the cells at 37 °C for 3.5 min. 
19. Add EDTA to a final concentration of 2 mM to quench the reactions. Collect 
nuclei by centrifugation at 100g for 5 min at 4 °C. 
20. Extract chromatin by discarding the supernatant and resuspending the nuclei 
in ice-cold extraction buffer at 5 x 107 cells per 3 ml. Rotate for 2 h to overnight at 
4 °C, protected from light. 
21. Centrifuge at 16,100g for 5 min at 4 °C to remove all insoluble material. 
Transfer the supernatant to a fresh tube and discard the pellet. 
22. Remove 0.5% of the total volume and save it as the ʻinputʼ sample. To the 
remaining lysate, add 20 μl of streptavidin-agarose beads per 1 x 107 cells. 
Rotate for 1.5 h to overnight at 4 °C, protected from light. 
23. Collect the beads by centrifugation at 1,800g for 1 min. Let the beads stand 
for another min to settle completely. Aspirate and discard the supernatant. 
24. Transfer the beads to a 1.5-ml centrifuge tube. 
25. Wash the beads twice with 1 ml of extraction buffer for 5 min at 4 °C. 
26. Add an equal volume of 2x SB and heat to 95 °C for 10 min. 
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27. Separate the recovered proteins with SDS-PAGE and analyze by 
immunoblotting or mass spectrometry. 
 
 
iPOND methodology for adherent 293T cells 
 
The iPOND protocol, experimental frameworks and treatments used in [1] 
and discussed in Chapters III and IV are described below.  
HEK 293T cells (~1.5-3 x 108 cells per sample) were incubated with 12 μM 
EdU (Vanderbilt Synthesis Core). For pulse-chase experiments with thymidine 
(Sigma), EdU-labeled cells were washed once with temperature and pH-
equilibrated medium containing 10 mM thymidine to remove the EdU, then 
chased into 10 μM thymidine. Other chemicals were added to the cell cultures at 
the following concentrations: HU (3 mM; Sigma), HAT inhibitor anacardic acid (30 
mM; Enzo), HDAC inhibitor FK228 (100 nM; kindly provided by Dineo Khabele), 
Mre11 inhibitor Mirin (100 mM; Sigma), ATM inhibitor (KU55933, 10 mM; 
AstraZeneca), DNAPK inhibitor (KU57788, 1 mM; AstraZeneca), and caffeine (10 
mM; ICN Biomedicals). DMSO was used as a vehicle control where appropriate. 
After labeling, cells were cross-linked, quenched, washed, permeabilized, 
and washed as described in the detailed iPOND protocol above. For the click 
reaction, cells were incubated in click reaction buffer (Invitrogen) for 1–2 h at a 
concentration of 2-3 x 107 cells per milliliter of click reaction buffer. The click 
reaction buffer contains Invitrogenʼs Click-iT cell reaction buffer and cell buffer 
additive (C10269), 2mM copper (II) sulfate (CuSO4), and 1 mM photocleavable 
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biotin azide [60] (kindly provided by Ned Porter). DMSO was added instead of 
biotin-azide to the negative control samples (no clk in all figures). Cell pellets 
were washed once with 0.5% BSA/PBS and once with PBS. 
 Cell lysis, sonication, purifications using streptavidin-agarose beads 
(Novagen), washes, elution of nascent DNA bound proteins, crosslink reversal, 
SDS-PAGE and immunoblotting were performed as detailed in the iPOND 
protocol above. In most cases, quantitative immunoblotting was performed using 
the Odyssey infrared imaging system. 
  
iPOND sample preparation for optimizations and iPOND-MS 
 The iPOND protocol used for proteomics approaches in Chapter III 
(iPOND-MS optimizations) and Chapter V (iPOND-MS screens) employed 
suspension 293T cells. The click reaction cocktail was reconstituted using PBS 
buffer and sodium ascorbate as detailed in the iPOND protocol above. 
 For iPOND-MS optimization experiments (Chapter III), UV photocleavage 
elution and TCA precipitation was performed as described in detail in the iPOND 
protocol above with the following modification. Purified proteins subjected to UV 
photocleavage were incubated at RT for 2 hours without magnetic stirring but 
with gentle mixing by hand every 30 mins. iPOND purifications performed using 
streptavidin-conjugated magnetic beads (Novagen, cat. no. 21344) were 
submitted to MudPIT analysis on a scale of 6x107cells and purifications using 
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streptavidin-conjugated agarose beads (Novagen, cat. no. 69203-3) were 
submitted to MudPIT analyses on a scale of 4x107cells. 
The iPOND-MS screens (Chapter V) used suspension 293T cells 
logarithmically growing at 3.3x106 cells per mL of 500ml cultures (total of 1.6x109 
cells) were pulsed with 12μM EdU (Vanderbilt Proteomics Core) for 15 mins. To 
collect cells for the ʻno clickʼ and elongating fork samples, formaldehyde was 
added to the suspension culture for 20 mins at a final concentration of 1% to halt 
cell processes, and crosslinking was quenched using glycine to a final 
concentration of 0.125M. For stalled and collapsed fork samples, EdU pulsed 
samples were chased into 3mM of HU by directly adding HU to EdU-containing 
cell cultures for 2 hours. In addition, the collapsed fork sample was co-treated 
with 3μM of ATR inhibitor (Vertex) [61, 62]. The thymidine chase sample was 
pulsed with EdU for 13 mins, cells were spun down at 1,000rpm for 4 mins, 
media was decanted carefully and cells were resuspended by pipetting using 
media equilibrated for temperature and pH (overnight) containing 10μM 
thymidine. The thymidine chase was conducted for 60 mins, cells were fixed with 
1% formaldehyde for 20 mins at RT, and crosslinking was quenched for 5 mins at 
RT using a final glycine concentration of 0.125M. 
Fixed samples were split evenly into 6 of 50ml conical tubes, spun down at 
2,000rpm at 4°C for 6 mins, washed 3 times with 1x PBS at RT and frozen at -
80°C. Five of the 6 tubes were independently processed on a scale of 2.7x10^8 
cells per sample for iPOND purifications. The conditions for permeabilization, 
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click chemistry, cell lysis, sonication, 18 hour purifications using streptavidin-
conjugated agarose beads (Novagen, cat. no. 69203-3) and washes are 
described in detail in the iPOND protocol above and detailed [57].  Purified 
replication fork proteins were eluted under reducing conditions by boiling in 2x 
sample buffer for 25 mins. The equivalent of 4x107 cells per sample were 
resolved 1cm into on a 10% Novex precast gel (Invitrogen) for 5 mins.  Gels were 
stained using Coomassie Blue (Invitrogen) and de-stained over-night according 
to manufacturerʼs standard instructions. The resolved proteins were excised from 
the gels at the Vanderbilt Proteomics Core, alkylated, and in-gel trypsin digested 
using standard procedures (performed by Hayes McDonald). 
 
Multidimensional Protein Identification Technology (MudPIT) (performed by 
Hayes McDonald) 
Recovered tryptic peptides were subjected to two-dimensional LC-MS/MS 
(MudPIT) separation as previously described [63] and [64]. Briefly, digested 
peptides were loaded onto a pre-column containing materials for reversed phase 
(RP) followed by strong cation exchange (SCX) separations. Peptides eluted 
from the SCX using seven 10 min salt pulses of increasing concentrations were 
separated by an RP gradient, ionized into an LTQ-XL mass spectrometer 
(Thermo Fisher Scientific), and MS/MS spectra were collected.  
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Mass spectrometric data analysis (performed by Hayes McDonald) 
The peptide spectral data was searched against the UniProt human 
protein database using the Myrimatch [65], Sequest [66], and Myrimatch and 
Sequest [67] database search engines.  Protein groups were assembled using 
IDPicker, which uses parsimony to report the minimum number of confident 
protein identifications [68]. Matched peptides were filtered at a 5% peptide and 
protein false discovery rate and each protein required a minimum of 2 
independent peptides for identification. Protein identifiers were converted to 
EntrezID unique identifiers using the UniProt ID mapping database [69] and the 
DAVID bioinformatics database [70, 71]. Unmapped identifiers were excluded 
from the final protein list reporting enriched proteins.  
  
QuasiTel statistical analysis and protein enrichment filtering criteria 
To determine fold enrichments of proteins relative to the negative controls, 
spectral count data was imported into the statistical software program QuasiTel 
[72] for pair-wise comparisons (performed by Hayes McDonald). QuasiTel 
applies a quasi-likelihood model to raw spectral count data and reports protein 
fold enrichment and statistical significance as a quasi p-value. Spectral count 
data is normalized for each MudPIT run using the total number of spectra 
reported for the run. The threshold for spectral counts was set at an average of 1 
spectral count per 1 experimental sample. For example, when comparing the 5 
replicates from the replication fork sample to the 5 replicates from the chromatin 
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chase sample, a minimum of 5 spectral counts was required in the replication 
fork sample for consideration in QuasiTel. Furthermore, to be considered a 
protein significantly enriched on nascent DNA, the filtering criteria required a 
minimum of 1.5-fold enrichment above both negative controls and a quasi p-
value of less than or equal to 0.05. 
These filtering criteria were applied to proteins identified using each of the 
three protein identification search types (Myrimatch plus Sequest, Myrimatch 
alone and Sequest alone). Therefore, 3 separate lists of enriched proteins were 
generated independently. The final lists reported in Tables 5.2, 5.3, and 5.4 
represent the union of all 3 lists and contain all the proteins that passed the fold 
enrichment and p-value filtering criteria in at least 1 of the 3 lists. The tables 
report the median number derived for fold enrichment relative to the chromatin-
bound negative control, p-value, and spectral counts. 
 
Bioinformatics data analyses 
Proteins identified at elongating, stalled and collapsed replication forks 
were classified based on gene ontology using ToppGene [73]. To display median 
fold enrichment relative to the chromatin chase control, median quasi p-value, 
and median spectral counts from the experimental sample were graphed using R 
(performed by Yaoyi Chen). Protein network modeling was performed using the 
GeneMANIA prediction server [74] and queried for physical interactions, 
functional pathways, and shared protein motifs.  
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Hypergeometric hypothesis testing of the significance of ATM/ATR 
substrates identified in the iPOND-MS screen was performed in R using the 
following command line: > phyper(18,700,20000-700,290, lower.tail=F). The 
values represent the following: 18 is the number of proteins identified at normal 
replication forks to be ATM/ATR substrates, according to reference [41] where 
over 700 ATM/ATR substrates were identified; 20,000 represents a conservative 
estimation of the total number of proteins in the human proteome [75]; 290 is the 
number of total proteins significantly enriched at normal, stalled and collapsed 
replication forks in the iPOND-MS screen. 
 
Selected reaction monitoring (SRM) label-free quantitative MS (performed by 
David Friedman) 
Sample preparation on a smaller scale was performed similarly to iPOND 
purifications detailed for MudPIT analyses. Three independent biological 
replicates were prepared in 200mL HEK 293T suspension cultures at a 
concentration of 3x x106 cells per ml. Five iPOND samples were processed using 
the experimental frameworks detailed in the MudPIT section above. Unscheduled 
runs were performed to examine the signal intensity and retention times for 60 
proteins of interest by monitoring 3 transition states per peptide. Peak picking 
and signal intensity was performed using Skyline [76]. Signal intensities for each 
peptide were normalized to the sum of the intensities of the internal reference 
peptides.  
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DNA fiber labeling 
 Loss of function studies with SMARCA1 were performed using the 
following siRNAs (Dharmacon): 
SMARCA1_1 target sequence GAAGAAACCAGUACGUGUA 
SMARCA1_2 target sequence CAACGAGAAUGGUAUACAA 
 Briefly, U2OS cells were plated at 2x105 cells and reverse transfected with 
40pmol of siRNA using Dharmafect1 lipid reagent.  Following 48 hours of 
knockdown, cells were pulse labeled for 20 mins with the nucleoside analog IdU 
(20μM), washed twice with pH and temperature equilibrated HBSS, pulsed with 
CldU (100μM), washed twice with HBSS, and collected with trypsin. Diluted and 
resuspended cells were lysed using spreading buffer (0.5% SDS, 200mM Tris-
HCl pH 7.4, 50mM EDTA), fibers were spread by tilting slides at 15 degrees and 
fixed with methanol:acetic acid (3:1).  For staining, slides were treated with 2.5M 
HCl, blocked with 10% goat serumin PBST (0.1% Triton), stained with rat 
monoclonal anti-BrdU antibody recognizing CldU and mouse anti-BrdU 
recognizing IdU. Secondary Alexa Fluor 594 and 488 antibodies were used to for 
fluorescent detection of fibers. Immunofluorescent images were captured using a 
Zeiss Axioplan microscope equipped with a Zeiss camera. To quantify fibers 
containing IdU (green) followed by CldU (red) tracks, immunofluorescent images 
captured from 2 independent slides per each sample were measured from 100 
fibers per sample using the Axiovision software.  
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CHAPTER III 
 
DEVELOPMENT OF iPOND (isolation of Proteins On Nascent DNA) 
TECHNIQUE* 
 
Introduction 
During S-phase, DNA replication and chromatin assembly are coordinated 
at the replication fork to duplicate the genome and epigenome rapidly and 
accurately. DNA template damage and other forms of replication stress challenge 
genetic stability and activate a DNA damage response [14]. This signaling 
pathway protects and repairs damaged replication forks to promote successful 
completion of chromosome replication and prevent diseases such as cancer [77]. 
To date, the main tool available for detecting protein accumulation at 
replication forks or damaged sites has primarily relied on immunofluorescence 
imaging. While a useful method, immunofluorescence imaging suffers from low 
resolution, poor sensitivity and a requirement for highly specific antibodies [52]. 
Other methods such as chromatin immunoprecipitation (ChIP) have limited 
applicability to mammalian cell replication because of difficulties in obtaining 
synchronous cultures and the lack of highly efficient, sequence-specified origins 
of replication [12]. Purification of replisome protein complexes through protein-
protein interactions is useful to identify potential components, but it provides 
limited spatial information about protein localization. 
 
*This Chapter contains the iPOND protocol from reference [57] and excerpts from 
reference [1]. 
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To overcome these technical challenges, I developed iPOND (isolation of 
Proteins On Nascent DNA) [1, 57]. In this chapter, I describe the development of 
iPOND as a useful tool for purifying and monitoring replisome and chromatin 
assembly dynamics in mammalian cells. In addition, I describe several iPOND 
experimental frameworks useful for monitoring the recruitment of proteins to 
elongating and damaged replication forks with spatial and temporal resolution 
previously unachievable. This chapter provides evidence for the power of 
employing iPOND in studies of genome and epigenome inheritance during DNA 
replication.   
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Results 
 
iPOND overview 
The iPOND methodology enables the purification of proteins bound 
directly or indirectly to the nascent DNA at replication forks. The method relies on 
labeling short fragments of nascent DNA with EdU, a nucleoside analog of 
thymidine [78]. EdU contains an alkyne functional group that permits copper-
catalyzed cycloaddition (click chemistry) [79] to a biotin azide to yield a stable 
covalent linkage (Fig. 3.1). This reaction effectively biotin tags the EdU-labeled 
nascent DNA. The cells are then fixed with formaldehyde, which serves to both 
stop DNA replication and cross-link protein-DNA complexes (Fig. 3.2). Some 
DNA fragmentation occurs during this step because of copper-catalyzed 
hydrolysis of the DNA [80]. Cells are then lysed in denaturing conditions and 
sonication completes the DNA fragmentation producing solubilized DNA-protein 
complexes. Streptavidin-coated beads purify the nascent, EdU-labeled DNA-
protein complexes.  
Next, the proteins are eluted from the complexes. For most applications, 
boiling in SDS sample buffer is sufficient to reverse cross-links and solubilize 
proteins after purification (Fig. 3.2, see elution option A discussed in Chapter II). 
However, this method also releases any proteins that bind to the bead matrix 
nonspecifically and does not release the DNA from the beads. The use of a 
cleavable biotin azide in the click reaction facilitates elution in milder conditions to 
improve specificity and recovery of the DNA (discussed in Chapter II).  
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Figure 3.1. Click chemistry addition of biotin tags to nascent DNA. EdU incorporated into nascent 
DNA is covalently tagged with biotin in the copper-catalyzed click reaction. Orange color 
represents the azide (biotin-N3) and alkyne (EdU) functional groups involved in the click 
chemistry reaction. 
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Figure 3.2. Schematic overview of the iPOND procedure. The iPOND procedure consists of 
pulsing cells with EdU to label nascent DNA in vivo, formaldehyde cross-linking protein-DNA 
complexes, covalently tagging EdU-labeled DNA with biotin by using click chemistry, lysing and 
sonicating cells, purifying the solubilized protein-DNA complexes and eluting bound proteins for 
analysis by SDS-PAGE, and immunoblotting or MS.  
. 
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This elution option may be useful in experimental systems where biotinylation of 
endogenous proteins is a concern. Several cleavable biotin azides have been 
described and we have used a UV-photocleavable biotin-azide synthesized by 
Ned Porterʼs group at Vanderbilt [60, 81].  
Lastly, to detect the purified proteins and post-translational modifications 
(PTMs) we can use standard immunoblotting or mass spectrometry (MS) 
methodologies. It may be beneficial to omit the formaldehyde cross-linking step, 
which may complicate proteomics analyses of proteins and particularly PTMs on 
lysine residues if the cross-links are not fully reversed. Jami FB Couch has 
adapted the iPOND protocol without cross-linking using the Igepal nondenaturing 
detergent in the lysis step and a reduced salt concentration in the wash steps 
(see Chapter II for native iPOND protocol developed by Jami FB Couch). 
 
iPOND proof of concept 
To validate the iPOND methodology, I first asked whether I could 
specifically detect replisome proteins on purified nascent DNA. I labeled cells 
with EdU for 10 mins, then performed iPOND. One important control to interpret 
iPOND results is analogous to the pre-immune control used in co-
immunoprecipation experiments. To test whether detection of replication proteins 
is specific to the purification of nascent DNA, the biotin azide was omitted from 
the click reaction of one sample (Fig. 3.3B lane 3, labeled ʻno clkʼ). No replication 
proteins were detected in this sample, indicating that protein-DNA complexes are 
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not purified in the absence of click chemistry (Fig. 3.3B, lane 3). An alternative 
control was a sample in which the cells were not incubated with EdU (Fig. 3.3C, 
labeled EdU min 0). If any protein were detected in the ʻno clickʼ negative control, 
it would represent nonspecific protein interactions with the streptavidin matrix.  
In contrast, after covalent tagging of EdU-labeled nascent DNA with biotin 
using click chemistry, we detected proliferating cell nuclear antigen (PCNA), 
chromatin assembly factor 1 (CAF-1), replication protein A (RPA), and two 
subunits of polymerase epsilon (Fig. 3.3B). These results indicate that iPOND 
can purify replisome proteins, including those indirectly bound to DNA such as 
CAF-1 [4]. Furthermore, they indicate that iPOND is a sensitive methodology that 
detects proteins such as POLE2 and POLE3, which are replisome components 
expected to be at a density of only one or two molecules per replication fork. 
Thus, unlike immunofluorescence, iPOND does not require high concentrations 
of proteins within a small nuclear region to track protein localization. It should be 
noted that proteins such as GAPDH that are not affiliated with DNA replication 
are not detectable in iPOND captures (data not shown). 
To ensure that a purified protein is enriched particularly at replication 
forks, a second control is essential. This is a sample in which EdU labeling of 
cells is followed by incubation with thymidine for several mins before sample 
collection (a chase sample). A true replisome protein that travels with the 
replication fork should be associated with DNA only before the thymidine chase  
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Figure 3.3. Development and proof-of-concept of the iPOND technology. (A) Average DNA 
fragments obtained before and after sonication of cell lysates used for iPOND purifications. (B) 
Cells were incubated with EdU for 10 mins prior to performing iPOND. Cells expressing POLE2-
HA or POLE3-HA were used to detect these proteins with the HA antibody. (C) Cells were 
incubated in EdU-containing medium for increasing times prior to performing the iPOND protocol. 
(D) Cells were incubated with EdU for 10 mins. The EdU-containing medium was removed and 
cells were washed once before incubating for increasing times in medium containing 10 mM 
thymidine prior to performing iPOND. In all experiments, the No Clk control is the input sample in 
the first lane processed with no biotin-azide. Jami FB Couch performed the experiments in Fig. 
3.3A and directed Jordan Feigerle in performing the experiment in Fig. 3.3B.   
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because the ʻchaseʼ fragment is located at a distance from the moving replication 
fork (Fig. 3.4A). In contrast, other chromatin-bound proteins such as histones 
may be detected in both samples because they are not specifically part of the 
replisome. 
Such an experimental pulse-chase framework was used to monitor 
nascent DNA-associated proteins at greater and greater distances from the 
moving fork. Cells were labeled with EdU, and then chased into thymidine for 
increasing amounts of time (Fig. 3.3D). In these experiments, histone levels 
remain constant, indicating that the procedure effectively captures a maturing 
chromatin segment of constant length. However, the replication fork proteins 
PCNA and CAF-1 levels purified with the EdU-labeled segment decline rapidly 
following the thymidine chase (Fig. 3.3D). These data indicate that iPOND 
isolates chromatin-associated proteins specifically located at the replication fork. 
Furthermore, this evidence suggests that PCNA and CAF-1 are rapidly unloaded 
and recycled once DNA synthesis of Okazaki fragments is completed on the 
lagging strand. 
To test the minimum amount of EdU pulse time needed to detect 
replisome proteins, time-course experiments were performed with increasing 
EdU labeling times (Fig. 3.3C). PCNA and CAF-1 were detected after a 2.5-min 
pulse of EdU, histones H2B and H3 after 5 mins, and the linker histone H1 at 20 
mins after EdU addition (Fig. 3.3C). It should be noted that interpreting 
differences in the signal intensities between different proteins is difficult since 
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different antibodies have varying antigen avidities. Nonetheless, the deposition of 
H1 on maturing chromatin is supported by independent iPOND proteomics 
screens [82] and previous fractionation data indicating that H1 is added 10-20 
mins after DNA replication to create higher-order chromatin structures [82, 83]. 
Therefore, my analysis indicates that a 2.5-min incubation with EdU is sufficient 
to capture replisome proteins and that longer incubations with EdU are required 
to isolate newly deposited chromatin. 
The spatial and temporal resolution achieved with iPOND depends on the 
size of the DNA fragments generated after cell lysis, the rate of DNA synthesis 
and the EdU pulse time. In practice, we consistently obtain DNA fragments of 
~100-300 base pairs (bp) (Fig. 3.3A), meaning that the latter two parameters 
dictate iPOND resolution. In mammalian cells, the rate of DNA synthesis varies 
between 0.75 and 2.5 kb/min [84]. Thus, a 2.5-min EdU pulse labels ~ 2–6 kbp, 
although this is likely a significant overestimation, since EdU must enter the cell 
and be phosphorylated before incorporation into DNA. Therefore, iPOND 
resolution is currently on the order of a few thousand base pairs. 
 
Experimental designs 
 
Thus far, I have described the utility of iPOND for identifying proteins 
associated with active replisomes (Fig. 3.3) by combining iPOND within a pulse-
chase experimental framework (Fig 3.4). This experimental design is also the 
method of choice for the second major iPOND application—monitoring changes 
in chromatin located at various distances from the replication fork.  
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Figure 3.4. Schematic of the experimental designs used to identify replisome or DNA damage 
proteins and modifications at the replication fork. (A) To identify replisome proteins, a pulse-chase 
variation of the iPOND protocol uses a thymidine chase to move the nascent, EdU-labeled DNA 
segment away from the replication fork. The chase sample provides a control to distinguish 
replisome components from general chromatin-binding factors. (B) To study proteins and 
modifications associated with damaged replication forks, an agent that stalls replication forks, 
such as HU, is added after the EdU-labeling period. 
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Chromatin reassembly after passage of the replication fork occurs as a function 
of time and hence distance from the elongating fork [3]. iPOND can be used to 
purify histones on a segment of EdU-labeled DNA after various times of 
thymidine chase, which permits an analysis of how chromatin architecture is 
restored behind the elongating fork. In Chapter IV, I use this experimental design 
to document the timing of the deacetylation of newly synthesized histone H4 after 
deposition. 
Additionally, iPOND can be used to detect protein recruitment or post-
translational modifications of proteins at damaged forks. The procedure in this 
case is to pulse for a short time with EdU, then to add a replication stress agent 
such as hydroxyurea (HU) or camptothecin (Fig. 3.4B). HU is particularly useful 
as high concentrations largely stop fork movement, facilitating an analysis of 
transiently or persistently stalled forks (evidenced in Chapter IV). Combining the 
DNA damaging protocol with the pulse-chase procedure also enables an 
examination of DNA damage–dependent events at different distances from the 
damaged fork. In Chapter IV, an example of this procedure demonstrates the 
spreading of histone variant H2AX phosphorylation from an HU-stalled fork.  
Thus, the high spatial resolution of iPOND is derived from the capacity to 
measure the position of protein changes in relation to the replication fork.  
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Discussion 
 
iPOND comparison to other methods 
Compared with conventional indirect immunofluorescence, iPOND has an 
improved sensitivity of detection since even low-abundance replisome proteins 
such as polymerases are isolated (Fig. 3.3B). It also provides improved spatial 
and temporal resolution. Although an enhanced imaging technique permits 
single-molecule detection of replisome proteins in bacteria [85], unlike imaging, 
iPOND is compatible with unbiased approaches for protein identification such as 
MS. 
ChIP is a powerful substitute for several iPOND capabilities in organisms 
such as S. cerevisiae that have highly efficient, sequence-defined origins of 
replication and cell cycle synchronization is easily achieved. ChIP has the 
advantage of being more sensitive than iPOND as it detects DNA sequences 
after PCR amplification. However, ChIP requires highly specific, often unavailable 
antibodies and is not compatible with unbiased approaches such as MS. 
Moreover, although ChIP has been used in mammalian systems to examine 
protein recruitment to origins of replication [86], it is generally not useful for 
studying the dynamic processes associated with fork elongation and chromatin 
maturation. Finally, adapting ChIP to studying damaged replication forks in 
mammalian cell culture awaits the development of ways to engineer site-specific 
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DNA lesions that stall forks with high efficiency as has been done using Xenopus 
egg extracts to study interstrand cross-link repair [26, 27]. 
The most comparable technology to iPOND is the immunoprecipitation of 
nascent DNA-protein complexes with antibodies to halogenated nucleoside 
analogs, which was used to examine the recruitment of the homologous 
recombination factor RAD51 to sites of replication fork stalling [87]. However, the 
relatively low affinity of this antibody-epitope interaction and the requirement for 
DNA denaturation for antibody access necessitated a long chlorodeoxyuridine 
(CldU)-labeling period (40 min), providing little advantage over biochemical 
fractionation of chromatin. In principle, biotin-dUTP could be used directly to label 
the nascent DNA, thus avoiding the need to perform the click chemistry reaction. 
However, biotin-dUTP is not cell permeable, thus necessitating some cellular 
manipulation to introduce it into cells, and the large biotin tag may interfere with 
DNA structure and protein associations with DNA. 
 
iPOND limitations and other considerations 
Currently, the major limitation of iPOND is the large amount of starting 
material needed. Each sample requires approximately 1x108 cells for efficient 
iPOND capture of replisome proteins with a 10 min EdU incubation. The large 
number of cells needed for the procedure is dictated by the sensitivity of the 
immunoblotting and MS detection methods. This cell number is based on 
unsynchronized cultures of 293T cells in which about 50% of the cells are in S-
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phase at the time of the experiment. Synchronizing cells such that 100% are in S-
phase would reduce the cells needed, whereas the use of cell types with fewer 
replicating cells would increase it. Although these cell numbers are large, they 
are obtainable by using standard cell culture methods. 
iPOND is currently an ensemble methodology, meaning that the data 
comes from hundreds of replication forks in millions of cells. It provides a picture 
of an average replication fork and cannot distinguish the significant heterogeneity 
between cells in the population or between forks within different genomic regions. 
Thus, identification of two proteins by iPOND does not mean the two proteins are 
necessarily recruited to the same nascent DNA segment. Coupling iPOND to 
single molecule analyses (iPOND-SM) of endogenous or tagged proteins of 
interest would provide improved resolution to the technique.  iPOND-SM could 
answer questions about the relative location of proteins on nascent or mature 
DNA. For example, at what distance away from the replisome does a nascent 
histone become a parental histone? A broad answer to this question can be 
gained with current iPOND techniques (explored in Chapter IV). However, 
dissecting out the molecule per molecule differences in progressing from new to 
old histone could be achievable using iPOND-SM (discussed further in Chapter 
VI). 
Finally, iPOND resolution may be improved in a system in which EdU 
exists as the sole nucleoside to pair with adenosine. This could be achieved in a 
cellular system such as Xenopus, in which dNTPs are added in a controlled 
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manner for incorporation into nascent DNA. Such studies have been successfully 
employed to study sister chromatin cohesion, which is a replication-coupled 
process (Susannah Rankin, Oklahoma Medical Research Foundation, 
unpublished results). 
 
iPOND applications (detailed further in Chapter VI) 
The iPOND experimental designs described above could be quite powerful 
when combined with genetic or small molecule–mediated inactivation of specific 
pathways that regulate DNA replication, chromatin deposition and maturation, 
and DNA repair. iPOND is compatible with proliferating cell types and we have 
used it successfully in HEK293T, NIH3T3 and mouse embryonic fibroblasts (see 
MEF results in Chapter IV). Thus, cell lines engineered to have mutations in 
specific pathways can be used directly with iPOND without any major 
modifications to the protocol.  
iPOND can also be extended for use beyond mammalian cell culture. Any 
cell type that can incorporate EdU during DNA synthesis (or be engineered to 
use EdU) can be used. In fact, we have used iPOND to purify DNA-protein 
complexes from the yeast Saccharomyces cerevisiae, although substantial 
optimization will be required to improve purification efficiency (Jami FB Couch, 
unpublished observations). 
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Furthermore, combining iPOND with quantitative MS should be a valuable 
methodology for identifying new replisome and DNA damage response proteins.  
This application (iPOND-MS) is the topic of Chapter V.  
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CHAPTER IV 
ANALYZING PROTEIN DYNAMICS AT NORMAL, STALLED AND COLLAPSED 
REPLICATION FORKS* 
 
Introduction 
 In the previous chapter, I described the rationale and development of 
iPOND as a biochemical method to purify replication forks and the associated 
proteins from mammalian cells. In this chapter, various iPOND experimental 
frameworks are used to examine the timing and spatial distribution of processes 
that maintain the epigenome and genome after replication fork passage and DNA 
damage.  
One mechanism necessary for maintaining epigenetic inheritance through 
DNA replication involves the timely removal of histone marks present on nascent 
histones (predeposition marks). This process of ʻchromatin maturationʼ is coupled 
to replication fork passage. In the first part of this chapter, I demonstrate that 
histone deacetylases remove the replication-coupled pre-deposition marks on 
histone H4, which are catalyzed by the HAT1 acetyltransferase. 
In the second part of this chapter, how replication forks respond to DNA 
damage that slows fork progression is analyzed. Replication fork stalling causes 
changes in the recruitment and phosphorylation of proteins at the damaged forks.  
 
 
 
 
*The majority of this chapter has been published in reference [1] and a portion has been 
published in reference [88]. 
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We show that checkpoint kinases catalyze phosphorylation of the histone variant 
H2AX and this mark spreads from the stalled fork to encompass adjacent 
chromatin domains. A switch in the damage response occurs at persistently 
stalled forks leading to assembly of the RAD51 recombinase. This loading 
depends on DNA end resection. Collectively, this chapter establishes the utility of 
iPOND for analyzing epigenomic and genomic processes occurring at active, 
stalled, and collapsed replication forks. 
  
	   72	  
Results 
 
Analysis of DNA-replication coupled chromatin maturation 
Maturation of the new chromatin requires addition and removal of histone 
post-translational modifications. Newly synthesized histone H4 imported from the 
cytosol is acetylated on two lysines (5 and12), and these evolutionarily conserved 
marks are removed after deposition [5, 89].  
The B type histone acetyltransferase HAT1 has been assumed to catalyze 
the formation of H4K5ac/H4K12ac during chromatin assembly [90, 91]. This 
hypothesis has not been formally tested in the mammalian system due to the lack 
of genetic and biochemical tools. Mark Parthunʼs laboratory has recently 
constructed a conditional mouse knockout model of HAT1 (in press). I used 
iPOND pulse-chase experiments to examine the acetylation status of H4 on K5 
and K12 following histone deposition at replication forks (Fig. 4.1). In HAT1 
homozygous null MEFs, H4K5/K12 acetylation is absent from nascent chromatin. 
This suggests that HAT1 is the replication-coupled acetyltransferase that 
modifies H4K5/K12 in higher organisms (Fig. 4.1).  
Following deposition of acetylated H4K5 (H4K5ac) and H4K12ac, time 
course experiments reveal that acetylated H4K5 is removed rapidly and H4K12ac 
deacetylation is slightly delayed (Fig. 4.2.A,B). The delay in K12 deacetylation 
could be due to the activity of chromatin-associated histone acetyltransferases 
that promote the acetylation of this site in some chromatin domains.  
	   73	  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.1. Hat1 is required for the acetylation of histone H4 deposited during replication-coupled 
chromatin assembly. Hat1+/+ and Hat1-/- MEFs were pulse-labeled with EdU for 15 mins and 
chased with thymidine for 90 mins as depicted in the experimental schematic. Proteins 
associated with nascent DNA were purified using iPOND and immunoblottted for the indicated 
proteins and histone post-translational marks. No clk represents the lack of biotin-azide in the 
click reaction that prevents biotin-tagging of nascent DNA. 
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Figure 4.2. Deacetylation of newly deposited histone H4 depends on HDACs and is independent 
of replication fork movement. (A–E). Cells were labeled with EdU for 10 mins followed, by a chase 
into thymidine-containing medium for the indicated times prior to performing iPOND. (B) 
Quantitation of H4 acetylation levels compared with total H4 in the click reaction samples from 
three independent experiments. Error bars in all figures are standard deviations. (C,D) Anacardic 
acid (30 mM) was added to the indicated samples. (E) HU (3 mM) was added to the indicated 
samples. (F) Cells labeled with EdU were chased into 3 mM HU medium with or without 100 nM 
FK228 prior to performing iPOND. Experiments in panels C and D were performed by Jami FB 
Couch. 
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Indeed, in the presence of the nonselective HAT inhibitor anacardic acid, the rate 
of H4K12 deacetylation becomes identical to H4K5, with a half-life of <20 mins 
(Fig. 4.2C,D).  
In principle, chromatin maturation—as measured by H4K5/K12 
deacetylation—could be coupled to fork progression. To test this hypothesis, I 
used high concentrations of hydroxyurea (HU) to stall active replisomes and stop 
DNA synthesis. HU addition stalls the fork effectively in these cells, since the 
amount of histone capture does not increase appreciably during the HU 
treatment (Fig. 4.2E). Deacetylation of newly deposited H4 proceeds at the same 
rate regardless of whether DNA synthesis is inhibited. Thus, chromatin 
maturation can be uncoupled from replisome movement. 
The histone deacetylase (HDAC) in human cells that catalyzes the 
deacetylation of H4K5 and K12 is unknown. HDAC1 and HDAC2 associate with 
CAF-1 [92], and HDAC3 is required—perhaps in late S phase or G2—to remove 
H4K5ac [93]. Indeed, in pulse-chase experiments, an enrichment of HDAC1, 
HDAC2, and HDAC3 is evident near the fork (Fig. 4.2A), and the selective class I 
HDAC inhibitor FK228 [94] prevented deacetylation of H4 (Fig. 4.2F), suggesting 
that all three of these HDACs are involved. 
 In addition to studying epigenetic events coordinated with ongoing DNA 
replication, iPOND permits the analysis of genome maintenance activities after 
damage encountered at replication forks. The next section analyzes replication 
forks that stall and eventually collapse after prolonged replication stress. 
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DDR response at stalled replication forks 
HU treatment causes DDR activation to stabilize the stalled fork and 
induce a cell cycle checkpoint. Previous studies suggest that HU-stalled forks 
remain stable and competent to resume DNA synthesis for several hours; 
however, eventually, the stalled fork collapses and DSBs are formed [87].  
To further examine this process, we monitored recruitment and 
modification of proteins at stalled forks. The amounts of PCNA and CAF-1 that 
are captured at the stalled fork decrease initially after adding HU to the medium, 
and then reach a steady state level of between 20% and 30% of that found at an 
elongating fork (Fig. 4.3A). This PCNA pattern is likely due to unloading of PCNA 
from the completed Okazaki fragments.  
We detected RPA associated with the fork both before and after HU 
addition (Fig. 4.3A). The amount of RPA detected remained constant even 
though RPA accumulates at stalled forks [14]. This discrepancy is explained 
because RPA binds only to the single-stranded, template strand of DNA, which 
lacks incorporated EdU. Therefore, iPOND detects only the RPA immediately 
adjacent to the newly synthesized dsDNA (Fig. 4.3D).  
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Figure 4.3. iPOND monitors post-translational modifications and recruitment of DDR proteins to 
stalled and collapsed replication forks. (A–D) Cells were labeled with EdU for 15 mins (A) or 10 
mins (B–D), followed by a chase into HU for the indicated times prior to performing iPOND. (D) 
Diagram for iPOND isolation of RPA bound adjacent to ssDNA-dsDNA junction at stalled 
replication forks. 
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In time course experiments, I noticed that at 120 and 240 minutes after 
addition of HU, the electrophoretic mobility of RPA decreased, consistent with 
phosphorylation (Fig. 4.3A). RPA S33 phosphorylation could be detected within 
10 minutes of HU addition, and S4/S8 phosphorylation appeared at 2 hours (Fig. 
4.3B). DNA-PK catalyzes S4/S8 phosphorylation and ATR catalyzes S33 
phosphorylation [95], suggesting that ATR phosphorylates RPA immediately after 
fork stalling, and DNA-PK phosphorylates RPA only at persistently stalled forks. 
H2AX phosphorylation (γH2AX) is often considered a marker for DSBs 
[96]. However, I observed γH2AX at stalled replication forks at even the earliest 
time points (10 minutes) after HU addition (Fig. 4.3B), well before evidence of 
DSB formation [87]. These data prompted us to examine the timing of recruitment 
of DSB repair proteins. MRE11, KU70, and KU80 exhibited a recruitment profile 
in which low amounts were observable before the addition of HU, and remained 
unchanged for 2 hours after HU addition (Fig. 4.3C).  
However, by 4 hours in HU, a significant increase was detected in all of 
these proteins near the stalled fork (Fig. 4.3C). RAD51 was first detectable after 
HU addition, but its levels also increased significantly by 4 hours, suggesting that 
DSBs may form between 2 and 4 hours after the fork is stalled. KU70 and KU80 
may bind to some of the single-ended breaks, and RAD51 may bind to others. An 
additional interpretation is that RAD51-mediated recombination and fork 
regression occurs at some stalled replication forks [87]. It is likely that both DSBs 
and HR occur following prolonged exposures to replication stress.  
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Figure 4.4. MRE11 promotes Rad51 accumulation at persistently stalled replication forks. EdU 
pulsed cells were treated with HU with or without the Mre11 inhibitor mirin (100 mM) as indicated. 
Experiment was performed by Jami FB Couch.  
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At DSBs, MRE11-dependent end resection is required to load RAD51 [97]. 
At collapsed forks, RAD51 may function to promote recombination-based 
methods to re-establish the replication fork [98]. To test whether the loading of 
RAD51 at stalled forks also requires MRE11, cells were treated with the MRE11 
nuclease inhibitor mirin [99]. Although the early recruitment of RAD51 occurred 
independently of MRE11, later accumulation required MRE11 activity (Fig. 4.3D), 
suggesting that end resection promotes this loading. The timing of MRE11 
recruitment also correlated with increased RPA S4/S8 phosphorylation (Fig. 
4.3C), which was been previously linked to DNA end resection at camptothecin-
damaged forks [100]. 
 
 γH2AX spreading from stalled forks before and after fork collapse 
I noticed that the rapid phosphorylation of H2AX near the fork saturates 
within 30 minutes; however, global levels (observed in inputs) continue to 
increase (Fig. 4.3B). One explanation for this observation is that the global 
increase stems from H2AX phosphorylation in regions adjacent to the stalled 
replication fork. This type of γH2AX spreading has been observed near DSBs 
where ATM promotes phosphorylation of H2AX immediately at the damage site 
and in chromatin surrounding the break to facilitate amplification of the DDR [101, 
102].  
To test the hypothesis that γH2AX spreads from stalled replication forks, 
cells were first labeled with EdU, then chased with thymidine for various lengths 
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of time to extend the distance between the EdU-labeled fragment and the fork, 
and finally added HU to stall the fork. We again observed maximum γH2AX at the 
fork 30 minutes after HU addition; however, the chromatin region distant from the 
fork contained low but detectable levels of γH2AX that increased when examined 
at 60 minutes after HU addition (Fig. 4.5A).  
A more detailed analysis revealed that the density of γH2AX gradually 
declined as a function of distance from the stalled fork (Fig. 4.5B,C). Compared 
with the saturated density at the fork, the γH2AX density decreased 
approximately twofold for every 15 min of thymidine chase time when cells were 
treated with HU for 1 h. By 2 h, we observed increased γH2AX density in all 
chromatin segments analyzed, suggesting that γH2AX spreading contributes 
significantly to the global change in γH2AX levels. 
To examine the chromatin at a single location distant from the fork, we 
repeated this experiment holding the thymidine chase time constant at 30 min, 
and treated with HU for varying times. We observed a steady increase in γH2AX 
at this distance from the fork (Fig. 4.5D). Importantly, these results indicate 
considerable spreading of the γH2AX signal even shortly after fork stalling. 
Assuming a conservative rate of fork elongation of 1 kb/min, these data imply 
that, within 1 h of fork stalling, γH2AX spreads to include a large domain 
containing tens of thousands of base pairs of DNA. 
 
	   82	  
 
 
Figure 4.5.  γH2AX spreads from a stalled replication fork. (A–D) Cells labeled with EdU for 10 
min were chased into thymidine containing medium prior to addition of HU, then processed using 
iPOND. The length of the thymidine and HU treatments is indicated. Quantitation of the click 
reaction samples in C at the 2-h HU-treated samples is from three independent experiments, and 
at the 1-h HU treated samples is from two independent experiments. B,C and D were performed 
by Jami Couch. 
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To identify the kinases that phosphorylate H2AX adjacent to the stalled 
fork and that promote spreading, we used small molecule kinase inhibitors. The 
selective DNA-PK and ATM inhibitors NU7441 [103] and KU55933 [104] had 
minimal effects on the spreading or total levels of γH2AX induced by a short (30- 
to 60-min) HU treatment (Fig. 4.6A; Fig. 4.7A). However, these inhibitors did 
significantly reduce γH2AX levels at all chromosomal positions relative to the fork 
in cells treated with HU for 4 h (Fig. 4.6B,C, Fig. 4.7).  
These results indicate that DNA-PK/ATM contributes to maintenance and 
spreading of γH2AX at persistently stalled forks. In contrast, treatment with 
caffeine, which preferentially inhibits ATR [105], significantly reduced γH2AX 
formation and spreading shortly after the fork is stalled (Fig. 4.6D). These results 
are consistent with a model in which ATR phosphorylates H2AX at a stalled fork 
and promotes initial spreading. At later time points, when DSBs likely form at the 
fork, ATM and DNA-PKcs maintain and further propagate the H2AX 
phosphorylation (Fig. 4.8). 
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Figure 4.6. Checkpoint kinases propagate H2AX phosphorylation from stalled replication forks. 
(A–C) Cells labeled with EdU for 10 min were chased into thymidine, followed by treatment with 
HU. The length of thymidine and HU treatments are indicated. DNA-PK (KU7441, 1 mM) and 
ATM (KU5593, 10 mM) inhibitors were added at the same time as HU in the indicated samples. 
(C) Quantitation of the click reaction samples is the average from two independent experiments 
and is normalized to the 1-h HU treatment. (D) Cells labeled with EdU for 10 min were chased 
into thymidine for either 0 or 30 min, followed by a 30-min treatment with HU. Caffeine (10 mM) 
was added at the same time as HU in the indicated samples. Experiment in panel D was 
performed by Jami FB Couch.  
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Figure 4.7. ATM/DNA-PK do not contribute to early γH2AX spreading from a stalled replication 
fork. (A, B) Cells labeled with EdU for 10 mins were chased into thymidine containing media prior 
to addition of HU, then processed using iPOND. The length of thymidine and HU treatments are 
indicated. DNA-PK (KU7441, 1mM) and ATM (KU5593, 10mM) inhibitors were added at the same 
time as HU in the indicate samples. 
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Figure 4.8. Model for the temporal mechanism of checkpoint kinase-dependent spreading of 
H2AX phosphorylation from stalled replication forks. At early time points after HU treatment (less 
than 2h), ATR is the most important kinase in phosphorylating H2AX both near the stalled fork 
and spreading the signal away from the fork. At later time points in HU (4h), ATM and DNA-PK 
become increasingly involved in both spreading the H2AX phosphorylation and in maintaining the 
phosphorylation near the stalled fork. 
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Discussion 
 
In this chapter, I provided further validation for the use of iPOND as a 
method for studies of genome and epigenome maintenance processes. Using 
various experimental frameworks, I examined the timing and distance from the 
fork of replication-coupled chromatin deposition and maturation, and the 
replication stress response. 
Chromatin assembly is thought to occur by a stepwise deposition of the 
core histones, followed by linker histones and changes in post-translational 
modifications [3]. My data confirm this assembly process in vivo in cultured 
mammalian cells. Furthermore, I found that at least some chromatin maturation 
processes, such as the removal of acetylation on H4K5 and H4K12, proceed 
even when decoupled from replisome movement. I showed that HAT1 is the 
mammalian acetyltransferase that catalyzes the replication-coupled modification 
on histone H4 K5/K12. HAT1 is essential to promote genome stability and 
homozygous deletion of HAT1 in murine models causes neonatal lethality 
(Prabakaran, in press).   
HDAC1, HDAC2, and HDAC3 are enriched on newly synthesized DNA, 
and an inhibitor that targets all three of these enzymes prevents H4K5ac and 
H4K12ac deacetylation. Intriguingly, deacetylation of H4K5ac and H4K12ac 
occurred at the same rate, but acetyltransferases rapidly reacetylated H4K12, 
suggesting a specific need for this modification in some chromatin domains. In 
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the yeast Saccharomyces cerevisiae, H3K56 acetylation is also associated with 
newly deposited histones during DNA replication, and promotes survival in 
response to replication stress [106]. We were unable to detect this acetylation 
mark on newly deposited histones or after HU treatment (data not shown). This 
observation is consistent with other human cell studies that found low levels of 
this post-translational modification in total chromatin that further decreased in 
response to DNA damage [107]. 
Prominent changes in response to replication stress include protein 
phosphorylation. Importantly, our data indicate that H2AX phosphorylation 
spreads to a large chromatin domain early in the response to fork stalling. This 
early phosphorylation is catalyzed by ATR and is unlikely to be due to the 
processing of the fork into a DSB intermediate. Our data are consistent with 
previous analyses implicating both ATR-dependent [108] and ATR-independent 
[15, 109] H2AX phosphorylating activities in response to fork arrest.  
Most models of ATR function suggest that it is active only when bound to 
the ssDNA at the stalled fork through an ATRIP–RPA interaction [14], but our 
data indicate that ATR helps spread the γH2AX signal. One possibility is that the 
early spreading of γH2AX is due to looping of the newly synthesized chromatin 
that brings it into proximity of ATR.  
One role for such looping may be improved DNA repair. In yeast, 
increased chromosomal mobility has recently been observed following induction 
of a DSB [110, 111]. This movement depends on the yeast ATR kinase, DNA end 
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resection, and RAD51. It would be interesting to test whether ATR-dependent 
γH2AX in chromatin domains away from the replication fork depend upon RAD51 
or the resection machinery.  
An alternative method for propagation of H2AX phosphorylation may 
signify that ATR has a method of spreading its signal beyond the immediate 
ssDNA vicinity. Such a mechanism would be similar to the ability of active ATM to 
spread along the dsDNA away from the DSB end [112] MDC1 may be involved in 
such a process [113, 114] and I detected enrichment of MDC1 at stalled 
replication forks using iPOND-MS (Chapter V). 
Persistent stalling of the fork for longer than 1–2 h causes a switch in the 
DDR. RPA is hyperphosphorylated on DNA-PK-dependent phosphorylation sites, 
ATM/ DNA-PK catalyzes further γH2AX spreading, and DSB repair proteins like 
MRE11, KU70/80, and RAD51 are enriched. RAD51 assembly at these 
persistently stalled forks depends on MRE11 activity, suggesting a requirement 
for end resection. The end resection may be on the template DNA strand, since 
we continued to capture EdU-labeled DNA and associated proteins. Resecting 
the leading strand template would yield a 3ʼ overhang of newly synthesized DNA, 
which could be used in recombination-based methods of fork repair and restart 
[87]. 
Overall, these data provide the first high-resolution, time-dependent 
analyses of protein dynamics at active, stalled, and collapsed replication forks in 
mammalian cells.  
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CHAPTER V 
 
 
iPOND PROTEOMIC IDENTIFICATION OF NOVEL GENOME AND 
EPIGENOME INHERITANCE PROTEINS* 
 
Introduction 
In the previous chapters, I described the utility of iPOND for monitoring the 
dynamics of known proteins that function in DNA replication and repair. While 
these represent a large fraction of the proteins that maintain genome integrity 
during chromosome duplication, a comprehensive view of the replisome and 
associated proteins has not been examined due to technical challenges of 
purifying replisomes from mammalian cells. In addition, how replisome 
composition is altered in response to DNA damage remains unclear. When 
replication forks encounter damage that halts the replicative polymerase but 
allows continued unwinding by the replicative helicase, single-stranded parental 
DNA accumulates [14, 115]. RPA coats the ssDNA and serves as the recruiting 
platform for many of the known checkpoint response proteins.  
But what are all of the proteins that accumulate at sites of damaged 
replisomes? What enzymatic activities protect genome and epigenome integrity 
during DNA replication?  
 
 
 
*Excerpts of the introduction and discussion of this chapter are in press Sirbu BM and Cortez D, 
CSHL Perspectives in Biology. 
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To answer these broad questions, I coupled iPOND to unbiased shotgun 
proteomics to probe the changes in replisome composition under different 
conditions. I propose to identify and validate new proteins recruited to replication 
forks.   
In addition to exploring the active and stalled replisome, I was interested in 
how the ATR kinase stabilizes stalled replication forks to prevent genomic 
instability. In the absence of ATR activity, replication forks are said to ʻcollapse.’ 
The mechanism of fork ʻcollapseʼ remains ambiguous, but changes in proteins 
and DNA at replication forks provide detectable evidence for fork breakdown. For 
example, S. cerevisiae mutants deficient in the ATR pathway lose the replicative 
polymerases from the fork [35-37] and accumulate abnormal DNA structures 
including long stretches of ssDNA and reversed fork structures resembling 
Holliday junctions [38, 39]. In yeast, the EXO1 nuclease generates the excess 
ssDNA at the stalled fork when the ATR pathway is inactivated [116]. Loss of 
ATR function in Xenopus egg extracts also causes loss of Polε and collapse of 
the fork into a DSB [40]. 
Studying fork collapse in human cells lacking ATR is difficult because ATR 
is essential for the viability of replicating cells [15]. Using a selective inhibitor of 
ATR kinase activity [61, 62], we observed that mammalian cells treated with the 
ATR inhibitor accumulate toxic levels of ssDNA that corresponds to the nascent 
DNA strand (Couch FB, results in press). The relevant targets of ATR in 
preventing replication fork collapse are unknown, but may include nucleases that 
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generate excess ssDNA and helicases that rearrange highly recombinogenic 
structures into detrimental fork structures. Hundreds of ATR substrates have 
been identified in large proteomics screens [41]. A portion of these substrates 
likely represents ATR targets that prevent fork collapse.  
Probing the changes in the replisome using iPOND-MS and an ATR-
specific inhibitor is of clinical relevance. Cancer cells exhibit high amounts of 
replication stress, which is partly due to the activation of oncogenes in 
precancerous lesions [117, 118]. Replication stress requires the ATR pathway for 
survival, making ATR an attractive therapeutic target for killing specific cancer 
types. Therefore, an examination of proteins that are enriched at stalled forks that 
collapse in the absence of ATR activity may offer mechanistic insights into how 
cancer cells treated with ATR inhibitors will respond to cancer therapies. 
Furthermore, we may gain information about the cancer patient population that 
may benefit the most from treatment with ATR inhibitors, which are currently 
being tested in Phase I clinical trials.   
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Results 
iPOND optimizations for shotgun proteomics approaches 
Prior to coupling iPOND purifications to quantitative proteomics 
approaches for identification of replication fork proteins, two MS strategies were 
considered. Stable isotope labeling offers high accuracy of protein identification, 
but requires extensive biochemical workup and cost [119]. We chose to pursue 
label-free spectral counting that provides relative quantitation of protein 
abundance across several samples simultaneously [120]. Preliminary 
experiments were performed in an effort to improve the signal to noise ratio prior 
to the iPOND-MS screens and are detailed in Chapter II and Appendix A.  
 
iPOND proteomics quality control 
To identify proteins associated with nascent DNA at replication forks and 
to explore the protein changes resulting from DNA damage, we coupled iPOND 
purifications to proteomics analyses. Five samples were prepared for iPOND-MS 
(Fig. 5.1A). For all samples, cells were treated for 15 mins with EdU to label 
nascent DNA. To examine proteins at normal, elongating replication forks, EdU 
pulsed cells were collected and proteins bound to nascent DNA were purified 
using iPOND (Fig. 5.1A). To monitor proteins associated with stalled replication 
forks, EdU labeled cells were treated with a high concentration of HU. This 
arrests fork movement and induces a DNA damage response (data not shown).  
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Figure 5.1. iPOND proteomics screen workflow. (A) Diagram of iPOND-MS pulse/chase frameworks. Cells 
pulsed with EdU for 15 mins were processed without the Click rxn reagent (Negative control) or treated with 
thymidine for one hour (Negative control) prior to iPOND. The experimental samples were collected 
immediately after the EdU pulse (Normal replication fork). EdU pulsed cells were treated with 3mM HU for 2 
hours (Stalled replication fork), or simultaneously chased into 3mM HU and ATR inhibitor (Collapsed 
replication fork) without removing EdU, and samples were then collected for iPOND. (B) Representative 
iPOND purifications from one of the five replicates submitted for proteomic analyses. The five samples 
described in (A) were iPOND purified and blotted for PCNA and H2B. (C) iPOND-MS experimental workflow. 
(D) Toppgene analysis for classification of statistically significant proteins found enriched at normal, stalled, 
and collapsed replication forks. 
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The third experimental sample explored proteins recruited to stalled forks that 
collapse in the absence of ATR activity. Thus, EdU pulsed cells were chased into 
a combination of HU and an ATR specific inhibitor [61, 62], at an inhibitor 
concentration that causes the accumulation of RPA on nascent-strand ssDNA 
(Couch FB unpublished results).  
The specificity of replication fork protein purifications was tested relative to 
two negative controls (Fig. 5.1A top panel). One negative control was treated 
identically to the normal replication fork sample but omitted the biotin azide that 
biotin tags nascent DNA. Proteins purified in this ‘no Click rxn’ sample represent 
those that interact non-specifically with streptavidin-conjugated beads. For the 
second negative control, cells pulsed with EdU were chased into thymidine for 1 
hour to monitor proteins bound to mature chromatin, which are no longer close to 
the replication fork. Proteins detected in this sample represent chromatin-bound 
proteins that are not specific to replisomes or the surrounding nascent chromatin.  
To test the relative enrichment of replication proteins in the samples 
submitted for MS analyses, iPOND purifications were examined for PCNA levels. 
As observed previously, PCNA was detected at elongating replication forks and 
its levels decreased upon chase into thymidine and replication stress (Fig. 5.1B).  
While still detectable, PCNA levels at stalled and ATR inhibited replication forks 
appear less enriched than at unperturbed forks. This may reflect unloading of 
PCNA from the lagging strand [121]. The relatively equal levels of histone H2B 
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detected on isolated chromatin (Fig. 5.1B) indicate that equivalent amounts of 
EdU-labeled DNA were purified in samples subsequently analyzed by MS. 
 
iPOND-MS view of proteins at replication forks 
 Following the described conditions, the five samples were iPOND purified 
independently five times from one cell culture (5 technical replicates). The eluted 
proteins were analyzed using two-dimensional liquid chromatography coupled 
with tandem mass spectrometry (multidimensional protein identification 
technology MudPIT) (Fig. 5.1B). The MS/MS spectra were matched to the human 
protein database using the Myrimatch and Sequest search engines [65-67]. 
Proteins identified using at least one of these search engines had to pass filtering 
criteria described in detail below and reported in Tables 5.2, 5.3 and 5.4. The fold 
enrichment, p-value and spectral count data is the median value generated from 
each search engine applied.  
To discern replication fork proteins from non-specific and chromatin-bound 
proteins, spectral counts were used to determine protein fold changes relative to 
the negative controls. The final lists include proteins enriched at least 1.5-fold 
(relative to both negative controls) with p-values less than or equal to 0.05, as 
calculated using QuasiTel [72]. To increase the stringency criteria, an additional 
filter required at least 5 spectral counts total per 5 experimental replicates. Tables 
5.2, 5.3 and 5.4 contain the significantly enriched proteins found at normal, 
stalled and collapsed replication forks, respectively.  
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These filtering criteria led to the identification of a total of 290 proteins, 
some of which overlapped in two or all three experimental conditions (Table 5.1).  
At least sixteen percent of the enriched proteins had previously been 
documented to function in DNA replication and damage (Fig. 5.1B, C). Functional 
characterization of the dataset revealed that gene ontology categories such as 
DNA repair, response to DNA damage, DNA metabolic process, DNA replication 
and cell cycle were overrepresented above random chance of expectancy (Fig. 
5.1D). This provides confidence that the iPOND-MS screen successfully 
identified DNA replication and damage proteins. 
Of the total proteins enriched on nascent DNA, 84 were found to 
accumulate at normal forks, 139 at stalled forks and 137 at collapsed forks.  
Several established genome maintenance proteins were among the 11 proteins 
enriched in all three experimental conditions tested (Table 5.1). For example, the 
interstrand crosslink repair factor FANCI, which is found mutated in Fanconi 
anemia, the ATR-activating replication stress protein TOPBP1, and the chromatin 
remodeler SMARCAD1 were enriched at replication forks under unperturbed and 
stressed conditions. The identification of genome maintenance proteins in 
unperturbed conditions supports the idea that basal levels of replication stress 
occur during each cell cycle and that every S phase requires checkpoint proteins 
to ensure faithful DNA replication [14]. 
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Table 5.1. Proteins enriched in common in the iPOND proteomics screens.  
 
 
 
 
 
 
 
 
 
 
 
 
 
At normal and ATR inhibited replication forks, I observed the core 
replisome components (polymerase epsilon, the large subunit of polymerase 
delta POLD1, and the replication clamp loader accessory factors RFC1-5) (Table 
5.1). Most models pose that ATR prevents dissociation of the replisome to 
maintain a stable replication fork competent for restart of DNA synthesis after 
DNA damage [14]. The presence of POLD1, POLE and RFC1-5 at forks lacking 
ATR activity suggests that maintaining an intact replisome is independent of ATR 
activity in human cells.  
Normal
Stalled
Collapsed
Normal
Stalled
Normal 
Collapsed
ACO1 ACO1 ACO1 ACO1 POLD1
FANCI CBS CA2 ADD1 PTRH2
IMMT CHAF1B FANCI CHTF18 RAD1
ISYNA1 FANCI HEATR3 CUL2 RPA2
MRPL13 IMMT IMMT CUL3 SLC25A11
PDCD4 ISYNA1 ISYNA1 DAK SMARCAD1
PIGT MRPL13 MRPL13 DNAJC8 SPATA5
POLD1 MSH3 PDCD4 FANCD2 TMTC3
SMARCAD1 NAA10 PIGT FANCI TOPBP1
TOPBP1 NCAPH POLD1 FKBP10 TRMT6
TRMT6 OSBPL9 POLE GOT1 UGGT1
PDCD4 RFC1 GSS VAC14
PHKB RFC4 IMMT XPO5
PIGT RFC5 ISYNA1 XRCC1
POLD1 RPA3 KIAA1598
RPL6P10 SEPT11. MAOA
SKP1 SLC4A2 MDC1
SMARCAD1 SMARCAD1 MRPL13
SPTLC2 TIMELESS MRPL28
SSB TM9SF4 PDCD4
TOPBP1 TOPBP1 PDS5B
TRMT6 TRMT6 PIGT
Known proteins
Stalled
Collapsed
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The elongating replisome and associated proteins 
The distribution of proteins identified at elongating replication forks 
revealed that the majority of proteins enriched with a p-value less than 0.01 (red 
colored dots in Fig. 5.2) are well-established replisome components. For 
example, PCNA, POLD1 and POLE were identified with numerous spectral 
counts, providing further confidence in the identification of these proteins (Fig. 
5.2A). It should be noted that when no spectra were detected in the chromatin-
bound negative control, QuasiTel calculates relative fold enrichment using a 
small, non-zero value in the denominator. This factor may lead to an 
overestimation of protein enrichment (see Table 5.2 fold enrichment for CP110 
and PIGT). While these values are included in Tables 5.2, 5.3, and 5.4, they are 
omitted from Figures 5.2, 5.3 and 5.4.  Overall, the highest confidence proteins 
from iPOND-MS have low p-values, are highly enriched relative to both negative 
controls and are detected with large spectral count numbers.  
To examine potential genetic and biochemical connections among the 
identified proteins, I performed bioinformatics searches using the GeneMANIA 
prediction server [74]. The network modeling showed that approximately one 
third of the identified proteins form a cohesive network based on curated physical 
interactions (Fig. 5.2B). PCNA represents a prominent node in this network and 
is a known recruiting scaffold for numerous replication and DNA damage 
proteins.  
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Figure 5.2. iPOND-MS identifies proteins significantly enriched on replicating DNA in unperturbed S phase. 
(A) The fold enrichment relative to the chromatin chase negative control, the p-value and the spectral count 
data, which passed the filtering criteria described in the text, are depicted for the proteins listed in Table 5.2. 
The dot size indicates the total number of MS spectra counted in the normal replication fork samples from 
the five replicate purifications. The dot color represents p-value as calculated using QuasiTel. The proteins 
in bold are proteins that were followed up in subsequent validation experiments. The dot plots were 
generated in R by Yaoyi Chen. (B) Protein network analyses used GeneMANIA predictions [74] to probe the 
physical interactions within the normal replication fork dataset. (C) The iPOND-MS normal replication fork 
proteins that contain potential PCNA interacting motifs [122] or putative ATM/ATR phosphorylation sites [41, 
123] are listed. iPOND-MS proteins were cross-referenced with genomics screens for genes that when 
knocked down cause significant H2AX phosphorylation [124, 125].  
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Table 5.2. Proteins significantly enriched on nascent chromatin during 
unperturbed DNA replication. Hayes McDonald performed QuasiTel 
comparisons between replication fork samples and negative controls. 
 
Entrez ID Official symbol Name
Median 
Enrichment
Median 
p-value
Median 
Spectral 
counts
5982 RFC2 Replication Factor C (Activator 1) 2, 40Kda 1.5 0.0484 58
6128 RPL6P10 Ribosomal Protein L6 Pseudogene 10 1.5 0.0037 55
760 CA2 Carbonic Anhydrase Ii 1.5 0.0330 64
8467 SMARCA5 Swi/Snf Related, Matrix Associated, Actin Dependent Regulator Of Chromatin, Subfamily A, Member 5 1.6 0.0211 195
55215 FANCI Fanconi Anemia, Complementation Group I 1.6 0.0408 87
51366 UBR5 Ubiquitin Protein Ligase E3 Component N-Recognin 5 1.6 0.0757 33
6594 SMARCA1 Swi/Snf Related, Matrix Associated, Actin Dependent Regulator Of Chromatin, Subfamily A, Member 1 1.6 0.0531 96
29128 UHRF1 Ubiquitin-Like With Phd And Ring Finger Domains 1 1.6 0.0214 59
10135 NAMPT Nicotinamide Phosphoribosyltransferase 1.6 0.0535 42
5351 PLOD1 Procollagen-Lysine 1, 2-Oxoglutarate 5-Dioxygenase 1 1.6 0.0357 14.5
875 CBS Cystathionine-Beta-Synthase 1.6 0.0431 28
6632 SNRPD1 Small Nuclear Ribonucleoprotein D1 Polypeptide 16Kda 1.6 0.0315 82
5984 RFC4 Replication Factor C (Activator 1) 4, 37Kda 1.7 0.0045 48
3251 HPRT1 Hypoxanthine Phosphoribosyltransferase 1 1.7 0.0310 36
5479 PPIB Peptidylprolyl Isomerase B (Cyclophilin B) 1.7 0.0401 55
48 ACO1 Aconitase 1, Soluble 1.7 0.0891 34
54517 PUS7 Pus7 Pseudouridylate Synthase 7 Homolog 1.7 0.0334 29.5
2885 GRB2 Growth Factor Receptor-Bound Protein 2 1.8 0.0910 17
6500 SKP1 S-Phase Kinase-Associated Protein 1 1.8 0.0638 18
5985 RFC5 Replication Factor C (Activator 1) 5, 36.5Kda 1.8 0.0091 44.5
64975 MRPL41 Mitochondrial Ribosomal Protein L41 1.8 0.0701 22
10491 CRTAP Cartilage Associated Protein 1.8 0.0659 10
6741 SSB Sjogren Syndrome Antigen B (Autoantigen La) 1.9 0.0319 100
5426 POLE Polymerase (Dna Directed), Epsilon 1.9 0.0003 53
8260 NAA10 Ard1 Homolog A, N-Acetyltransferase (S. Cerevisiae) 1.9 0.0625 17
57634 EP400 E1A Binding Protein P400 2.0 0.0794 15
8125 ANP32A Acidic (Leucine-Rich) Nuclear Phosphoprotein 32 Family, Member A 2.0 0.0731 26
55752 SEPT11 Septin 11 2.0 0.0680 24
4436 MSH2 Muts Homolog 2, Colon Cancer, Nonpolyposis Type 1 (E. Coli) 2.0 0.0154 46
9031 BAZ1B Bromodomain Adjacent To Zinc Finger Domain, 1B 2.0 0.0041 125
2956 MSH6 Muts Homolog 6 (E. Coli) 2.0 0.0005 288
5424 POLD1 Polymerase (Dna Directed), Delta 1, Catalytic Subunit 125Kda 2.0 0.0030 108.5
55027 HEATR3 Heat Repeat Containing 3 2.1 0.0502 25
10620 ARID3B At Rich Interactive Domain 3B (Bright-Like) 2.1 0.0986 24
29089 UBE2T Ubiquitin-Conjugating Enzyme E2T (Putative) 2.1 0.0066 40
26164 GTPBP5 Gtp Binding Protein 5 (Putative) 2.2 0.0002 266.5
29028 ATAD2 Atpase Family, Aaa Domain Containing 2 2.2 0.0180 45
5983 RFC3 Replication Factor C (Activator 1) 3, 38Kda 2.2 0.0457 41
5721 PSME2 Proteasome (Prosome, Macropain) Activator Subunit 2 (Pa28 Beta) 2.3 0.0474 37
9777 TM9SF4 Transmembrane 9 Superfamily Protein Member 4 2.3 0.0866 14
11073 TOPBP1 Topoisomerase (Dna) Ii Binding Protein 1 2.3 0.0378 9
11169 WDHD1 Wd Repeat And Hmg-Box Dna Binding Protein 1 2.6 0.0173 30
5257 PHKB Phosphorylase Kinase, Beta 2.6 0.0553 10
9039 UBA3 Ubiquitin-Like Modifier Activating Enzyme 3 2.6 0.0450 13
3978 LIG1 Ligase I, Dna, Atp-Dependent 2.6 0.0438 47
5111 PCNA Proliferating Cell Nuclear Antigen 2.6 0.0003 124
58525 WIZ Widely Interspaced Zinc Finger Motifs 2.6 0.0004 37
902 CCNH Cyclin H 2.7 0.0307 9
29925 GMPPB Mitochondrial Ribosomal Protein L37 2.7 0.0441 11
8914 TIMELESS Timeless Homolog (Drosophila) 2.8 0.0194 23
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Table 5.2 continued. Proteins significantly enriched on nascent chromatin 
during unperturbed DNA replication. 
 
Entrez ID Official symbol Name
Median 
Enrichment
Median 
p-value
Median 
Spectral 
counts
51477 ISYNA1 Inositol-3-Phosphate Synthase 1 2.8 0.0615 12
112936 VPS26B Vacuolar Protein Sorting 26 Homolog B (S. Pombe) 2.9 0.0084 22
28998 MRPL13 Mitochondrial Ribosomal Protein L13 3.0 0.0297 15
79813 EHMT1 Euchromatic Histone-Lysine N-Methyltransferase 1 3.0 0.0289 9
1786 DNMT1 Dna (Cytosine-5-)-Methyltransferase 1 3.1 0.0001 201
79915 ATAD5 Atpase Family, Aaa Domain Containing 5 3.1 0.0437 26
5981 RFC1 Replication Factor C (Activator 1) 1, 145Kda 3.2 0.0018 61
25923 ATL3 Atlastin Gtpase 3 3.2 0.0440 13
7329 UBE2I Ubiquitin-Conjugating Enzyme E2I (Ubc9 Homolog, Yeast) 3.2 0.0270 14
51605 TRMT6 Trna Methyltransferase 6 Homolog (S. Cerevisiae) 3.4 0.0485 16
283237 TTC9C Tetratricopeptide Repeat Domain 9C 3.5 0.0679 7
1820 ARID3A At Rich Interactive Domain 3A (Bright-Like) 3.5 0.0679 7
27250 PDCD4 Programmed Cell Death 4 (Neoplastic Transformation Inhibitor) 3.5 0.0768 11
6166 RPL36AL Ribosomal Protein L36A-Like 3.7 0.0549 12
23397 NCAPH Non-Smc Condensin I Complex, Subunit H 3.7 0.0245 12
54454 ATAD2B Atpase Family, Aaa Domain Containing 2B 3.8 0.0158 19
84153 RNASEH2C Ribonuclease H2, Subunit C 4.0 0.0379 8
114883 OSBPL9 Oxysterol Binding Protein-Like 9 4.0 0.0144 11.5
10036 CHAF1A Chromatin Assembly Factor 1, Subunit A (P150) 4.1 0.0033 30
8208 CHAF1B Chromatin Assembly Factor 1, Subunit B (P60) 4.3 0.0011 42
51478 HSD17B7 Hydroxysteroid (17-Beta) Dehydrogenase 7 4.5 0.0797 4.5
55559 HAUS7 Three Prime Repair Exonuclease 2; Haus Augmin-Like Complex, Subunit 7 4.6 0.0472 6.5
10166 SLC25A15 Solute Carrier Family 25 (Mitochondrial Carrier; Ornithine Transporter) Member 15 4.7 0.0237 11
6522 SLC4A2 Solute Carrier Family 4, Anion Exchanger, Member 2 (Erythrocyte Membrane Protein Band 3-Like 1) 5.0 0.0843 5
10989 IMMT Inner Membrane Protein, Mitochondrial (Mitofilin) 5.0 0.0237 10
56916 SMARCAD1
Swi/Snf-Related, Matrix-Associated Actin-Dependent 
Regulator Of Chromatin, Subfamily A, Containing 
Dead/H Box 1 5.5 0.0732 11
55869 HDAC8 Histone Deacetylase 8 6.0 0.0311 8.5
4437 MSH3 Muts Homolog 3 (E. Coli) 6.2 0.0001 51
80142 PTGES2 Prostaglandin E Synthase 2 6.5 0.0452 6.5
9517 SPTLC2 Serine Palmitoyltransferase, Long Chain Base Subunit 2 7.0 0.0348 9
6119 RPA3 Replication Protein A3, 14Kda 8.0 0.0309 8
9156 EXO1 Exonuclease 1 24.0 0.0006 20
9738 CP110 Cp110 Protein 289859429.9 0.0371 6
51604 PIGT Phosphatidylinositol Glycan Anchor Biosynthesis, Class T 1050559491.8 0.0044 8
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Several of the iPOND-MS proteins contain predicted PCNA-interacting motifs 
(PIP boxes), as determined by cross-referencing [122] (Fig. 5.2C). For example, 
the Williams syndrome transcription factor WSTF (also known as BAZ1B), DNA 
methyltransferase (DNMT1), ligase 1, mismatch repair proteins MSH3 and 
MSH6, chromatin remodelers SNF2L and SNF2H, and the E3 ubiquitin ligase 
UBR5 have been shown to localize to replication forks. It is unknown if the PIP 
box of each factor is essential for localization to replication forks.  
A second PCNA-interacting motif APIM (AlkB homologue 2 PCNA-
interacting motif) is commonly found in proteins exhibiting damage-inducible 
PCNA interactions [122]. The centrosomal protein CP110, the DNMT1 recruiting 
protein UHRF1, and the euchromatic histone methyltransferase EHMT1 have 
predicted APIM motifs, suggesting these three proteins may function during 
replication stress. 
To further analyze the proteins, the dataset was compared to published 
proteomics screens focused on finding new genome maintenance proteins. ATM 
and ATR regulate DDR proteins through phosphorylation. However, it is largely 
unknown which of the over 600 checkpoint kinase substrates are located at 
replication forks. Eighteen of the iPOND-MS enriched proteins are potential 
ATM/ATR substrates at unperturbed replication forks (Fig. 5.2C), according to 
cross-referencing with large-scale proteomics screens [41]. This represents a 
statistically significant fraction of proteins, as determined by hypergeometric 
hypothesis testing (p-value 0.0013, see Chapter II for bioinformatics analyses). 
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The majority of these kinase substrates are known DDR proteins, such as MSH2, 
MSH3, MSH6, POLE, RFC1, RFC3, TOPBP1, the TOPB1 ubiquitin ligase UBR5, 
FANCI, the exonuclease EXO1, the replication initiating factor WDHD1 (also 
known as AND1), and the alternative PCNA clamp loader ATAD5 (also known as 
ELG1). Other potential substrates that localized to forks have been affiliated with 
chromatin assembly and maturation during replication. These include the histone 
chaperone CAF1A, the chromatin remodeler SMARCAD1, and EHMT1. TRNA 
methyltransferase (TRMT6) and vacuolar protein sorting homolog B (VPS26) are 
putative ATM/ATR substrates that have not been previously linked to DNA 
replication, but were identified at elongating forks using iPOND-MS.   
Lastly, the iPOND-MS list was cross-referenced with large-scale genomics 
screens that identified genes that when silenced activate the DNA damage 
response [124, 125]. Eleven iPOND-MS proteins may cause H2AX 
phosphorylation when depleted. Five of these have not been previously 
associated with functions during DNA replication, but may represent novel 
proteins of interest (Fig. 5.2C). Overall, the iPOND-MS screen for proteins 
associated with nascent DNA identified known replication fork proteins and novel 
proteins that may function during DNA replication. In later sections, I show 
validations of SNF2L recruitment to nascent chromatin and discuss the function 
of this chromatin remodeler in replication fork progression.  
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The stalled replisome and associated proteins 
Enriched proteins were plotted as described for the undamaged fork 
dataset to visualize proteins found at stalled replication forks (Fig. 5.3A). 
Although few known DDR proteins were identified, the dataset was significantly 
enriched in gene ontologies classified under cellular response to stress (p-value 
8e-5), DNA metabolic process (p-value 6e-4) and cell cycle (p-value 1.7e-3), as 
determined by Toppgene bioinformatics analyses. The low number of DDR 
proteins in this iPOND-MS sample may reflect poor iPOND purification of stalled 
replication forks where large stretches of parental RPA-ssDNA are generated 
from uncoupling of helicase and polymerase activities [115]. Since iPOND only 
purifies nascent DNA, this parental ssDNA signaling platform with bound 
checkpoint proteins may not be isolatable under these conditions.  
However, of the known proteins, mediator of DNA damage checkpoint 1 
(MDC1), RPA2, the DNA helicase RECQL1, the single-stranded DNA repair 
factor XRCC1, the Fanconi ID complex, and the Rad1 component of the 
checkpoint activating Rad9-Hus1-Rad1 (9-1-1) complex were clearly enriched. 
Several of the identified proteins are putative ATM/ATR substrates, harbor 
PCNA-interacting motifs, helicase domains, or cause DNA damage when 
depleted (Fig. 5.3B-D), linking the iPOND-MS stalled fork proteins to 
chromosome stability. 
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Figure 5.3. iPOND-MS identifies proteins significantly enriched on replicating DNA during replication stress.  
(A) The fold enrichment relative to the chromatin chase negative control, the p-value and the spectral count 
data, which passed the filtering criteria described in the text, are depicted for the proteins listed in Table 5.3. 
The dot size indicates the total number of MS spectra counted in the stalled replication fork samples from 
the five replicate purifications. The dot color represents p-value as calculated using QuasiTel. The dot plots 
were generated in R by Yaoyi Chen. (B,C) Protein network analyses used GeneMANIA predctions to probe 
proteins in common functional pathways or those containing helicase domains. (D) The iPOND-MS stalled 
replication fork proteins that contain potential PCNA interacting motifs or putative ATM/ATR phosphorylation 
sites are listed. iPOND-MS proteins were cross-referenced with genomics screens for genes that when 
knocked down cause significant H2AX phosphorylation.  
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Table 5.3. Proteins significantly enriched on nascent chromatin during 
replication fork stalling. Hayes McDonald performed QuasiTel comparisons 
between stalled replication fork samples and negative controls. 
Entrez ID Official symbol Name
Median 
Enrichment
Median 
p-value
Median 
Spectral 
counts
2820 GPD2 Glycerol-3-Phosphate Dehydrogenase 2 (Mitochondrial) 1.4 0.0125 48
178 AGL Amylo-1, 6-Glucosidase, 4-Alpha-Glucanotransferase 1.4 0.0948 80
7086 TKT Transketolase 1.4 0.0295 209
7372 UMPS Uridine Monophosphate Synthetase 1.5 0.0251 20
5424 POLD1 Polymerase (Dna Directed), Delta 1, Catalytic Subunit 125Kda 1.5 0.0429 78
8664 EIF3D Eukaryotic Translation Initiation Factor 3, Subunit D 1.5 0.0955 115
3064 HTT Huntingtin 1.5 0.0470 67
54505 DHX29 Deah (Asp-Glu-Ala-His) Box Polypeptide 29 1.5 0.0288 42
5691 PSMB3 Proteasome (Prosome, Macropain) Subunit, Beta Type, 3 1.5 0.0257 68
6128 RPL6P10 Ribosomal Protein L6 1.5 0.0344 53
5965 RECQL Recq Protein-Like (Dna Helicase Q1-Like) 1.5 0.0236 58
166378 SPATA5 Spermatogenesis Associated 5 1.6 0.0517 62
128 ADH5 Alcohol Dehydrogenase 5 (Class Iii), Chi Polypeptide 1.6 0.0270 39
7515 XRCC1 X-Ray Repair Complementing Defective Repair In Chinese Hamster Cells 1 1.6 0.0140 22
6599 SMARCC1 Swi/Snf Related, Matrix Associated, Actin Dependent Regulator Of Chromatin, Subfamily C, Member 1 1.6 0.0906 33
118 ADD1 Adducin 1 (Alpha) 1.6 0.0694 22
5515 PPP2CA Protein Phosphatase 2 (Formerly 2A), Catalytic Subunit, Alpha Isoform 1.6 0.0396 39
8453 CUL2 Cullin 2 1.6 0.0473 41
22826 DNAJC8 Dnaj (Hsp40) Homolog, Subfamily C, Member 8 1.6 0.0957 23
2314 FLII Flightless I Homolog (Drosophila) 1.7 0.0890 45
2475 MTOR Mechanistic Target Of Rapamycin (Serine/Threonine Kinase) 1.7 0.0569 34
9675 TTI1 TELO2 interacting protein 1 1.7 0.0516 25
79187 FSD1 Fibronectin Type Iii And Spry Domain Containing 1 1.7 0.0585 11
9678 PHF14 Phd Finger Protein 14 1.7 0.0955 7
8604 SLC25A12 Solute Carrier Family 25 (Mitochondrial Carrier, Aralar), Member 12 1.8 0.0985 30
56886 UGGT1 Udp-Glucose Ceramide Glucosyltransferase-Like 1 1.8 0.0659 30
10973 ASCC3 Activating Signal Cointegrator 1 Complex Subunit 3 1.8 0.0859 49
8452 CUL3 Cullin 3 1.8 0.0297 57
2037 EPB41L2 Erythrocyte Membrane Protein Band 4.1-Like 2 1.8 0.0204 34
8260 NAA10 Ard1 Homolog A, N-Acetyltransferase (S. Cerevisiae) 1.8 0.0563 16
847 CAT Catalase 1.8 0.0784 18
6500 SKP1 S-Phase Kinase-Associated Protein 1 1.8 0.0345 18
875 CBS Cystathionine-Beta-Synthase 1.8 0.0853 29
51651 PTRH2 Peptidyl-Trna Hydrolase 2 1.8 0.0150 29
6118 RPA2 Replication Protein A2, 32Kda 1.8 0.0569 31
2805 GOT1 Glutamic-Oxaloacetic Transaminase 1, Soluble (Aspartate Aminotransferase 1) 1.8 0.0130 38
57510 XPO5 Exportin 5 1.8 0.0047 53
2224 FDPS Farnesyl Diphosphate Synthase 1.8 0.0345 24
4128 MAOA Monoamine Oxidase A 1.8 0.0245 48
80218 NAA50 N-Acetyltransferase 13 (Gcn5-Related) 1.8 0.0308 34
5714 PSMD8 Proteasome (Prosome, Macropain) 26S Subunit, Non-Atpase, 8 1.9 0.0311 26
381 ARF5 Adp-Ribosylation Factor 5 1.9 0.0364 27
811 CALR Calreticulin 1.9 0.0472 48
55276 PGM2 Phosphoglucomutase 2 1.9 0.0311 23
11231 SEC63 Sec63 Homolog (S. Cerevisiae) 1.9 0.0212 30
6741 SSB Sjogren Syndrome Antigen B (Autoantigen La) 2.0 0.0142 109
4976 OPA1 Optic Atrophy 1 (Autosomal Dominant) 2.0 0.0272 45
51552 RAB14 Rab14, Member Ras Oncogene Family 2.0 0.0830 21
10785 WDR4 Wd Repeat Domain 4 2.0 0.0432 12
4715 NDUFB9 Nadh Dehydrogenase (Ubiquinone) 1 Beta Subcomplex, 9, 22Kda 2.0 0.0406 23
347688 TUBB8 Tubulin, Beta 8 2.1 0.0937 66
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Continued Table 5.3. Proteins significantly enriched on nascent chromatin 
during replication fork stalling. 
Entrez ID Official symbol Name
Median 
Enrichment
Median 
p-value
Median 
Spectral 
counts
23047 PDS5B Pds5, Regulator Of Cohesion Maintenance, Homolog B (S. Cerevisiae) 2.2 0.0206 57
8402 SLC25A11 Solute Carrier Family 25 (Mitochondrial Carrier; Oxoglutarate Carrier), Member 11 2.2 0.0069 41
5931 RBBP7 Retinoblastoma Binding Protein 7 2.2 0.0763 22
6251 RSU1 Ras Suppressor Protein 1 2.2 0.0138 17
2287 FKBP3 Fk506 Binding Protein 3, 25Kda 2.2 0.0515 38
5217 PFN2 Profilin 2 2.3 0.0776 12
55623 THUMPD1 Thump Domain Containing 1 2.3 0.0831 10.5
55622 TTC27 Tetratricopeptide Repeat Domain 27 2.4 0.0321 22
23193 GANAB Glucosidase, Alpha; Neutral Ab 2.4 0.0057 59
55239 OGFOD1 2-Oxoglutarate And Iron-Dependent Oxygenase Domain Containing 1 2.5 0.0307 8
1500 CTNND1 Catenin (Cadherin-Associated Protein), Delta 1 2.5 0.0041 40
7410 VAV2 Vav 2 Guanine Nucleotide Exchange Factor 2.5 0.0615 10
55181 C17ORF71 Chromosome 17 Open Reading Frame 71 2.5 0.0355 10
8632 DNAH17 Dynein, Axonemal, Heavy Chain 17 2.5 0.0332 18
4437 MSH3 Muts Homolog 3 (E. Coli) 2.6 0.0030 23
10447 FAM3C Family With Sequence Similarity 3, Member C 2.6 0.0392 19
6169 RPL38 Ribosomal Protein L38 2.6 0.0419 30
8208 CHAF1B Chromatin Assembly Factor 1, Subunit B (P60) 2.6 0.0293 27
9656 MDC1 Mediator Of Dna-Damage Checkpoint 1 2.7 0.0001 117
55681 SCYL2 Scy1-Like 2 (S. Cerevisiae) 2.7 0.0856 17
8976 WASL Wiskott-Aldrich Syndrome-Like 2.7 0.0441 11
6888 TALDO1 Transaldolase 1 2.8 0.0123 22
63922 CHTF18 Ctf18, Chromosome Transmission Fidelity Factor 18 Homolog (S. Cerevisiae) 2.8 0.0796 15
327 APEH N-Acylaminoacyl-Peptide Hydrolase 2.8 0.0044 54
3052 HCCS Holocytochrome C Synthase (Cytochrome C Heme-Lyase) 2.8 0.0184 15
1663 DDX11 Dead/H (Asp-Glu-Ala-Asp/His) Box Polypeptide 11 (Chl1-Like Helicase Homolog, S. Cerevisiae) 2.9 0.0572 13
51719 CAB39 Calcium Binding Protein 39 3.0 0.0303 14
3162 HMOX1 Heme Oxygenase (Decycling) 1 3.0 0.0301 12
55768 NGLY1 N-Glycanase 1 3.0 0.0289 9
10554 AGPAT1 1-Acylglycerol-3-Phosphate O-Acyltransferase 1 3.0 0.0289 9
160418 TMTC3 Transmembrane And Tetratricopeptide Repeat Containing 3 3.1 0.0029 45
9590 AKAP12 A Kinase (Prka) Anchor Protein 12 3.2 0.0097 16
9114 ATP6V0D1 Atpase, H+ Transporting, Lysosomal 38Kda, V0 Subunit D1 3.2 0.0708 10
55215 FANCI Fanconi Anemia, Complementation Group I 3.3 0.0000 186
92092 ZC3HAV1L Zinc Finger Ccch-Type, Antiviral 1-Like 3.3 0.0411 12
119559 SFXN4 Sideroflexin 4 3.3 0.0553 10
5257 PHKB Phosphorylase Kinase, Beta 3.4 0.0386 15
81502 HM13 Histocompatibility (Minor) 13 3.4 0.0339 13
51605 TRMT6 Trna Methyltransferase 6 Homolog (S. Cerevisiae) 3.4 0.0073 16
56889 TM9SF3 Transmembrane 9 Superfamily Member 3 3.4 0.0063 17
83732 RIOK1 Rio Kinase 1 (Yeast) 3.5 0.0679 8
2937 GSS Glutathione Synthetase 3.6 0.0096 19
60681 FKBP10 Fk506 Binding Protein 10, 65 Kda 3.7 0.0813 10
259217 HSPA12A Heat Shock 70Kda Protein 12A 3.7 0.0451 11
28998 MRPL13 Mitochondrial Ribosomal Protein L13 3.8 0.0067 21
26007 DAK Dihydroxyacetone Kinase 2 Homolog (S. Cerevisiae) 3.8 0.0007 19
48 ACO1 Aconitase 1, Soluble 4.0 0.0195 13
10573 MRPL28 Mitochondrial Ribosomal Protein L28 4.0 0.0209 40
51477 ISYNA1 Inositol-3-Phosphate Synthase 1 4.0 0.0069 18
27250 PDCD4 Programmed Cell Death 4 (Neoplastic Transformation Inhibitor) 4.2 0.0102 17
55697 VAC14 Vac14 Homolog (S. Cerevisiae) 4.5 0.0328 17
23043 TNIK Traf2 And Nck Interacting Kinase 4.5 0.0196 9
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Continued Table 5.3. Proteins significantly enriched on nascent chromatin 
during replication fork stalling. 
  
Entrez ID Official symbol Name
Median 
Enrichment
Median 
p-value
Median 
Spectral 
counts
11073 TOPBP1 Topoisomerase (Dna) Ii Binding Protein 1 4.5 0.0063 18
8634 RTCD1 Rna Terminal Phosphate Cyclase Domain 1 4.7 0.0019 14
114883 OSBPL9 Oxysterol Binding Protein-Like 9 4.9 0.0065 14
23397 NCAPH Non-Smc Condensin I Complex, Subunit H 5.0 0.0045 19
8927 BSN Bassoon (Presynaptic Cytomatrix Protein) 5.0 0.0423 5
9513 FXR2 Fragile X Mental Retardation, Autosomal Homolog 2 5.7 0.0027 17
57698 KIAA1598 Kiaa1598 5.7 0.0033 13
9368 SLC9A3R1 Solute Carrier Family 9 (Sodium/Hydrogen Exchanger), Member 3 Regulator 1 6.0 0.0557 6
56916 SMARCAD1
Swi/Snf-Related, Matrix-Associated Actin-Dependent 
Regulator Of Chromatin, Subfamily A, Containing 
Dead/H Box 1 6.0 0.0493 12
90231 KIAA2013 Kiaa2013 6.0 0.0313 6
55101 ATP5SL Atp5S-Like 7.0 0.0203 6
10989 IMMT Inner Membrane Protein, Mitochondrial (Mitofilin) 7.0 0.0076 12
2177 FANCD2 Fanconi Anemia, Complementation Group D2 7.2 0.0004 58
23167 EFR3A Efr3 Homolog A (S. Cerevisiae) 9.0 0.0329 9
9517 SPTLC2 Serine Palmitoyltransferase, Long Chain Base Subunit 2 11.0 0.0029 11
51199 NIN Ninein (Gsk3B Interacting Protein) 12.0 0.0101 12
1291 COL6A1 Collagen, Type Vi, Alpha 1 12.0 0.0437 12
5810 RAD1 Rad1 Homolog (S. Pombe) 57297.5 0.0425 5
399687 MYO18A Myosin Xviiia 79037.2 0.0917 6
84033 OBSCN Obscurin, Cytoskeletal Calmodulin And Titin-Interacting Rhogef 152603.8 0.0948 5
8688 KRT37 Keratin 37 195494434.4 0.0270 11
284110 GSDMA Gasdermin A 241549526.6 0.0300 5
3658 IREB2 Iron-Responsive Element Binding Protein 2 264604246.8 0.0450 5.5
79646 PANK3 Pantothenate Kinase 3 289859428.7 0.0090 6
26292 MYCBP C-Myc Binding Protein 656599691.0 0.0008 5
26658 OR7C2 Olfactory Receptor, Family 7, Subfamily C, Member 2 656599691.0 0.0008 5
147912 SIX5 Six Homeobox 5 656599691.0 0.0008 5
9833 MELK Maternal Embryonic Leucine Zipper Kinase 656599694.6 0.0033 5
9757 MLL4 Myeloid/Lymphoid Or Mixed-Lineage Leukemia 4 656599700.1 0.0008 5
2717 GLA Galactosidase, Alpha 656599703.2 0.0008 5
80208 SPG11 Spastic Paraplegia 11 (Autosomal Recessive) 656599713.7 0.0008 5
5598 MAPK7 Mitogen-Activated Protein Kinase 7 656599733.5 0.0008 5
51604 PIGT Phosphatidylinositol Glycan Anchor Biosynthesis, Class T 1181879433.9 0.0003 9
10919 EHMT2 Euchromatic Histone-Lysine N-Methyltransferase 2 2855716504.9 0.0002 8
8554 PIAS1 Protein Inhibitor Of Activated Stat, 1 3192788694.0 0.0002 9
800 CALD1 Caldesmon 1 5821982068.5 0.0000 7
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The ATR inhibited and collapsed replisome with associated proteins 
The iPOND-MS proteins enriched at collapsed forks were plotted as 
described in Fig. 5.4 to examine the distribution of proteins at replication forks 
that become unstable during replication stress without ATR. As noted before, 
QuasiTel statistical analyses overestimate the relative fold enrichment when zero 
spectral counts are detected in the chromatin chase control. Thus, the top 18 
most enriched proteins listed in Table 5.4 are outside the linear range plotted in 
Fig. 5.4.  
One such highly enriched protein is the methyl methansulfonate-sensitivity 
protein MMS22L (Table 5.4). In complex with the DNA repair protein TONSL, 
MMS22L is recruited to sites of RPA-coated ssDNA to promote recombinatorial 
repair of damaged replication forks [126-128]. TONSL was also found highly 
enriched (8-fold) at collapsed replication forks (highlighted in Table 5.4). The 
MMS22L-TONSL complex facilitates HR after DNA end resection through 
promoting Rad51 filament formation. Interestingly, Rad51 was also found highly 
enriched at ATR inhibited forks (Table 5.4). Other known DDR proteins present at 
ATR inhibited forks play roles in DSB repair. Factors such as BRIP1 and MCD1 
harbor BRCT motifs that bind phosphorylated proteins important for DNA repair. 
Collectively, this supports the idea that ATR prevents aberrant processing of 
unstable replication forks into DSBs and limits the accumulation of DNA repair 
factors at replication forks.  
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Figure 5.4. iPOND-MS identifies proteins significantly enriched on replicating DNA after replication stress 
and ATR inhibition. (A) The fold enrichment relative to the chromatin chase negative control, the p-value and 
the spectral count data, which passed the filtering criteria described in the text, are depicted for the proteins 
listed in Table 5.4, which passed the filtering criteria described in the text. The dot size indicates the total 
number of MS spectra counted in the collapsed replication fork samples from the five replicate purifications. 
The dot color represents p-value as calculated using QuasiTel. The dot plots were generated in R by Yaoyi 
Chen. (B) Protein network analyses probed the physical interactions at collapsed replication forks using the 
GeneMANIA prediction server. Yellow highlight indicates proteins known to function or accumulate after ATR 
inhibition. (C) List of iPOND-MS collapsed replication fork proteins that either: contain potential PCNA 
interacting motifs, are annotated to interact with RPA1 or RPA2 according to GeneMANIA, are predicted 
ATM/ATR substrates, or cause DNA damage when depleted.  
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Table 5.4. Proteins significantly enriched on nascent chromatin during ATR 
inhibition at stalled replication forks. Hayes McDonald performed QuasiTel 
comparisons between collapsed replication fork samples and negative controls. 
 
Entrez ID Official symbol Name
Median 
Enrichment
Median 
p-value
Median 
Spectral 
counts
26128 KIAA1279 Kiaa1279 1.4 0.0176 35
9733 SART3 Squamous Cell Carcinoma Antigen Recognized By T Cells 3 1.4 0.0719 43
9330 GTF3C3 General Transcription Factor Iiic, Polypeptide 3, 102Kda 1.5 0.0644 38
760 CA2 Carbonic Anhydrase Ii 1.5 0.0118 61
403 ARL3 Adp-Ribosylation Factor-Like 3 1.5 0.0607 22
57510 XPO5 Exportin 5 1.5 0.0221 44
65080 MRPL44 Mitochondrial Ribosomal Protein L44 1.5 0.0397 28
23196 FAM120A Family With Sequence Similarity 120A 1.5 0.0154 33
64225 ATL2 Atlastin Gtpase 2 1.5 0.0469 25
5701 PSMC2 Proteasome (Prosome, Macropain) 26S Subunit, Atpase, 2 1.5 0.0105 66
118 ADD1 Adducin 1 (Alpha) 1.6 0.0205 22
51727 CMPK1 Cytidine Monophosphate (Ump-Cmp) Kinase 1, Cytosolic 1.6 0.0440 35
5426 POLE Polymerase (Dna Directed), Epsilon 1.6 0.0042 45
5232 PGK2 Phosphoglycerate Kinase 2 1.6 0.0314 31
8453 CUL2 Cullin 2 1.6 0.0550 40
10613 ERLIN1 Er Lipid Raft Associated 1 1.7 0.0486 32
7174 TPP2 Tripeptidyl Peptidase Ii 1.7 0.0823 32
2805 GOT1 Glutamic-Oxaloacetic Transaminase 1, Soluble (Aspartate Aminotransferase 1) 1.7 0.0334 33
8452 CUL3 Cullin 3 1.7 0.0667 56
8295 TRRAP
Transformation/Transcription Domain-Associated Protein
1.7 0.0608 28
51651 PTRH2 Peptidyl-Trna Hydrolase 2 1.7 0.0629 26
166378 SPATA5 Spermatogenesis Associated 5 1.7 0.0025 72
5984 RFC4 Replication Factor C (Activator 1) 4, 37Kda 1.8 0.0131 51
4128 MAOA Monoamine Oxidase A 1.8 0.0480 46
5424 POLD1 Polymerase (Dna Directed), Delta 1, Catalytic Subunit 125Kda 1.8 0.0027 97
23471 TRAM1 Translocation Associated Membrane Protein 1 1.8 0.0380 11
5985 RFC5 Replication Factor C (Activator 1) 5, 36.5Kda 1.8 0.0038 46
10226 PLIN3 Mannose-6-Phosphate Receptor Binding Protein 1 1.9 0.0369 34
7386 UQCRFS1 Ubiquinol-Cytochrome C Reductase, Rieske Iron-Sulfur Polypeptide-Like 1 1.9 0.0001 36
25873 RPL36P14 Ribosomal Protein L36 Pseudogene 14 1.9 0.0888 23
56886 UGGT1 Udp-Glucose Ceramide Glucosyltransferase-Like 1 1.9 0.0687 33
83743 GRWD1 Glutamate-Rich Wd Repeat Containing 1 1.9 0.0068 33
51234 TMEM85 Transmembrane Protein 85 2.0 0.0955 7
81609 SNX27 Sorting Nexin Family Member 27 2.0 0.0472 20
5558 PRIM2 Primase, Dna, Polypeptide 2 (58Kda) 2.0 0.0201 40
1962 EHHADH Enoyl-Coenzyme A, Hydratase/3-Hydroxyacyl Coenzyme A Dehydrogenase 2.0 0.0659 9
8402 SLC25A11 Solute Carrier Family 25 (Mitochondrial Carrier; Oxoglutarate Carrier), Member 11 2.1 0.0205 38
9656 MDC1 Mediator Of Dna-Damage Checkpoint 1 2.1 0.0006 93
55027 HEATR3 Heat Repeat Containing 3 2.1 0.0261 26
5981 RFC1 Replication Factor C (Activator 1) 1, 145Kda 2.1 0.0067 40
2171 FABP5 Fatty Acid Binding Protein 5 (Psoriasis-Associated) 2.1 0.0093 23
160418 TMTC3 Transmembrane And Tetratricopeptide Repeat Containing 3 2.2 0.0123 32
9897 KIAA0196 Kiaa0196 2.2 0.0393 56
5356 PLRG1 Pleiotropic Regulator 1 (Prl1 Homolog, Arabidopsis) 2.2 0.0047 40
26263 FBXO22OS F-Box Protein 22 2.2 0.0409 14
55752 SEPT11 Septin 11 2.2 0.0251 26
10914 PAPOLA Poly(A) Polymerase Alpha 2.2 0.0489 22
9942 XYLB Xylulokinase Homolog (H. Influenzae) 2.2 0.0466 14
9777 TM9SF4 Transmembrane 9 Superfamily Protein Member 4 2.2 0.0935 11
55215 FANCI Fanconi Anemia, Complementation Group I 2.2 0.0009 125
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Continued Table 5.4. Proteins significantly enriched on nascent chromatin 
during ATR inhibition at stalled replication forks. 
  
Entrez ID Official symbol Name
Median 
Enrichment
Median 
p-value
Median 
Spectral 
counts
5001 ORC5L Origin Recognition Complex, Subunit 5-Like (Yeast) 2.2 0.0030 20
9044 BTAF1 Btaf1 Rna Polymerase Ii, B-Tfiid Transcription Factor-Associated, 170Kda (Mot1 Homolog, S. Cerevisiae) 2.3 0.0260 21
55218 EXD2 Exonuclease 3'-5' Domain Containing 2 2.3 0.0018 16
23047 PDS5B Pds5, Regulator Of Cohesion Maintenance, Homolog B (S. Cerevisiae) 2.3 0.0420 60
3619 INCENP Inner Centromere Protein Antigens 135/155Kda 2.3 0.0821 15
8914 TIMELESS Timeless Homolog (Drosophila) 2.3 0.0320 21
84342 COG8 Peptide Deformylase (Mitochondrial); Component Of Oligomeric Golgi Complex 8 2.4 0.0289 23
22826 DNAJC8 Dnaj (Hsp40) Homolog, Subfamily C, Member 8 2.5 0.0011 31
48 ACO1 Aconitase 1, Soluble 2.5 0.0154 50
84993 UBL7 Ubiquitin-Like 7 (Bone Marrow Stromal Cell-Derived) 2.5 0.0966 5
545 ATR* Ataxia Telangiectasia And Rad3 Related 2.5 0.0546 20
472 ATM Similar To Serine-Protein Kinase Atm (Ataxia Telangiectasia Mutated) 2.5 0.0602 15
10550 ARL6IP5 Adp-Ribosylation-Like Factor 6 Interacting Protein 5 2.6 0.0519 23
11344 TWF2 Twinfilin, Actin-Binding Protein, Homolog 2 (Drosophila) 2.6 0.0762 14
29105 C16ORF80 Chromosome 16 Open Reading Frame 80 2.7 0.0431 16
5238 PGM3 Phosphoglucomutase 3 2.7 0.0616 17
7515 XRCC1 X-Ray Repair Complementing Defective Repair In Chinese Hamster Cells 1 2.7 0.0012 35
25820 ARIH1 Ariadne Homolog, Ubiquitin-Conjugating Enzyme E2 Binding Protein, 1 (Drosophila) 2.7 0.0602 11
63875 MRPL17 Mitochondrial Ribosomal Protein L17 2.7 0.0441 11
55697 VAC14 Vac14 Homolog (S. Cerevisiae) 2.8 0.0926 9
6117 RPA1 Replication Protein A1, 70Kda 2.8 0.0000 287
23133 PHF8 Phd Finger Protein 8 2.8 0.0411 12
10573 MRPL28 Mitochondrial Ribosomal Protein L28 2.8 0.0217 29
28998 MRPL13 Mitochondrial Ribosomal Protein L13 2.8 0.0268 17
3305 HSPA1L Heat Shock 70Kda Protein 1-Like 2.9 0.0223 136
10478 SLC25A17 Solute Carrier Family 25 (Mitochondrial Carrier; Peroxisomal Membrane Protein, 34Kda), Member 17 2.9 0.0365 13
2937 GSS Glutathione Synthetase 3.0 0.0366 17
5514 PPP1R10 Protein Phosphatase 1, Regulatory (Inhibitor) Subunit 10 3.0 0.0529 12
5269 SERPINB6 Serpin Peptidase Inhibitor, Clade B (Ovalbumin), Member 6 3.0 0.0125 18
10016 PDCD6 Programmed Cell Death 6 3.0 0.0651 12
6118 RPA2 Replication Protein A2, 32Kda 3.1 0.0010 55
3980 LIG3 Ligase Iii, Dna, Atp-Dependent 3.1 0.0183 30
79654 HECTD3 Hect Domain Containing 3 3.2 0.0392 16
51594 NBAS Neuroblastoma Amplified Sequence 3.2 0.0456 13
51605 TRMT6 Trna Methyltransferase 6 Homolog (S. Cerevisiae) 3.4 0.0249 16
60681 FKBP10 Fk506 Binding Protein 10, 65 Kda 3.5 0.0489 9
7570 ZNF22 Zinc Finger Protein 22 (Kox 15) 3.5 0.0387 7
29925 MRPL37 Mitochondrial Ribosomal Protein L37 3.5 0.0078 14
2177 FANCD2 Fanconi Anemia, Complementation Group D2 3.6 0.0172 30
8776 MTMR1 Myotubularin Related Protein 1 3.7 0.0011 18
63922 CHTF18 Ctf18, Chromosome Transmission Fidelity Factor 18 Homolog (S. Cerevisiae) 4.0 0.0269 21
1312 COMT Catechol-O-Methyltransferase 4.0 0.0379 8
57665 RDH14 Retinol Dehydrogenase 14 (All-Trans/9-Cis/11-Cis); 5'-Nucleotidase, Cytosolic Ib 4.0 0.0571 8
51477 ISYNA1 Inositol-3-Phosphate Synthase 1 4.0 0.0173 19
23549 DNPEP Aspartyl Aminopeptidase 4.0 0.0079 16
10025 MED16 Mediator Complex Subunit 16 4.0 0.0995 11
8526 DGKE Diacylglycerol Kinase, Epsilon 64Kda 4.0 0.0313 7
27250 PDCD4 Programmed Cell Death 4 (Neoplastic Transformation Inhibitor) 4.2 0.0059 14
6811 STX5 Syntaxin 5 4.5 0.0102 9
26007 DAK Dihydroxyacetone Kinase 2 Homolog (S. Cerevisiae) 4.6 0.0024 23
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Continued Table 5.4. Proteins significantly enriched on nascent chromatin 
during ATR inhibition at stalled replication forks. 
  
Entrez ID Official symbol Name
Median 
Enrichment
Median 
p-value
Median 
Spectral 
counts
5875 RABGGTA Rab Geranylgeranyltransferase, Alpha Subunit 5.0 0.0423 6
253635 CCDC75 Coiled-Coil Domain Containing 75 5.0 0.0423 5
57698 KIAA1598 Kiaa1598 5.0 0.0348 14
10325 RRAGB Ras-Related Gtp Binding B 5.5 0.0071 11
11073 TOPBP1 Topoisomerase (Dna) Ii Binding Protein 1 6.0 0.0005 24
7486 WRN Similar To Werner Syndrome Protein; Werner Syndrome, Recq Helicase-Like 6.0 0.0089 14
7374 UNG Uracil-Dna Glycosylase 6.0 0.0371 12
10989 IMMT Inner Membrane Protein, Mitochondrial (Mitofilin) 6.5 0.0116 11
56916 SMARCAD1
Swi/Snf-Related, Matrix-Associated Actin-Dependent 
Regulator Of Chromatin, Subfamily A, Containing 
Dead/H Box 1 6.5 0.0322 13
7156 TOP3A Topoisomerase (Dna) Iii Alpha 6.7 0.0036 20
9557 CHD1L Chromodomain Helicase Dna Binding Protein 1-Like 7.0 0.0141 11
22904 SBNO2 Strawberry Notch Homolog 2 (Drosophila) 7.0 0.0203 7
10591 DNPH1 2'-Deoxynucleoside 5'-phosphate N-hydrolase 1 8.0 0.0309 8
4796 TONSL Tonsoku-like; DNA repair protein 8.0 0.0309 8
9538 EI24 Etoposide Induced 2.4 Mrna 8.0 0.0120 7
6522 SLC4A2 Solute Carrier Family 4, Anion Exchanger, Member 2 10.0 0.0058 5
641 BLM Bloom Syndrome, Recq Helicase-Like 11.0 0.0178 17
83990 BRIP1 Brca1 Interacting Protein C-Terminal Helicase 1 13.0 0.0025 13
6119 RPA3 Replication Protein A3, 14Kda 15.0 0.0024 15
50485 SMARCAL1 Swi/Snf Related, Matrix Associated, Actin Dependent Regulator Of Chromatin, Subfamily A-Like 1 16.0 0.0005 16
80856 KIAA1715 Kiaa1715 57297 0.0425 5
9527 GOSR1 Golgi Snap Receptor Complex Member 1 67795 0.0131 6
253714 MMS22L MMS22-like, DNA repair protein 85755 0.0156 7.5
51604 PIGT Phosphatidylinositol Glycan Anchor Biosynthesis, Class T 241288 0.0422 8.5
9910 RABGAP1L Rab Gtpase Activating Protein 1-Like 289859431 0.0090 6
49855 SCAPER S-Phase Cyclin A-Associated Protein In The Er 656599691 0.0161 5
201475 RAB12 Rab12, Member Ras Oncogene Family 656599691 0.0058 5
56955 MEPE Matrix Extracellular Phosphoglycoprotein 656599696 0.0058 5
91875 TTC5 Tetratricopeptide Repeat Domain 5 656599708 0.0058 5
10776 ARPP19 Camp-Regulated Phosphoprotein, 19Kda 656599709 0.0058 5
118426 LOH12CR1 Loss Of Heterozygosity, 12, Chromosomal Region 1 656599732 0.0058 5
5810 RAD1 Rad1 Homolog (S. Pombe) 656599732 0.0008 5
195977 ANTXRL Anthrax Toxin Receptor-Like 656599732 0.0008 5
23210 JMJD6 Jumonji Domain Containing 6 719268928 0.0007 5.5
5888 RAD51 Rad51 Homolog (Reca Homolog, E. Coli) (S. Cerevisiae) 787919631 0.0035 6
5908 RAP1B Rap1B, Member Of Ras Oncogene Family 787919645 0.0035 6
1756 DMD Dystrophin 35849128351 0.0000 5
64785 GINS3 Gins Complex Subunit 3 (Psf3 Homolog) 35849128461 0.0000 5
!"#"$% !"#$%&'
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To examine physical interactions at collapsed replication forks, I queried 
the GeneMANIA bioinformatics database [74], which revealed that one-fourth of 
the identified proteins form a tight network (Fig. 5.4B). ATM and the 
heterotrimeric RPA complex are highlighted as major contributors to the system. 
The recruitment of ATM is consistent with genetic studies demonstrating that 
ATR inhibition activates ATM [61] and we have directly detected DSB formation 
after ATR inhibition using comet assays (Couch FB and Cortez, unpublished 
results). These findings support the idea that DSB formation is prevalent at ATR 
inhibited replication forks. Furthermore, RPA subunits were also highly enriched 
at collapsed forks (Table 5.4). This provides additional support to the idea that 
iPOND-MS purifies forks that have collapsed into DSBs and recombinogenic 
structures.  
Since RPA accumulated at collapsed forks, I next assessed whether any 
of the identified proteins are known to interact with RPA. Several disease-
associated helicases including the Blooms Syndrome protein BLM, the oncogene 
and chromodomain helicase CHD1L (also known as ALC1), the SIOD syndrome 
mutated annealing helicase SMARCAL1, and the Werner Syndrome RecQ 
helicase WRN were highly enriched at collapsed replication forks (Fig. 5.4C) 
[129, 130]. Other RPA1 or RPA2 binding proteins linked to DNA damage 
responses (BRIP1, CUL3, TOP3A, TOPBP1 and UNG) were also detected at 
ATR inhibited forks (Fig. 5.4C).  
	   116	  
Furthermore, RPA-coated ssDNA is the checkpoint-activating structure for 
the recruitment of ATR [14]. Although slightly below the filtering criteria for 
significance (p-value of 0.0546), ATR was enriched at collapsed forks and 
included in Table 5.4 (marked * for insignificant). The ATR activating protein 
TOPBP1 accumulated as well, although most ATR molecules are likely inactive 
under these conditions. Collectively, iPOND-MS purification of collapsed 
replication forks identified numerous RPA-interacting proteins. 
To determine if the collapsed fork protein dataset contains genes 
previously linked to DNA damage response signaling, I cross-referenced several 
genomic and proteomic screens [41, 123-125]. Sixteen identified proteins are 
potential ATM/ATR substrates (p-value 0.03, hypergeometric test, see Chapter II) 
and 23 of the proteins may cause DNA damage when deleted (Fig. 5.4C). 
Overall, iPOND purification of collapsed replication forks led to the identification 
of several high confidence genome maintenance proteins. 
 
Prioritization and validation of replication fork proteins identified with iPOND-MS 
To prioritize the 244 novel proteins identified in the iPOND-MS screens, 
my initial strategies for narrowing the list of proteins of interest included: (a) 
applying stringent filtering criteria for fold enrichment relative to two negative 
controls, requiring a low p-value derived from QuasiTel statistical analyses of raw 
spectral counts, and high spectral count values; (b) cross-referencing the dataset 
with genomic and proteomics screens that identified DNA damage response 
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proteins [41, 123-125]; (c) searching bioinformatics databases for references to 
predicted domains implicated in replication or repair [73, 74]; (d) performing 
extensive literature searches to find proteins of interest.  Proteins containing 
domains linked to DNA replication (eg. PCNA-interacting motifs) [122], having 
predicted enzymatic activity (ATPase domains) [73], and other known functional 
domains were ranked with highest interest. A broad initial prioritization of proteins 
that fulfilled at least one of these criteria led to 148 proteins of interest (Appendix 
B). 
To further narrow the list of replication fork proteins of interest, a high-
throughput immunofluorescence screen was performed to find genes that 
function similarly to ATR (Kavanaugh G, unpublished data). Silencing of ATR 
causes DNA damage and compromises the restart of persistently stalled 
replication forks [14]. To find ATR-like genes, the 148 genes of interest were 
silenced using 4 siRNAs and the phosphorylation of H2AX and incorporation of 
EdU were measured after release from treatment with HU. ATR silencing results 
in high γH2AX and low EdU values since forks collapse into DSBs and do not 
resume DNA synthesis. Thus, an ATR-like gene would be predicted to have high 
γH2AX and low EdU values (a high ʻATR-like scoreʼ) (Fig. 5.5).  
Silencing of the chromatin remodeler SNF2L and the phosphatase 
PPP1R10 exhibited an ATR-like phenotype with 3 of 4 siRNAs (Fig 5.5). 
Interestingly, the chromatin remodeler SNF2H, which is highly related to SNF2L, 
did not phenocopy loss of SNF2L in this screen.  
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Figure 5.5 Functional genomic screen reveals SNF2L and PPP1R10 function in the DNA damage response. 
Cells depleted of SNF2L and PPP1R10 were treated with HU for 24 hours, released from replication stress, 
and pulse labeled with EdU to monitor restart of DNA replication. The immunofluorescence screen monitored 
fork restart (EdU incorporation) and phosphorylation of histone H2AX (a marker of DNA damage). The ATR-
like score plotted on the y axis represents the average ratio of γH2AX to EdU values obtained for individual 
siRNAs targeting the genes of interest. ATR-like scores were calculated from individual nuclei visualized in 
the screen. The red dot color indicates a significant ATR-like score for the specified siRNA. Statistical 
significance relative to non-targeting siRNA negative control was calculated using Wilcoxin sum rank 
statistical testing. The plotted dots represent the 16 genes that exhibited significant ATR-like scores with at 
least 2 of 4 siRNAs tested. 
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While it is tempting to speculate that the two remodelers may function in 
separate genetic pathways, more experiments are needed to directly test this 
hypothesis (see Chapter VI). SNF2L was deemed of highest interest and pursued 
for further validation and preliminary functional characterization. 
 
The chromatin remodeler SNF2L localizes to elongating replication forks 
To validate SNF2L localization to elongating replication forks, two 
independent iPOND identification methods were employed. First, quantitative MS 
in selected reaction monitoring (SRM) mode was used to determine the 
enrichment of SNF2L on nascent chromatin. The same experimental framework 
was used for SRM analyses as that used in the original iPOND-MS screen (Fig. 
5.1A). The signal intensities showed an enrichment of SNF2L and the positive 
control BAZ1B at elongating replication forks relative to the chromatin chase (Fig. 
5.6B-E). Detection of RPA2 enrichment at collapsed replication forks (SRM 
sample 5) indicates that the iPOND-SRM method identified proteins enriched 
with a maximum 3-fold range of detection. The RPA binding protein UNG and the 
ATPase ATAD2 were also validated using iPOND-SRM (Fig. C.1.). 
The second SNF2L validation method used a standard iPOND purification 
scheme followed by immunoblotting. SNF2L and the related chromatin remodeler 
SNF2H accumulated on nascent DNA at elongating replication forks (Fig. 5.6F).   
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Figure 5.6. Validation of SNF2L association with elongating replication forks. (A–E) Quantitative mass 
spectrometry in selected reaction monitoring mode (SRM) examined the indicated peptides for RPA2, 
BAZ1B, and SNF2L after iPOND purifications and was performed by David Friedman in the Vanderbilt 
Proteomics Core. SRM samples 2, 3, 4, and 5 represent normal replication forks, thymidine chase negative 
control, HU-treated stalled forks, HU and ATR inhibited collapsed forks, respectively. The signal intensity 
measured for each peptide is normalized to the sum of the internal reference peptides (Σ4IRPs). (F) Cells 
labeled with EdU for 10 min were collected or chased into thymidine for 60 mins, iPOND was performed and 
followed by immunoblotting using antibodies specific to SNF2L and SNF2H.  
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To test if SNF2L functions in DNA replication, I silenced SNF2L with two 
siRNAs and examined nascent DNA fiber lengths after short labeling times with 
the nucleoside analogs IdU and CldU under unperturbed conditions. In one 
preliminary experiment, cells lacking SNF2L exhibited shorter DNA fibers, 
consistent with a function for SNF2L in fork progression (data not shown). 
Collectively, I validated that SNF2H, BAZ1B, and SNF2L localize to moving 
replication forks and provided preliminary evidence suggesting that SNF2L may 
promote replication fork progression.   
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Discussion 
 
In this chapter, I coupled iPOND purification of replication forks with two-
dimensional LC-MS/MS to identify the replisome components and nascent DNA-
associating proteins under normal and DNA damage conditions. The iPOND-MS 
screen yielded a total of 290 proteins that were significantly enriched at 
elongating, HU-stalled, and ATR inhibited replication forks. The dataset included 
a statistically significant fraction of proteins known to function in DNA damage 
responses, cell cycle control, DNA repair and replication (Fig. 5.2D).  
For example, at normally elongating replication forks, 15 of the top 20 
most noteworthy proteins, as measured by fold enrichment and p-value, are 
established replisome components and chromatin replication factors. These 
include the replicative polymerases, PCNA, the replication-loading complex RFC 
(RFC1-5), and the chromatin assembly factors CAF1A and CAF1B. Although the 
number of positive controls identified at stalled forks is lower than those observed 
under unperturbed conditions, the dataset still enriched for DDR proteins above 
random chance of occurrence. Collapsed replication forks exhibited strong 
enrichment of RPA, double-strand break proteins, fork remodeling helicases, and 
replisome components.  
Although numerous DNA replication and damage proteins were identified, 
not all components of the replisome were found enriched in my iPOND-MS 
studies. This may reflect poor fold enrichments of replisome proteins in the 
iPOND conditions used. Another group successfully identified the majority of the 
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replisome components using a similar iPOND-MS purification framework, but a 
different MS approach with a more sensitive MS instrument (see Chapter VI for 
further discussion on differences in both experimental conditions and MS 
analyses) [82]. Nonetheless, both screens identified the following 20 replisome 
components: ATAD5, BAZ1B, CHAF1A, CHAF1B, DNMT1, EXO1, LIG1, MSH2, 
MSH3, MSH6, PCNA, POLD1, POLE, RFC1-5, UHRF1, and WIZ. While 39 of the 
additional 48 replication fork proteins identified by the other group are known 
replication fork proteins, 64 additional proteins from my screen have not been 
associated with functions during DNA replication. This suggests that the 
biological false discovery rate in my iPOND-MS screen may be high and will 
require future optimization to increase the signal to noise ratio (see Chapter VI for 
further discussion on potential solutions).  
Proteins that were observed at normal, stalled, and collapsed replication 
fork types and have previous links to DNA replication and the DNA damage 
response are discussed below. 
 
EXO1 and mismatch repair activities at elongating replication forks 
 The exonuclease EXO1 was one of the highest enriched proteins at 
unperturbed replication forks in my study and was confirmed in a recently 
published iPOND-MS screen [82]. EXO1ʼs best-established function is in 
extending DNA end resection of double-strand breaks after MRE11-dependent 
nicking [131]. In S. cerevisiae and X. laevis, EXO1ʼs nucleolytic activity in the 5ʼ-
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to-3ʼ direction generates a substrate for Rad51 binding and is essential for 
homology-directed repair [131-133].  Additionally, Exo1 possesses flap 
endonuclease activity that facilitates Okazaki fragment maturation [134]. 
At least in S. cerevisiae, EXO1 also functions in mismatch repair (MMR), a 
repair pathway activated during each S phase to remove bases mis-incorporated 
by DNA polymerases. EXO1 interacts with the MMR protein MSH2, which 
localizes in a complex with MSH3 or MSH6 to replication foci in a PCNA-
dependent manner [135]. EXO1 excises mismatched bases encountered 
primarily on the lagging strand produced by the proofreading-deficient 
polymerase alpha [135, 136]. EXO1ʼs role in MMR surveillance at replication 
forks is not as crucial as that of MSH2 since deletion of EXO1 causes fewer 
mutations than does deletion of MSH2 alone or a double knockout EXO1 and 
MSH2 mutant [137, 138]. It appears that EXO1 becomes most important for 
MMR when the MSH6-PCNA interaction is disrupted [135]. Perhaps EXO1 is 
needed when replication forks experience a high burden of base damage that 
canonical MMR proteins cannot repair alone.  
My iPOND-MS results indicate an enrichment of the mammalian MMR 
proteins MSH2, MSH3 and MSH6 and EXO1, confirming that MMR activity is 
coupled to replisomes in higher organisms. These findings are further supported 
by another iPOND-MS screen that identified MMR proteins as the most enriched 
factors at forks after PCNA [82]. Since iPOND is an ensemble methodology, 
whether EXO1 and the MMR proteins co-localize and function to repair the same 
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nascent DNA fragment remains to be determined. Coupling iPOND to single 
molecule analyses would provide the necessary relative spatial resolution 
needed to answer this question. 
Why such considerable enrichment of MMR at elongating forks?  One 
possible explanation is that the MSH2-MSH3 and MSH3-MSH6 complexes are 
recruited to forks via interactions with PCNA and CAF1 [139, 140]. Aside from the 
endogenous base mis-incorporations that occur in each S phase, MMR proteins 
may recognize EdU labeled nascent DNA. Any damage due to EdU incorporation 
does not appear to activate the checkpoint as measured by the lack of H2AX 
phosphorylation at iPOND purified elongating replication forks (see previous 
chapters).  
 
Fanconi anemia proteins at replication forks 
The Fanconi anemia mutated FANCI and FANCD2 genes encode 
intercrosslink repair proteins and were found highly enriched at stalled and 
collapsed replication forks (Table 5.3 and 5.4). Current models pose that FANCI 
and FANCD2 function in complex (the ID complex) during interstrand crosslink 
repair [46]. These lesions are some of the most difficult to repair substrates, 
requiring specialized repair mechanisms governed by genes mutated in patients 
with Fanconi anemia (FA), as well as components of nucleotide excision and 
DSB repair [28]. Although FA patient-derived cells are hypersensitive to 
crosslinking reagents such as mitomycin C (MMC), Iack of FANC ID renders cells 
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only mildly sensitive to HU, suggesting that the main function of the ID complex is 
during ICL repair and not replication stress [141].  
Why would the ID complex enrich at stalled and collapsed forks? Perhaps 
DNA structures generated at stalled and collapsed forks resemble those at ICL 
repair sites. Indeed, recent structural studies indicate a preference of the ID 
complex for binding ssDNA-dsDNA junctions [142], a structure likely prevalent at 
replication forks as a result of polymerase-driven repriming events that promote 
checkpoint signaling [115, 143]. FANCI also passed the filtering criteria for 
enrichment at elongating replication forks while FANCD2 did not (Table 5.2-5.4). 
In support of an ID complex-independent role for FANCD2, recent evidence 
shows that FANCD2 may promote restart of aphidicholin-stalled replication forks 
independently of FANCI [144]. Collectively, the ID complex localizes to damaged 
replication forks and future work is needed to examine the function of this 
complex at normal, stalled and collapsed forks.  
 
ATAD2 ATPase localization to replication forks 
ATAD2 is an oncogene amplified in MYC-driven endometrial cancers [145] 
that I found localizes to elongating replication forks. Several lines of evidence 
make ATAD2 an attractive target for further studies. First, ATAD2 encodes an 
ATPase with a bromo domain that has been shown to bind acetylated H4K5 
[146]. A testable hypothesis would pose that ATAD2ʼs bromo domain localizes 
the protein to nascent chromatin that contains acetylated H4K5. Second, ATAD2 
	   127	  
co-localizes with BrdU that marks actively replicating cells [145], although it is 
difficult to distinguish whether ATAD2 forms distinguishable S-phase foci. Third, 
ATAD2 depletion sensitizes breast cancer cell lines to the histone deacetylase 
inhibitor trichostatin-A [145]. This suggests that ATAD2 may be a good 
prognostic marker for HDAC inhibitors currently in clinical use. However, no 
publications address a mechanistic role for ATAD2 during DNA replication. 
Further validation and testing ATAD2 function at the replication fork should be of 
high interest for future studies. 
 
Fork remodeling enzymes at ATR inhibited and collapsed replication forks 
The high enrichment of the heterotrimeric ssDNA-binding protein RPA is a 
striking feature of stalled replication forks that collapse after ATR inhibition (Table 
5.4, first observed independently by Jami FB Couch, unpublished results). 
Concomitant with RPA accumulation, I observed the enrichment of the disease-
associated helicases BLM, CHD1L, SMARCAL1 and WRN, which are all RPA 
interacting proteins, suggesting that their enrichment at collapsed forks is at least 
partially due to RPA accumulation.   
The formation of excess RPA-coated ssDNA at damaged forks may reflect 
aberrant fork remodeling activities driven by or normally resolved by these 
helicases. For example, SMARCAL1 is an SNF2 family ATPase that is activated 
by complex DNA structures and uses the energy of ATP hydrolysis to re-anneal 
DNA strands [47]. The WRN helicase unwinds a variety of complex DNA 
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structures. Both enzymes can catalyze regression of replication forks, generating 
a Holliday junction on model replication substrates [147-150]. SMARCAL1 and 
WRN also branch migrate the Holliday junctions, which could restore the normal 
fork structure via a reversed fork intermediate [39, 148].  
Thus, ATR may stabilize a fork and prevent fork collapse and disease by 
restricting aberrant ATPase-dependent reorganization of DNA structures at 
stalled replication forks (Fig. 5.7). ATR directly phosphorylates both SMARCAL1 
and WRN and cells expressing a non-phosphorylatable WRN mutant exhibit 
increased fork breakage [151]. DDR kinase phosphorylation of SMARCAL1 also 
controls the helicaseʼs enzymatic activity (Couch, Bansbach and Cortez, 
unpublished results). Therefore, the accumulation of RPA and several helicases 
at stalled forks lacking ATR activity reflects an essential ATR function in blocking 
fork restructuring to ensure genome stability.  
ATR may also restrict ssDNA accumulation by restraining fork movement 
driven by uncontrolled DNA unwinding. This concept is supported by the fact that 
ATR phosphorylates several replisome components including the Cdc45-MCM-
GINS (CMG) helicase subunits [41, 152-156]. Phosphorylation of CMG may 
regulate helicase activity to prevent excessive unwinding and is necessary to 
promote rescue of stalled forks from adjacent origins [155, 156]. In yeast, lack of 
ATR activity causes ssDNA gaps as visualized by electron microscopy [39]. Such 
gaps may be the consequence of unproductive DNA polymerization coupled to 
unrestrained fork movement.  
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Single and double-strand break repair proteins at collapsed replication forks 
I observed the enrichment of double-strand break repair (DSBR) and 
recombination proteins Rad51 and the MMS22L-TONSL complex at collapsed 
forks. This observation further supports the model that ATR limits collapse of 
stalled forks into DSBs, which may be resolved using recombinatiorial 
mechanisms (Fig. 5.7). Too many recombination events can cause abnormal fork 
structures, but too few events can prevent proper Rad51-mediated fork restart 
after DNA damage [39, 87].  
In addition to DSBR factors, the single-strand break repair (SSBR) 
proteins XRCC1 and Ligase III showed significant enrichment (3-fold) when ATR 
was inhibited (Table 5.4). After IR, the damage-induced localization of these 
factors depends on PARP1-mediated poly(ADP-ribosyl)ation and the PAR-
binding domains of XRCC1 and Ligase III [157, 158].  PARP1-mediated 
localization of XRCC1 and Ligase III to single-stranded DNA breaks is likely 
critical for cell survival in the absence of ATR. In support of this idea, knockdown 
of ATR is synthetic lethal with PARP inhibition [159]. It will be important to 
examine other synthetic lethal interactions following ATR inhibition to understand 
the potential mechanisms governing fork collapse. Inhibition of Ligase III may be 
an interesting therapeutic target given that Ligase III accumulates at ATR 
inhibited forks and both enzymes are currently being considered as single agent 
cancer treatments [160]. 
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Figure 5.7. Model for how ATR prevents replication fork collapse. ATR prevents the accumulation 
of single and double-strand breaks and limits recombination and fork remodeling activities. 
Whether ATR stabilizes stalled replication forks by preventing replisome disassembly remains to 
be elucidated. Yellow circles represent RPA, which accumulates on nascent ssDNA generated 
when ATR is inhibited.  
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Replisome composition without ATR  
I observed that ATR inhibited forks exhibit enrichment of the replicative 
polymerases (POLD1 and POLE) and the clamp loader complex (RFC1-5) 
similarly to elongating replication forks. Several possibilities may explain these 
results. One possibility is that a fraction of replication forks are still intact and 
have not collapsed. Another explanation is that an intact replisome is maintained 
at collapsed replication forks in mammalian cells. This could suggest that ATR 
activity is dispensable for replisome stability. Such a scenario would be in 
contrast to previous findings in yeast and Xenopus reporting loss of at least some 
replisome components in the absence of ATR function [35-37, 40], although 
recent biochemical evidence contests these results [156]. A third possibility is 
that replisomes are enriched on the nascent DNA generated at newly established 
replication forks. ATR inhibition causes new origin firing (Couch FB et al, 
publication in press), consistent with the established role of ATR in suppressing 
new origin firing in the presence of DNA damage. Since some level of origin firing 
occurs in the absence of ATR activity under these experimental conditions, I 
cannot determine if the mammalian replisome disassembles without ATR activity 
(Fig. 5.7). 
  
Replicating and restoring chromatin after replication fork passage 
 Several SWI/SNF-like chromatin remodeling enzymes were enriched at 
replication forks including SMARCAD1, SNF2L and SNF2H. SMARCAD1 
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interacts with PCNA, which localizes the remodeler to replication forks where it 
promotes deacetylation of histones H3 and H4 [161, 162].  Deacetylation permits 
subsequent histone methylation of H3K9, a histone modification required to 
maintain heterochromatin domains and prevent aberrant transcription that 
threatens genome stability [162-164].    
 
ISWI nucleosome remodelers localize to elongating replication forks 
The highly related SNF2H and SNF2L chromatin remodelers represent the 
human homologs of the Drosophila ISWI complex responsible for regulating 
transcriptional and replication events [165]. In complex with BAZ1B, SNF2H is 
recruited to replication forks via an interaction with PCNA to maintain the 
chromatin landscape through DNA replication [166]. SNF2Lʼs activity at 
replication forks has not been well described. A discussion of the potential role of 
SNF2L at replication forks is provided in Chapter VI.  
Collectively, the use of iPOND as a screening platform for the identification 
of novel replication fork proteins could provide a discovery tool to examine the 
activities that maintain genomic and epigenomic integrity through DNA 
replication.  
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CHAPTER VI 
SYNOPSIS AND FUTURE DIRECTIONS* 
 
Synopsis 
The in vivo analysis of dynamic events that protect genomic and 
epigenomic integrity during DNA replication has been a challenging task. The 
proteins that ensure the accurate inheritance of the genome act directly at 
replication forks. Unfortunately, tracking and purifying replication forks has been 
difficult in mammalian cells because the location of elongating forks is difficult to 
predict. I have developed the iPOND (isolation of Proteins On Nascent DNA) 
technique as a tool to isolate, analyze and discover proteins that localize to 
replication forks during active DNA replication and following conditions of DNA 
damage. The iPOND technique provides a useful tool to investigate the 
coordinated mechanisms that maintain the genome and epigenome through DNA 
replication. These pathways are perturbed in human diseases such as cancer. 
 
Development of iPOND for analysis of normal, stalled and collapsed replication 
forks 
 
In Chapter III, I described the development of iPOND as a technology to 
purify nascent DNA and the associated proteins from mammalian cells.  
 
 
 
 
*Excerpts of this chapter are in published in reference [57]. Sirbu BM, Couch FB and Cortez D, 
Nature Protocols. 
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iPOND is based on the concept that replication forks are sites of active DNA 
polymerization that can incorporate tagged nucleoside analogs. I showed that 
labeling of short nascent DNA fragments with the thymidine analog EdU 
facilitates biotin-tagging of nascent DNA using click chemistry. Nascent DNA 
fragments with associated proteins are purified using streptavidin-conjugated 
beads in a single step. To validate this technique, I showed that replication fork 
proteins PCNA and CAF1 associate specifically with nascent chromatin at 
elongating replication forks but not with mature chromatin. The sensitivity of the 
technique permits the detection of low-copy number proteins such as polymerase 
epsilon, which is undetectable using standard immunofluorescent methods. I 
further establish iPOND as a tool for monitoring chromatin assembly in vivo.  
 
iPOND analysis of chromatin maturation dynamics at elongating replication forks 
 
In Chapter IV, I examined the enzymatic requirements for reestablishing 
epigenetic marks on nascent chromatin after replication fork passage. Unlike 
parental histones, new histones contain the evolutionarily conserved di-
acetylation mark on histone H4 (H4K5ac/K12ac) [2]. I provide the first in vivo 
evidence that Class 1 histone deacetylases remove H4K5/K12 acetylation at 
elongating replication forks in mammalian cells. We showed that H4K12 is 
reacetylated on nascent DNA, suggesting a potential role for this modification 
independently of H4K5ac/K12ac. Previous circumstantial evidence had 
suggested that the HAT1 acetyltransferase catalyzes diacetylation of H4K5/K12. 
In collaboration with Mark Parthunʼs laboratory, I showed that murine HAT1 is the 
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acetyltransferase responsible for the replication-coupled di-acetylation of 
H4K5/K12. Collectively, iPOND analysis of chromatin maturation revealed the 
timely histone modifications essential for preserving genomic and epigenomic 
integrity [1, 88]. 
 
iPOND reveals changes in proteins and post-translational modifications at stalled 
and collapsed replication forks  
 
In chapter IV, I furthermore investigated the recruitment dynamics of 
established DNA damage response proteins and the post-translational 
modifications (PTMs) to damaged replication forks. I found that replication fork 
stalling results in rapid phosphorylation of RPA on Serine 33 and is followed by 
phosphorylation on Serines 4/8, a mark associated with formation of double-
strand breaks. An enrichment of double-strand break repair proteins RAD51, 
MRE11 and KU70/80 was detectable after prolonged treatment with HU, 
suggesting that DSBs and recombination-based repair occur. At DSBs, MRE11 
end-resection facilitates loading of the Rad51 recombinase. Jami Couch showed 
that Rad51 accumulation at stalled forks is MRE11-dependent after prolonged, 
but not short exposures to replication stress. This suggests that MRE11 end-
resection occurs at persistently stalled replication forks to promote homology-
directed DNA repair. 
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γH2AX spreading from stalled replication forks depends on checkpoint kinases 
Phosphorylation of the histone variant H2AX is often considered a marker 
of DSBs, but I observed γH2AX phosphorylation at stalled forks within 10 mins 
after replication stress. We detected H2AX phosphorylation in regions distal to 
the stalled replication fork, supporting the idea that γH2AX spreads from stalled 
replication forks. Lastly, we provide evidence that ATR catalyzes the early and 
proximal spreading of γH2AX. During prolonged replication stress, I showed that 
ATM and DNA-PK contribute to spreading and maintenance of γH2AX in 
chromosomal regions proximal and distal to the stalled replication fork. 
 
iPOND-MS for discovery of genome and epigenome maintenance activities 
To further demonstrate the utility of iPOND as a screening for discovery of 
genome maintenance activities, I coupled iPOND to spectral counting-based 
shotgun proteomics to identify new proteins that maintain genomic and 
epigenomic integrity during DNA replication. I was most interested in identifying 
proteins at elongating and stalled replication forks. To gain insights into how the 
ATR kinase prevents fork collapse into toxic DSBs, I also explored the replisome 
composition in the absence of ATR activity using an ATR inhibitor.  
I identified 290 proteins significantly enriched at normal, stalled and 
collapsed replication forks. Forty-six of these proteins have been previously 
linked to DNA damage responses, DNA replication and the cell cycle. Several are 
predicted phosphorylation substrates of ATM/ATR, contain PCNA binding 
	   137	  
domains, or have been identified in genomic screens aimed at finding genes that 
maintain genome stability.  
The replisome components identified at unperturbed replication forks 
included some of the canonical replisome factors such as the replicative 
polymerases POLD1 and POLE, the processivity factor PCNA, and the clamp 
loader RFC1-5. Proteins that maintain the epigenomic landscape were also 
enriched. For example, DNA methyltransferase DNMT1 and the hemimethylated 
DNA binding protein UHRF1 preserve semiconservative DNA methylation at 
forks [2]. In contrast to unperturbed forks, iPOND detection of stalled replication 
forks revealed few expected proteins. Potential explanations for this result are 
described in the next section.  
At collapsed replication forks, I validated previous observations that RPA 
accumulates on nascent strand ssDNA, a toxic structure that causes genomic 
instability. I discovered that several replication-fork remodeling enzymes that are 
found mutated in human diseases enrich at collapsed forks. The helicases 
SMARCAL1, WRN and BLM localized to collapsed forks, perhaps due to 
recruitment through RPA binding. ATR directly phosphorylates SMARCAL1 and 
BLM to regulate their enzymatic activities [151, 167]. This evidence supports the 
hypothesis that ATR prevents aberrant fork processing by inhibiting the 
accumulation of fork-remodeling enzymes. Without ATR regulation, these 
enzymes may drive the formation of aberrant and mutagenic DNA fork structures, 
causing genome instability. Furthermore, I discovered the enrichment of single-
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strand and double-strand break repair proteins such as Ligase III, XRCC1, 
RAD51, MMS22L and TONSL. Recruitment of these proteins may represent an 
attempt to maintain competent stalled forks that can restart by initiating 
recombination-based rescue mechanisms.   
Lastly, as validation for the iPOND-MS screen, I showed that the two 
human homologs of the ISWI chromatin remodeler SNF2L and SNF2H travel with 
elongating replication forks. While SNF2H has been implicated in replication of 
heterochromatin, the function of SNF2L during replication has remained 
unexplored. I provide preliminary genetic evidence that SNF2L facilitates 
replication fork progression.   
Overall, the development of iPOND has provided a powerful biochemical 
tool to ascertain the mechanisms that maintain genome and epigenome integrity 
at replication forks. iPOND-MS revealed interesting observations about the 
proteomic changes as replication forks transition from elongating to stalling to 
collapsing. Improving the iPOND-MS platform and combining these findings with 
functional genomics screens should reveal critical targets that maintain 
replication fork stability.  
Understanding the activities that preserve replication-coupled chromatin 
maintenance and repair is relevant to understanding human disease. 
Disturbances in these pathways cause mutations and replication stress. This 
genomic instability is the hallmark of diseases such as cancer. Overall, my thesis 
work has provided a new biochemical tool that can be exploited to answer 
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questions about how the genome and epigenome are preserved during DNA 
replication to prevent disease.  
In the future directions section, I discuss (i) testable hypotheses 
addressing the function of SNF2L during DNA replication, (ii) interpretations of 
stalled and collapsed replication forks isolated with iPOND, (iii) comparisons to 
other recent iPOND-MS screens, (iv) potential biochemical improvements the 
iPOND platform for large-scale screening, (v) ideas for other applications of 
iPOND to improve spatial resolution and analyze the protein composition of 
replicating forks in various genomic regions.  
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Future Directions 
  
(i) Functions of human ISWI chromatin remodelers at replication forks 
I have validated the recruitment of the mammalian Imitation Switch (ISWI) 
chromatin remodeling enzymes SNF2L and SNF2H to elongating replication 
forks. The remodelers constitute the ATPase motors for several protein 
complexes that slide and replace histones to facilitate a variety of processes from 
transcription to preserving higher order chromatin organization to DNA replication 
[168]. SNF2H is recruited to replication sites in complex with BAZ1B, the gene 
deleted in the haploinsufficiency Williams-Beuren Syndrome [166, 169]. In this 
WICH complex, SNF2H promotes replication through heterochromatin and 
facilitates double-strand break repair [166, 170]. SNF2H also binds ACF1 to 
regulate replication of pericentromeric DNA, presumably by facilitating chromatin 
decondensation to allow proper chromatin assembly [171].  
While SNF2Hʼs function during DNA replication is well established, the 
significance of SNF2L recruitment to sites of active replication [172] is unclear. 
Several lines of evidence suggest a function for SNF2L during replication. First, a 
fraction of SNF2L is retained longer on chromatin during S phase [172]. Second, 
Snf2l mice expressing a mutant SNF2L with diminished catalytic activity exhibit 
increased brain sizes due to increased proliferation [173]. Third, I provided 
preliminary evidence showing that SNF2L depletion causes shorter nascent DNA 
fibers, suggestive of a role in promoting replication fork progression.   
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One significant unanswered question is whether SNF2L and SNF2H 
perform redundant roles during DNA replication. One preliminary piece of genetic 
data supporting distinct functions for the two remodelers is our observation that 
silencing of SNF2L but not SNF2H causes DNA damage during replication fork 
restart (Gina Kavanaugh, unpublished screen results). Also, the yeast ISWI1 and 
ISW2 complexes exhibit different in vitro biochemical activities in spacing of 
nucleosomes [174]. It is tempting to speculate that such distinct activities render 
distinct functions in vivo.  
Despite high sequence similarities between the mammalian ISWIs, small 
differences in the amino and carboxy termini drive the formation of different 
protein complexes containing either SNF2L or SNF2H [168]. SNF2Lʼs best-
established role is as a component of the nucleosome remodeling NURF 
complex that functions in transcriptional regulation [175]. SNF2L has not been 
reported to interact with BAZ1B or ACF1, perhaps due to low protein expression 
in the cell models used to describe the formation of SNF2H-containing 
complexes [166, 169]. While SNF2H is expressed in a majority of cell lines and 
tissues, SNF2Lʼs expression pattern is restricted to undifferentiated cell types 
and stem-cell like cell types [169, 176]. Therefore, it is plausible that SNF2L and 
SNF2H may perform similar functions at different developmental stages, but this 
hypothesis needs to be formally tested. 
How does proper nucleosome positioning ensure proper DNA replication? 
In Figures 6.1-6.2, I present several testable models for SNF2L regulation of 
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DNA replication. Prior to testing these hypotheses, it will be important to confirm 
that SNF2L and/or SNF2H affect replication fork progression.  
As depicted in Figure 6.1, SNF2L contains a conserved PCNA-interacting 
motif (PIP box). It is possible that SNF2L localization to replication forks depends 
on recruitment via PCNA. The localization of SNF2H to sites of heterochromatin 
replication depends on interaction with BAZ1B and BAZ1Bʼs PIP box [166]. 
Elucidating the SNF2L-containing protein complexes in HEK 293T cells that were 
used for the iPOND-MS screen will provide insight into how SNF2L may be 
recruited to replication forks. Identifying the replication localization domain of 
SNF2L will be crucial to generate separation-of-function mutants. Such mutants 
will be necessary to complement any replication defects of SNF2L depletion. 
Alternatively, a fusion protein that could artificially localize SNF2L to replication 
forks would be useful. Either the mutant or fusion SNF2L proteins would be 
useful to test the hypothesis that SNF2Lʼs role during DNA replication is 
independent of its role in transcription or at other genomic loci. 
Further fiber labeling experiments in cells lacking SNF2L should test 
whether the remodeler could affect DNA replication by promoting origin firing 
(Fig. 6.2). The yeast Isw2 facilitates replication of late origins [177], perhaps 
through a role in chromatin remodeling of origins. Clearly, much remains to be 
studied about SNF2Lʼs role during replication, but these examinations could 
provide important insights into how ATP-dependent chromatin remodelers 
maintain genome integrity at the replication fork.  
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Figure 6.1. Model of SNF2L and SNF2L-containing complex localization to replication forks. 
SNF2Lʼs PCNA-interacting motif [122] may facilitate SNF2L localization to replication forks, 
similarly to the recruitment mechanism of the related chromatin remodeler SNF2H [166]. The 
SNF2L protein complexes that localize with SNF2L to the elongating fork have been unexplored. 
SNF2H may localize as part of the NURF complex (containing BPTF and RbAp46/48) or in 
complex with BAZ1B. Once recruited to replication forks, SNF2L likely catalyzes sliding of 
nucleosomes behind the replication fork on nascent chromatin. 
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Figure 6.2. Model of SNF2L function in promoting DNA replication. SNF2L may facilitate 
progression through replication by affecting events within the same S phase in front of the 
replication fork, such as regulation of DNA topology that may affect fork movement [178]. 
Alternatively, SNF2L may promote incorporation of histone H1 into nascent chromatin behind the 
replication fork [179]. At least on the inactive X chromosome, SNF2L maintains chromatin 
condensation through H1 [180], which prevents aberrant transcription. Proper H1 positioning may 
affect chromatin disassembly in the next S phase. SNF2L may play a role at replication forks 
during origin firing by promoting histone sliding to induce an environment conducive for initiation 
of DNA replication.  
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(ii) Interpretations of stalled and collapsed replication forks isolated with iPOND 
 
(iia) Stalled replication forks 
 
 I observed poor enrichment of known replication stress proteins to HU-
stalled forks. This may be attributable to the mechanism by which HU stalls 
replication forks. HU depletes cellular dNTP pools and causes uncoupling of 
helicase and polymerase activities [115]. This generates stretches of parental 
strand RPA-coated ssDNA that signals the recruitment of numerous known 
replication stress proteins including ATR and the 9-1-1 complex.   
Since iPOND purifies nascent DNA fragments, it is possible that HU may 
not be a feasible reagent to use for isolating replication forks using iPOND (Fig. 
4.3D). If polymerase-dependent repriming occurs on the parental DNA strand, 
iPOND may be able to isolate proteins at HU-stalled forks. Such repriming events 
have been observed only in Xenopus oocytes and not mammalian cells [115]. 
One way to test whether re-priming occurs in mammalian cells would be to 
examine if the 9-1-1 clamp loader is enriched in HU-stalled iPOND purifications 
when EdU is kept in the media. Since 9-1-1 is loaded onto the 5ʼ end of a ssDNA-
dsDNA junction, accumulation of the clamp loader may reflect polymerase alpha-
dependent 5ʼ-to-3ʼ DNA synthesis. Inhibition of polymerase alpha activity using 
aphidicholin could further test this hypothesis. Future iPOND experiments 
designed to identify stalled replication fork proteins may benefit from using 
another replication stress reagent that blocks both the helicase and replicative 
polymerase.  
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(iib) Collapsed replication forks: collapsed or newly fired?  
The ATR-dependent mechanisms that promote fork stability are essential 
for cell viability and yet remain some of the least understood. I used iPOND-MS 
to gain insights into the function of ATR during replication stress by probing the 
protein landscape at stalled replication forks lacking ATR activity. I observed the 
enrichment of several helicases implicated in recombinatorial repair to collapsed 
forks. One hypothesis is that these helicases catalyze the formation of the toxic 
ssDNA structures observed without ATR. If this were true, then depletion of 
SMARCAL1, WRN or BLM should prevent the formation of nascent strand 
ssDNA observed when ATR is inhibited. Jami FB Couch has provided elegant 
genetic evidence to support that SMARCAL1 is partially responsible for the toxic 
accumulation of RPA-ssDNA resulting from ATR inhibition (results in press). 
However, depletion of WRN or BLM had no apparent effect in these assays.  
Throughout my thesis I have used the term ʻcollapsedʼ to indicate stalled 
replication forks that collapse into DSBs and prevent fork restart. ATR restricts 
such detrimental mechanisms to protect genome integrity. In addition, ATR also 
limits the initiation of new origins of DNA replication in the presence of DNA 
damage. We have shown that new origins initiate when cells are treated with the 
ATR inhibitor, as detected in DNA fiber labeling studies (Jessica Luzwick and 
Jami Couch, results in press). Therefore, proteins discovered at ATR-inhibited, 
HU-stalled replication forks may represent proteins at either collapsed or newly 
fired forks. To distinguish between these scenarios, future iPOND-MS 
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experiments may benefit from co-treatment of ATR inhibitor with a CDK inhibitor. 
CDK activity is essential for origin firing. Therefore, proteins enriched at 
replication forks after ATR and CDK inhibition, as measured relative to levels 
observed at ATR inhibited cells, may represent proteins that localize to collapsed 
forks.  
Lastly, the nature of the underlying event that causes fork collapse 
remains elusive. Is fork collapse irreversible? If so, when does this event occur 
and how? Analysis of the underlying DNA structure purified from ATR inhibited 
forks may shed light onto these questions.  
 
(iii) Comparison to other iPOND-MS datasets 
Two groups have recently employed iPOND and an iPOND-like technique 
to identify replisome components using proteomics methods [82, 181]. The first 
group utilized a derivative of iPOND called DmChIP (DNA mediated pulldown) 
combined with quantitative MS using SILAC. They examined the composition of 
the replisome during early and late stages of S phase as compared to a sample 
without tagged nascent DNA and therefore no purified replisomes [181].  The 
majority of the identified proteins represent chromatin-bound factors that have 
established roles in chromatin organization.  
Another group examined the proteins associated with elongating 
replication forks in comparison to chromatin-bound proteins using iPOND 
coupled to label-free proteomics [82].  This methodology identified proteins 
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known to associate with leading and lagging strand synthesis, as well as proteins 
implicated in mismatch repair, histone deposition and maturation, nucleosome 
sliding, and the MRN complex. Interestingly, they identified the components of 
the MCM2-7 replicative helicase. The GINS3 subunit of the CMG helicase 
complex was also enriched, perhaps explaining the enrichment of the MCM 
helicase. Table 6.1 lists the proteins enriched in my iPOND-MS screen compared 
to the Lopez-Contreras screen. 
 
Table 6.1. Replication fork proteins identified in two independent iPOND-MS 
screens. 
 
Normal fork 
proteins in 
common (Sirbu 
and Lopez-
Contreras)
Lopez-
Contreras 
additional 
normal fork 
proteins
ATAD5/ELG1 ACO1 ISYNA1 SNF2H ATXN10
BAZ1B/WSTF ANP32A MRPL13 SMARCAD1 DNAJA1
CHAF1A ARID3A MRPL41 SNRPD1 EHMT2
CHAF1B ARID3B NAA10 SPTLC2 FEN1
CTF4/WDHD1 ATAD2 NAMPT SSB GINS3
DNMT1 ATAD2B NCAPH TIMELESS GTF2I
EHMT1/GLP ATL3 OSBPL9 TM9SF4 MCM2
EXO1 CA2 PDCD4 TOPBP1 MCM4
LIG1 CBS PHKB TRMT6 MCM5
MSH2 CCNH PIGT TTC9C MRE11A
MSH3 CP110 PLOD1 UBA3 POLA1
MSH6 CRTAP PPIB UBE2I POLD3
PCNA EP400 PSME2 UBE2T PPM1E
POLD1 FANCI PTGES2 UBR5 PRIM2
POLE GMPPB PUS7 VPS26B RAD50
RFC1 GRB2 RNASEH2C RNASEH2B
RFC2 GTPBP5 RPA3 RPA1
RFC3 HAUS7 RPL36AL RPA2
RFC4 HDAC8 RPL6P10 RPL11
RFC5 HEATR3 SEPT11. SSRP1
SNF2L HPRT1 SKP1 SUPT16H
UHRF1 HSD17B7 SLC25A15 TCEA1
WIZ IMMT SLC4A2 TUBB4A
ZNF24
Sirbu additional normal fork proteins
known 
replication 
protein
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Overall, Lopez-Contreras identified more known replisome components 
than my iPOND-MS screen. A direct comparison between the fold enrichments 
detected in the two screens is difficult given the different analytical MS platforms. 
Three key factors distinguish the two experimental procedures: cellular scale, 
chromatin shearing, and proteomic analysis. First, a 10-fold larger cellular scale 
(3x108 of 293T cells) was utilized in [82]. A larger scale would improve detection 
of proteins of lower abundance and should be achievable using suspension 293T 
cells for label-free quantitative MS. The rationale for my experimental scale was 
based on the observation that initial MudPIT analyses revealed 2 to 12-fold 
enrichment of positive controls such as polymerases. However, this enrichment 
was measured relative to a sample that omitted the biotin azide (ʻno clickʼ 
control). A more appropriate negative control for future iPOND optimization 
experiments will be purification of mature chromatin. Lopez-Contreras performed 
several such optimization experiments. Using immunoblotting for known proteins 
and MS approaches, they evaluated the best fold enrichments of iPOND-purified 
replisomes relative to chromatin chases of varying lengths. Future iPOND 
optimization experiments would benefit from such optimizations (see v below). 
Second, chromatin was sheared to 80 base pair sizes. This is twice as 
small as the DNA fragment sizes achievable using original iPOND conditions. 
Theoretically, smaller fragment sizes should not improve iPOND-MS resolution. 
In fact, it may be beneficial to increase nascent DNA fragment sizes, perhaps 
through altering copper(II)sulfate concentrations. The larger the fragment sizes, 
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the more likely that a piece of nascent chromatin will have been EdU labeled and 
the associated proteins purified.  
Third, the group utilized a completely different label-free proteomics and 
data analysis approaches. Relative protein abundance was calculated using 
signal intensities and not spectral counting. Purified replication fork peptides were 
separated in one dimension for LC-MS/MS analysis using the high performance 
LTQ Orbitrap Velos mass spectrometer. This instrument is superior because it 
provides improved capacity to extract ion chromatographs from full-scan spectra 
[182] (discussed more below). Overall, an improved upfront biochemical iPOND 
purification technique that increases the signal to noise ratio will benefit the 
development of a high-throughput iPOND-MS platform. 
 
(iv) iPOND 2.0-improving biochemical purification of replication forks 
For future iPOND proteomics screens, it will be critical to minimize the 
background observed in the chromatin-bound negative control. One of the major 
challenges I encountered in preparing iPOND samples for MS was not having a 
quick method to examine the effectiveness of optimizations on reducing the 
background. Silver staining of purifications showed that the majority of purified 
proteins were chromatin-bound, but proved to not be a useful method for 
screening out the background. Identifying a benchmark protein that should not be 
enriched in iPOND purifications should facilitate such studies. 
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Future experiments could incorporate: (1) an improved elution using TEV-
cleavable biotin azide (currently being tested in our laboratory; (2) a pre-
fractionation step to remove cytoplasmic proteins using RIPA buffer has been 
suggested to be improve the signal of known proteins (personal communication 
with Cimprich laboratory and lysis described in [181]); (3) further optimization of 
bead types will be necessary since preliminary MS results revealed that magnetic 
beads may capture different known proteins than streptavidin-conjugated 
agarose beads (Appendix A).  
Lastly, exploring the possibility of performing comparative proteomics 
using isobaric chemical labeling (iTRAQ) or metabolic labeling (SILAC) may be of 
interest. Spectral counting provides depth of proteome coverage, but requires 
numerous replicates to reproducibly quantify protein changes across samples 
[119]. Since biochemical sample preparations are performed independently, this 
may introduce systematic errors that could be eliminated by using SILAC.  
Recently, a group compared three quantitative proteomics approaches 
using the same analytical platform of the LTQ Orbitrap Velos [182]. This study 
showed that spectral counting methods for protein quantification are less 
accurate and reproducible than metabolic or isobaric chemical labeling 
techniques. One advantage to using iTRAQ is the capacity to compare up to 8 
samples in one proteomic analysis [183]. This would be valuable for iPOND-MS 
studies that aim to identify protein changes across numerous samples. One 
disadvantage of iTRAQ is the necessity of tagging the amine group on lysines 
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[182]. The current iPOND platform requires formaldehyde crosslinking for protein 
purification and may complicate the efficiency of iTRAQ tagging. Nonetheless, 
iTRAQ should be explored as an option for future quantitative iPOND-MS studies. 
The advent of more quantitative mass spectrometric instruments, protein 
identification algorithms, scaffolds for protein assembly and improved statistical 
methods to analyze label-free MS data will prove invaluable to analyses of 
replication fork proteins purified using iPOND.  
 
 
(v) Other iPOND applications  
 
One current limitation of iPOND has been the spatial resolution, which is 
on the order of several kbp. For example, it would be beneficial to distinguish the 
distribution of proteins relative to one another within the chromosomal space at 
the replication fork. Such high-resolution mapping has been achieved with in vitro 
replication systems by using T4 DNA polymerase and primer template DNA that 
contains a position-specific cross-linkable aryl azide [184]. This elegant study 
provided topographical information about the location of binding of accessory 
proteins respective to polymerase interaction with and movement along the DNA 
template. Potential coupling of iPOND to single-molecule analyses [185] of 
replisome proteins would significantly improve iPOND resolution. 
Theoretically, iPOND can be used to study other processes that involve 
DNA or even RNA synthesis. An example would be DNA repair synthesis outside 
of S-phase. Synchronized or terminally differentiated cell cultures could be 
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exposed to DNA damaging agents in the presence of EdU. The late steps in 
repair of that damage or the re-establishment of chromatin following repair 
synthesis can be monitored with iPOND. Synchronized cell cultures could also be 
used to examine the differences in DNA replication, chromatin deposition or DNA 
repair that occur in early versus late S-phase cells. iPOND could theoretically be 
adapted to analyze even proteins on nascent RNA, as click chemistry has been 
used to label newly synthesized RNA with the uridine analog 5-ethynyluridine 
[186]. A variation of iPOND-MS lacking the crosslinking step would be beneficial 
for monitoring the substantial variety of post-translational modifications at 
damaged forks. Lastly, second step purifications of telomere-binding proteins or 
transcription factors after   iPOND-purified replisomes could reveal information 
about how telomere ends are replicated or what occurs when replication forks 
encounter the transcriptional machinery. These studies will be important to 
expand our understanding of how the genome and epigenome is maintained 
during DNA replication.   
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Figure 6.3. Applications of iPOND to studies of genome and epigenome integrity.  
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APPENDIX A 
 
Preliminary efforts to optimize the iPOND methodology for coupling to 
MudPIT analyses were performed to decrease the background observed in the 
negative controls. Proteins bound to nascent DNA were eluted by UV 
photocleavage, which permits the release of nascent DNA and bound proteins, 
and compared to proteins eluted under denaturing conditions and high heat using 
2x sample buffer. In one experiment, elution by sample buffer as compared to 
elution by photocleavage proved superior for MudPIT identification of known 
replisome components (Fig. A1C). Replication proteins such as PCNA, DNA 
polymerases delta and epsilon, and replication clamp loading proteins (RFC1-5) 
were enriched 2 to 14-fold relative to the negative control that lacked the click 
reaction. These results suggested that iPOND-MS worked to detect positive 
controls.  It is important to note that the studies above provided no measurement 
of biological false positive protein identifications (addressed in Chapter V and VI). 
In one experiment, streptavidin conjugated magnetic and agarose beads 
were used to purify replisome components by iPOND (Fig. A2A). Since a larger 
cellular scale was used for the magnetic bead purifications, it is difficult to directly 
compare the MudPIT results. However, agarose and magnetic beads enrich 
differently for different known proteins (Fig. A2C, D). Future experiments should 
focus on repeating these results and comparing the elution and bead parameters 
to a chromatin chase negative control. 
	   156	  
	  	  
 
 
 
 
 
 
 
Figure A1. Optimization for iPOND-MS comparing various elution methods. (A) Suspension 
HEK293T cells were labeled with EdU for 15 mins and collected or chased into HU for 30 mins. 
Samples were processed by iPOND and eluted for 2h under UV light (365nm). The 2x SB (after 
UV) represents proteins not eluted by UV but subsequently eluted by boiling in 2x SB. (B) Silver 
staining of iPOND purifications submitted for MudPIT analyses. (C) Relative fold enrichment of 
several known replisome components as calculated by dividing raw spectral counts obtained for 
the experimental sample by the ʻno clickʼ negative control. When zero spectral counts were 
encountered in the negative control, a value of 1 was used. 
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Figure A2. Optimization for iPOND-MS using magnetic and agarose beads. (A) Cells pulsed with 
EdU for 15 mins were collected or chased into HU for 10 mins and processed by iPOND using 
streptavidin-conjugated magnetic or agarose beads. (B) Silver staining of samples submitted for 
MudPIT analyses. (C,D). Relative fold enrichment of known replisome components as calculated 
by dividing raw spectral counts from the experimental sample by the ʻno clickʼ negative control. 
When zero spectral counts were encountered in the negative control, a value of 1 was used. 
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APPENDIX B 
 
Table B.1. List of 148 genes examined in functional genomic screen for ATR-like 
genes. 
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Table B.1 (continued). List of 148 genes examined in functional genomic screen 
for ATR-like genes. 
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APPENDIX C 
 
iPOND-MS validation using immunofluorescence detection of tagged protein 
localization 
 
To examine the subcellular localization of 32 proteins of interest using 
immunofluorescence, three rotation students helped me generate epitope-tagged 
cDNAs (Table C.1). Approximately one-third of the purchased cDNA clones 
lacked the full-length cDNA or exhibited undetectable protein expression.  
Table C.1. List of 32 genes cloned into GFP-expressing vectors. 
Gene name OpenBiosystems CloneID
TRMT6   1842 in pDONR223 without stop codon
ASCC3 isoform 2 (short isoform)   11778 in pDONR223
UBE2T   5367 in pDONR223
SNX5   8887 in pDONR223
GRWD1   3222 in pDONR223
FAM120A   53080 in pDONR223
DAK   2753 in pDONR223
PLRG1   13135 in pDONR223
RRAGB  100066617 (with native stop codon) in pENTR221
PDC4 100004275 (with native stop codon) in pENTR221
!"#$%&'()*)+!,   6845 in pDONR223
BTAF1   55143 in pDONR223
MAPK4K4 100004275 (with native stop codon) in pENTR221
KIAA1598   15060 in pDONR223
PIAS1   56382 in pDONR223
NCAPH 100006062 (with native stop codon) in pENTR221
USP7 100066416 (with native stop codon) in pENTR223.1
ZC3HAV1L   5168 in pDONR223
ANP32B   6023 in pDONR223
PPP1CA   3788 in pDONR223
ARID3A   10855 in pDONR223
-./01   4616 in pDONR223
ARID3B   10878 in pDONR223
FKBP3   273 in pDONR223
-234   2753 in pDONR223
CMPK1   13135 in pDONR223
FKBP10 100066975 (with native stop codon) in pENTR221
ISYNA1 100006095 (with native stop codon) in pENTR221
PP2CA   4071 in pDONR223
RBBP7   56361in pDONR223
ASCC3 isoform 1 (long isoform) 100001999 without stop codon 
ATAD2   55166 in pDONR223
problematic no cDNA or no expression of GFP-taggged protein
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The remaining GFP-tagged proteins showed no change in localization 
following HU-induced replication stress or DNA damage after inhibition of ATR. 
These negative results are difficult to interpret. Some possibilities include: protein 
tagging interfered with proper localization, immunofluorescence is not sensitive 
enough to validate proteins identified using iPOND, or biological false-discovery 
rate in the iPOND-MS screen is high.  
 
 
iPOND-MS validation using selected reaction monitoring (SRM) 
 
I attempted to validate proteins identified in the MudPIT proteomics 
analysis using label-free quantitative mass spectrometry in selected reaction 
monitoring (SRM) mode. The advantage of SRM to shotgun proteomics is the 
capacity to schedule a specific window of time for examination of a limited 
number of spectra. This provides deeper and more accurate quantitative 
proteomics analyses. In collaboration with David Friedman at the Vanderbilt 
Proteomics Core, we evaluated the quality of unscheduled runs for 60 proteins 
(given a minimum of 2 independent peptides with 3 transition states per peptide). 
A total of 42 proteins were analyzed (Table C.2).   
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Table C.2. Proteins analyzed by MS in single reaction monitoring mode. 
 
RPA2, SNF2L, BAZ1B, UNG, and 3are highlighted in Table C.2 and 
exhibited similar patterns of relative enrichment as observed in the MudPIT 
analyses (Fig. 5.5 and Fig. C.1). Comparing results across different analytical 
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platforms is difficult, but it should be noted that overall, higher enrichments were 
observed using MudPIT analyses. For example, whereas RPA2 was enriched 5-
fold relative to levels on chromatin (Table 5.4) measured with MudPIT, the 
intensity observed for one of two peptides by SRM was only 3-fold (Fig. 5.5). 
Two-dimensional protein separation after iPOND purification reduces the mixture 
complexity prior to MS analyses and may enhance the dynamic range of 
detection. Therefore, future iPOND experiments would continue to benefit from 
MudPIT studies. 
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Figure C.1 Validation of ATAD2 and UNG as proteins associated with elongating or collapsed forks, 
respectively. Quantitative mass spectrometry in selected reaction monitoring mode (SRM) examined the 
indicated peptides after iPOND purifications and was performed by David Friedman in the Vanderbilt 
Proteomics Core. SRM samples 2, 3, 4, and 5 represent normal replication forks, thymidine chase negative 
control, HU-treated stalled forks, HU and ATR inhibited collapsed forks, respectively. The signal intensity 
measured for each peptide is normalized to the sum of the internal reference peptides (Σ4IRPs). 
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APPENDIX D 
 
This appendix includes the review publication in Sirbu BM and Cortez D. 
DNA damage response: three levels of DNA repair regulation, 2013. Cold Spring 
Harbor Perspectives in Biology. doi: 10.1101/cshperspect.a012724. 
  
DNA Damage Response: Three Levels of DNA
Repair Regulation
Bianca M. Sirbu and David Cortez
Department of Biochemistry, Vanderbilt University School of Medicine, Nashville, Tennessee 37027
Correspondence: david.cortez@vanderbilt.edu
Genome integrity is challenged by DNA damage from both endogenous and environmental
sources. This damage must be repaired to allow both RNA and DNA polymerases to accu-
rately read and duplicate the information in the genome. Multiple repair enzymes scan the
DNA for problems, remove the offending damage, and restore the DNA duplex. These repair
mechanisms are regulated by DNA damage response kinases including DNA-PKcs, ATM,
and ATR that are activated at DNA lesions. These kinases improve the efficiency of DNA
repair by phosphorylating repair proteins to modify their activities, by initiating a complex
series of changes in the local chromatin structure near the damage site, and by altering the
overall cellular environment to make it more conducive to repair. In this review, we focus on
these three levels of regulation to illustrate how the DNA damage kinases promote efficient
repair to maintain genome integrity and prevent disease.
The DNA in each of our cells accumulatesthousands of lesions every day. This dam-
aged DNA must be removed for the DNA code
to be read properly. Fortunately, cells contain
multiple DNA repair mechanisms including:
base excision repair (BER) that removes dam-
aged bases, mismatch repair (MMR) that rec-
ognizes base incorporation errors and base
damage, nucleotide excision repair (NER) that
removes bulky DNA adducts, and cross-link re-
pair (ICL) that removes interstrand cross-links.
In addition, breaks in the DNA backbone are
repaired via double-strand break (DSB) repair
pathways including homologous recombina-
tion (HR) and nonhomologous end joining
(NHEJ). Some of thesemechanisms can operate
independently to repair simple lesions. Howev-
er, the repair of more complex lesions involving
multiple DNA processing steps is regulated by
the DNAdamage response (DDR). For themost
difficult to repair lesions, the DDRcan be essen-
tial for successful repair.
The DDR consists of multiple pathways, but
for the purposes of this review we will focus on
the DDR kinase signaling cascades controlled
by the phosphatidylinositol 3-kinase-related ki-
nases (PIKK). These kinases include DNA-
dependent protein kinase (DNA-PKcs), ataxia
telangiectasia-mutated (ATM), and ATM and
Rad3-related (ATR). DNA-PKcs and ATM are
primarily involved in DSB repair, whereas ATR
responds to a wide range of DNA lesions, espe-
cially those associated with DNA replication
(Cimprich and Cortez 2008). ATR’s versatility
makes it essential for the viability of replicating
cells inmice and humans (Brown and Baltimore
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2000; de Klein et al. 2000; Cortez et al. 2001).
In the case of ATM, inherited biallelic muta-
tions cause ataxia-telangiectasia—a disorder
characterized by neurodegeneration, immu-
nodeficiency, and cancer (Shiloh 2003; Lavin
2008).ATMmutations are also frequently found
in several types of tumors (Negrini et al. 2010).
The DDR kinases share several common
regulatory mechanisms of activation (Lovejoy
and Cortez 2009). All three DDR kinases sense
damage through protein–protein interactions
that serve to recruit the kinases to damage sites.
Once localized, posttranslational modifications
and other protein–protein interactions fully ac-
tivate the kinases to initate a cascade of phos-
phorylation events. The best-studied substrate
of DNA-PKcs is actually DNA-PKcs itself, and
autophosphorylation is an important step in
direct religation of theDSB via nonhomologous
end joining (NHEJ) (Weterings and Chen 2007;
Dobbs et al. 2010). ATM and ATR have both
unique and shared substrates that participate
in DNA repair, checkpoint signaling, and deter-
mining cell fate decisions such as apoptosis and
sensescence.
THREE LEVELS OF REPAIR REGULATION
BY THE DDR KINASES
DDR kinases control DNA repair at three levels
(Fig. 1). First, they regulateDNA repair enzymes
directly through posttranslational modifica-
tions that alter their activity. These modifica-
tions appear to be especially important in the
repairof complex lesions such as ICLs and repair
associatedwith stalled replication forks. Second,
the DDR kinasesmodify the chromatin near the
DNA lesion to create a permissive local environ-
ment for repair. This chromatin response also
provides a scaffolding function for the recruit-
ment of additional DDR factors regulating both
repair and signaling. Finally, the DDR kinases
act at a more global level of the nucleus or even
the entire cell to provide a cellular environment
conducive to repair. This global response in-
cludes changes in transcription, the cell cycle,
chromosome mobility, and deoxynucleotide
(dNTP) levels. Controlling these processes may
be most important for repair when damage is
persistent.
This review will highlight examples of each
level of regulation. For the direct regulation of
repair functions, we will discuss how DDR ki-
nases regulate ICL repair and more general rep-
lication fork-associated repair. In discussing the
local chromatin environment, we highlight the
important role of chromatin modifications sur-
rounding a DSB. Finally, at the global level, we
discuss how the DDR alters nuclear architecture
and maintains proper cellular dNTP pools to
promote repair.
DDR KINASES DIRECTLY REGULATE THE
REPLICATION-ASSOCIATED DNA REPAIR
MACHINERY
DNA lesions pose an especially important prob-
lemwhen they interfere with DNApolymerases.
Errors during DNA replication as well as mis-
takes in DNA repair cause mutations and chro-
mosomal aberrations that are a source of genetic
instability driving tumorigenesis. Additional-
ly, many rare childhood diseases are the result
of defects in replication-associated DNA repair.
These include Seckel syndrome caused by mu-
tations in ATR and other disorders caused by
mutations in ATR substrates like BLM, WRN,
and SMARCAL1 (Ciccia and Elledge 2010).
Thus, the DNA damage response is particularly
critical to ensure complete and accurate dupli-
cation of the genome.
Repair
machinery
Local
chromatin
Cellular
environment
DDR
kinases
Figure 1. DDR kinases promote efficient DNA repair
by directly regulating the DNA repair machinery,
changing the local chromatin environment near the
DNA lesion, and altering the cellular environment.
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ICL Repair during DNA Replication
Interstrand cross-links are perhaps themost dif-
ficult lesions to repair, requiring specialized
repair mechanisms governed by genes mutated
in patients with Fanconi anemia (FA), as well as
components of nucleotide excision and DSB
repair (Kim andD’Andrea 2012). In the context
of DNA replication, interstrand cross-links are
potent fork stalling lesions that activate ATR.
Perhaps for these reasons, the ATR kinase has
an especially critical function in initiating ICL
repair (Fig. 2).
When the ICL stalls a replication fork, the
DNA structure signals the recruitment of sever-
al Fanconi proteins beginning with the FANCM
helicase (Meetei et al. 2005; Raschle et al. 2008;
Knipscheer et al. 2009). FANCM may remodel
the damaged fork to help recruit the FA core
complex, a multisubunit ubiquitin ligase. An
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Figure 2. A simplified model of ICL repair indicating steps regulated by ATR phosphorylation.
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essential activity of the core complex is mono-
ubiquitination of FANCD2 and FANCI within
the FANCI-FANCD2 (ID) complex (Garcia-
Higuera et al. 2001). Repair then initiates with
synchronized incision on both sides of the
cross-link. Incision may be mediated by the
flap endonuclease FAN1whose ubiquitin-bind-
ing motif recognizes mono-ub FANCD2 and is
essential for ICL repair (Kratz et al. 2010; Liu et
al. 2010; Smogorzewska et al. 2010). Additional
nucleases such as those associated with SLX4
may also participate in ICL repair given that
SLX4mutations cause FA (Kimet al. 2011). Fork
cleavage results in “unhooking” of the cross-link
allowing error-pronepolymerases to extendpast
the lesion and NER to remove the cross-linked
base. The unhooking reaction also generates a
DSB intermediate that is processed by HR to
restore the replication fork (Long et al. 2011).
ATR controls the earliest events in the FA
pathway and is essential for successful repair.
Thus, ATR-deficiency yields high sensitivity to
DNA cross-linking agents. ATR phosphorylates
several FA proteins including FANCD2, FANCI,
FANCA, FANCG, and FANCM (Andreassen et
al. 2004; Ishiai et al. 2008; Wilson et al. 2008;
Collins et al. 2009; Sobeck et al. 2009). The
phosphorylation of FANCI is a particularly crit-
ical event for FA pathway activation, as it is
needed for monoubiquitination and localiza-
tion of FANCD2 to sites of damage. FANCI is
phosphorylated on several conserved ATR and
ATM consensus sites (Matsuoka et al. 2007),
andmutants that cannotbephosphorylatedpre-
vent FANCD2 mono-ub and cause hypersensi-
tivity tocross-linkingreagents(Ishiaietal.2008).
Expression of FANCImutants thatmimic phos-
phorylation induce FANCD2 monoubiquitina-
tion even in the absence of exogenous DNA-
damaging agents. These findings suggest that
FANCI phosphorylation is a necessary and
perhaps sufficient step for FANCD2 mono-
ubiquitination and FA pathway activation. The
mechanism by which phosphorylation induces
ubiquitylation remains unknown. However, it
should be noted that FANCI hasWD40 repeats,
which might act analogous to F-box proteins
to recruit phosphorylated substrates for ubiq-
uitination.
Analysis of the crystal structure of the FANC
ID complex has revealed that the ubiquitination
sites are buried in the ID interface (Joo et al.
2011). It is possible that ATR phosphorylation
of ID in cis may inform ID of the presence of
dsDNA and ssDNA junctions. A simple model
would be that once phosphorylated at the cross-
link, the ID complex alters its conformation al-
lowing core complex recognition.
ATRmay also regulate FANCD2 ubiquityla-
tion by targeting the FANCD2 deubiquitination
complex USP1-UAF1. Consistent with this no-
tion, USP1 was identified as a putative ATM/
ATR substrate (Matsuoka et al. 2007), and the
interaction of USP1/UAF1 with FANCI is reg-
ulated by DNA damage (Yang et al. 2011). Fur-
thermore, in response to DNA damage, USP1
undergoes inactivating autoproteolysis, further
promoting FANC ID ubiquitination.
The activities of other FA proteins including
FANCA and FANCG are also under the control
of the ATR kinase. FANCA is a direct ATR sub-
strate, andmutation of the phosphorylation site
creates a protein that cannot fully complement
FANCA-deficient cells (Collins et al. 2009).
FANCG is phosphorylated on multiple sites and
at least one (serine 7) is ATR-dependent (Wilson
et al. 2008). Phosphorylation of FANCG regu-
lates the interactions of BRCA2 with com-
ponents of the core complex and FANCD2.
FANCG S7 mutants fail to rescue the cross-
link sensitivity of FANCG-deficient cells (Qiao
et al. 2004).
In addition to controlling early events in
cross-link repair, the ATR pathwaymay also reg-
ulate later steps. For example, ATR regulates the
NER-dependent unhooking reaction pathway
by regulating the localization of XPA (Wu et al.
2007; Shell et al. 2009). Also, ATR regulates the
HR step by promoting the recruitment of the
key RAD51 recombinase (Sorensen et al. 2005).
Thus, ATR regulates nearly every step of
the ICL repair process. Why is this necessary?
Perhaps the answer lies in the complexity of
removing an ICL. ICL repair requires the co-
ordinated activities of multiple repair steps
often at a time of maximum vulnerability for
the genome (when the replication fork reaches
the cross-link). Perhaps ATR signaling provides
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a mechanism of ordering the repair steps to
prevent undesirable DNA intermediates, which
might yield aberrant repair products. In this
context, it might be expected that the more dif-
ficult a DNA lesion is to repair, the more im-
portant the DDR pathways become for success.
DDR Kinase-Dependent Regulation of
Replication Fork Repair Pathways
DDR regulation of ICL repair during DNA rep-
lication is a specialized version of amore general
DDR response that coordinates repair of stalled
forks. Base damage, dNTP depletion, and even
difficult to replicate sequences that form sec-
ondary structures or RNA–DNA hybrids can
cause fork damage. A stalled fork itself may
not be a particularly devastating event to a cell
because DNA replication will usually be com-
pleted from an adjacent origin of replication.
In such cases, the DDR stabilizes the damaged
fork to prevent aberrant DNA processing. In
other cases, such as in replication of fragile sites
that contain few replication origins, fork sta-
bilization may be insufficient and DDR ki-
nase-dependent restart of the stalled fork be-
comes essential (Casper et al. 2002).
The fork-stabilization activity of ATR is
functionally defined either in terms of the abil-
ity to restart replication once a blockage is re-
moved or by the changes in DNA or protein
composition at the fork. Yeast mutants deficient
in the ATRpathway lose the replicative polymer-
ases from the fork (Cobb et al. 2003, 2005; Lucca
et al. 2004) and accumulate abnormal DNA
structures including long stretches of ssDNA
and reversed fork structures resembling Holli-
day junctions (Lopes et al. 2001; Sogo et al.
2002). At least in yeast, the Exo1 nuclease is
involved in generating the excess ssDNA at the
stalled fork when the ATR pathway is inacti-
vated (Cotta-Ramusino et al. 2005). Loss of
ATR function in Xenopus extracts also causes
loss of Pol epsilon and collapse of the fork into
a DSB (Trenz et al. 2006).
Thus, one way ATRmay stabilize a fork is by
preventing dissociation of replisome proteins
and thereby inhibiting aberrant enzymatic pro-
cessing of the DNA. However, a recent paper by
the Labib group has challenged this model (De
Piccoli et al. 2012). This group monitored rep-
lisome stability in budding yeast lacking the
Mec1ATR or Rad53Chk2 checkpoint kinases by
immunoprecipitating a subunit of the replica-
tive helicase and immunoblotting for other rep-
lisomeproteins. In contrast to expectations, they
did not observe disassembly of the replisome,
and chromatin immunoprecipitation assays
suggested that the replisome remained near or-
igins in cells treated with high doses of hydroxy-
urea to stall forks. A subset of earlyorigins lacked
replisome proteins, but the authors concluded
that this was as a result of replisome movement
away from the earliest origins in the absence of
DDR kinase activity instead of replisome disas-
sembly. Thus, in this case, the ATR pathwaymay
be important for restraining fork movement. If
fork movement is not accompanied by produc-
tive leading and lagging strand synthesis, it could
help generate the ssDNA gaps observed by elec-
tron microscopy in Mec1ATR-deficient yeast.
Exactly how ATR prevents replisome disso-
ciation, movement, and aberrant fork process-
ing is one of the least understood parts of the
DDR. One DDR target is the downstream ki-
nase CHK1, which is activated by ATR phos-
phorylation and needed to prevent fork collapse
and regulate origin firing (Cimprich and Cortez
2008). Note that the mammalian and yeast
functions of CHK1 and CHK2 have been re-
versed during evolution so that human CHK1
is the functional equivalent of yeast Rad53 with
respect to replication fork regulation. ATR also
directly phosphorylates replisome components
including several Cdc45-MCM-GINS (CMG)
helicase subunits (Cortez et al. 2004; Yoo et al.
2004;Matsuoka et al. 2007; Shi et al. 2007; Trenz
et al. 2008; De Piccoli et al. 2012). Phosphory-
lation of CMG may regulate helicase activity
to prevent excessive unwinding and is impor-
tant to promote rescue of stalled forks from
adjacent origins.
In addition, other replication fork proteins
including RPA, CLASPIN, and members of the
replication fork-pausing complex like TIME-
LESS, TIPIN, and AND1 are ATR substrates
(Matsuoka et al. 2007). Deficiencies in these
proteins cause hypersensitivity to replication
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stress agents (Chou and Elledge 2006; Errico et
al. 2007; Unsal-Kacmaz et al. 2007; Yoshizawa-
SugataandMasai 2007, 2009;Lemanetal. 2010).
They act in part through promoting ATR-de-
pendent CHK1 activation but may have addi-
tional roles in regulating the repair of damaged
forks.
The DDR also targets several repair enzymes
that remodel damaged forks including WRN,
FANCM, and SMARCAL1. The WRN and
FANCM proteins are helicases capable of un-
winding a variety of complex DNA structures.
SMARCAL1 is an SNF2 family ATPase that is
activated by complex DNA structures and uses
the energy of ATP hydrolysis to reanneal DNA
strands (Yusufzai andKadonaga 2008). All three
enzymes are recruited to damaged forks and can
catalyze fork regression generating a Holliday
junction on model replication substrates
(Machwe et al. 2006; Gari et al. 2008a; Betous
et al. 2012; Ciccia et al. 2012). They can also
branch migrate the Holliday junction, which
could restore the normal fork structure (Gari
et al. 2008b; Machwe et al. 2011; Betous et al.
2012). All three are targets of ATR phosphoryla-
tion (Yannone et al. 2001; Karmakar et al. 2002;
Pichierri et al. 2003;Meetei et al. 2005; Bansbach
et al. 2009; Sobeck et al. 2009; Ammazzalorso
et al. 2010), and deficiencies in WRN and
SMARCAL1 activity lead toMUS81-dependent
fork cleavage and DSB formation (Franchitto
et al. 2008; Betous et al. 2012).
ATR phosphorylation ofWRNand FANCM
promotes their recruitment to stalled forks (So-
beck et al. 2009; Ammazzalorso et al. 2010), and
cells expressing a nonphosphorylatable mutant
WRN show increased fork breakage (Ammazza-
lorso et al. 2010). SMARCAL1 phosphorylation
by DDR kinases does not regulate its localiza-
tion but does regulate its enzymatic activity (D
Cortez, unpubl.). The exact substrates of these
fork remodeling enzymes at stalled forks and
how their activities promote fork restart in cells
is not yet known. Additionally, many other hel-
icases and DNA translocases including BLM
have roles at damaged forks and are regulated
by ATR phosphorylation (Davalos et al. 2004;
Li et al. 2004; Sengupta et al. 2004; Rao et al.
2005; Tripathi et al. 2008).
Clearly, a great deal remains to be learned
about how ATR promotes replication fork sta-
bility, replication-associated DNA repair, and
fork restart. These are likely the most important
functions of ATR in maintaining genome sta-
bility and cell viability based on results from
separation of function mutants in both yeast
and human ATR (Paciotti et al. 2001; Cobb
et al. 2005; Nam et al. 2011). Yet, they are also
arguably the least understood. The develop-
ment of new reversible ATR inhibitors (Charrier
et al. 2011; Reaper et al. 2011; Toledo et al. 2011),
as well as new techniques to study DNA repli-
cation such as iPOND should accelerate the
mechanistic studies (Sirbu et al. 2011, 2012).
Such studies will be equally critical in defining
the pathways that lead to the elevated levels of
replication stress observed in cancer cells (Hala-
zonetis et al. 2008). Combined with defects in
other genome-maintenance activities, this stress
creates an increased dependency on ATR for
successful cell division. Thus, the ATR pathway
is a promising target for new cancer drug devel-
opment. Defining how ATR inhibition alters
replication-associated DNA repair will be im-
portant for understanding the mechanism of
action of these drugs.
DDR REGULATES LOCAL CHROMATIN
STRUCTURE TO PROMOTE REPAIR
DNA lesions occur in various chromosomal
contexts including compacted and opened
chromatin, which influences both the activation
of the DDR and DNA repair efficiency. For ex-
ample, in highly condensed chromatin, repair-
ing the damaged structure is more difficult pre-
sumably because repair proteins are physically
occluded from accessing the damaged structure.
Independently of DDR kinases, an ATP-depen-
dent mechanism induces rapid chromatin re-
laxation around a DSB, and is required for
recruitment of break-sensing proteins (Kruh-
lak et al. 2006). However, several DDR kinase-
dependent local chromatin changes also pro-
mote a local environment conducive for repair.
These activities include creation of a chromatin
platform for recruitment of repair and signaling
factors, regulating repair factor accessibility to
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the DNA, and inhibition of nearby transcrip-
tion to prevent potential interferencewith DNA
repair (Fig. 3). Herewe discuss the DDR-depen-
dent chromatin response as it relates to DSB
repair.
gH2AX as a Platform for DSB Repair
One of the earliest consequences of ATMactiva-
tion at a DSB is phosphorylation of the histone
variant H2AX on an evolutionarily conserved
serine (S139) producing gH2AX (Fernandez-
Capetillo et al. 2004; Stucki and Jackson 2006;
Dickey et al. 2009). A complex of MRN,MDC1,
andgH2AXrecruits additional ATM toflanking
regions of chromatin and facilitates propaga-
tion of gH2AX to a large chromatin domain.
gH2AX-MDC1 is a platform for the recruit-
ment of many additional chromatin modify-
ing, DDR signaling, and DNA repair proteins.
This scaffold recruits the RINGubiquitin ligases
RNF8 and RNF168 to trigger a ubiquitylation
cascade surrounding the DSB (Al-Hakim et al.
2010). This recruitment is mediated by ATM-
dependent phosphorylation sites on MDC1,
which are recognized by the FHA domain of
RNF8. Along with the E2 enzyme UBC13,
RNF8 catalyzes the formation of Lys63-linked
polyubiquitin chains at DSBs (Huen et al. 2007;
Kolas et al. 2007; Mailand et al. 2007). Subse-
quently, RNF168, the protein encoded by the
RIDDLIN syndrome gene recognizes and amp-
lifies these ubiquitin chains (Doil et al. 2009;
Stewart et al. 2009), whereas another ring finger
protein RNF169 antagonizes the ubiquitin cas-
cade (Chen et al. 2012; Poulsen et al. 2012). An-
other ATM substrate, HERC2, also regulates this
process. HERC2 contains an ATM phosphory-
lation site that binds theRNF8FHAdomain and
helps assemble the functional RNF8-UBC13 en-
zyme (Bekker-Jensen et al. 2010).
Ubiquitylation at the DSB regulates the re-
cruitment of the DSB repair proteins BRCA1
and 53BP1 (Al-Hakim et al. 2010). BRCA1 is it-
self a ubiquitin ligase and is regulated by ATM
and ATR-dependent phosphorylation (Cortez
et al. 1999; Tibbetts et al. 2000). BRCA1 is re-
cruited via an interactionwith a complexof pro-
teins containing the K63-linked ubiquitin bind-
ingproteinRap80 (Kimet al. 2007; Sobhian et al.
2007; Wang et al. 2007; Yan et al. 2007). Three
distinct BRCA1 repair complexes (BRCA1-A,
BRCA1-B, and BRCA1-C) are recruited, which
contain different accessory proteins to regulate
checkpoint activation or HR repair (Greenberg
et al. 2006). 53BP1 accumulation near the DSB
is also dependent on these ubiquitylation events
although the mechanism is likely indirect. The
overall effect of BRCA1 and 53BP1 recruitment
downstream of histone phosphorylation and
ubiquitylation is likely regulation of repair
choice between NHEJ and HR.
In addition to recruiting repair factors to
a DSB, DDR-dependent H2AX phosphoryla-
tion also induces changes to chromatin struc-
ture by recruiting ATP-dependent chromatin
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repair factor recruitment
DSB
MDC1
Ub
Ub
Ub
Ub
Ub
RAP80
53BP1
BRCA1
BRIT1
SWI/SNF
INO80
KU
SWR1
MRE11
RNF168 KAP1
RNF8
Ac
HERC2ATM
ATM ATM
ATM
?
H2A-Ub
P P
P
P
P
P
Chromatin
relaxation
Histone removal/
exchange
Inhibition of
transcription
γH2AX
P
DSB
PP
Figure 3. DDR kinases regulate the chromatin near a double-strand break to provide a scaffold for the recruit-
ment of DNA repair proteins, promote repair protein access through nucleosome remodeling, and inhibit local
transcription.
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remodeling complexes including SWI/SNF,
SWR1, and INO80. The SWI/SNF chromatin
remodeling activity is targeted to DSBs through
interactions with acetylated H3 (Lee et al. 2010)
and BRIT1/MCPH1, a protein that binds
gH2AX after damage (Wood et al. 2007; Peng
et al. 2009). ATM and ATR phosphorylate a
SWI/SNF subunit leading to an increased asso-
ciationwith BRIT1 and DSBs (Peng et al. 2009).
SWI/SNF presumably relaxes chromatin near
the break to improve access of DNA repair en-
zymes to the damaged DNA.
The INO80 and SWR1 complexes are re-
cruited to damage sites through direct interac-
tion with gH2AX. At least in yeast, these com-
plexes promote repair through two distinct
mechanisms. INO80 catalyzes histone removal
that facilitates Mre11 binding and DNA end re-
section to promote HR repair, whereas SWR1
promotes KU binding and NHEJ (van Attikum
et al. 2007; van Attikum and Gasser 2009).
INO80-dependent remodeling may also be im-
portant to promote the strand invasion step
of HR through displacement of histones at the
homologous donor sequences (Tsukuda et al.
2009).
H2AX-Independent but DDR Kinase-
Dependent Regulation of Local Chromatin
Besides gH2AX-dependent regulation of repair,
ATMcontrols other chromatinmodifications to
allow access for repair factors. H2B is mono-
ubiquitylated near DSBs (Moyal et al. 2011).
H2B-Ub is catalyzed by an RNF20-RNF40 het-
erodimer (the human ortholog of yeast Bre1),
and thismodification is typicallyassociatedwith
actively transcribed genes (Zhu et al. 2005). The
levels of H2B-Ub increase near a DSB owing to
recruitment of the RNF20-RNF40 proteins
through a mechanism that may involve their
interaction with ATM and NBS1 (Moyal et al.
2011). Both RNF20 and RNF40 are ATM sub-
strates, and increased H2B-Ub surrounding the
break is dependent on RNF20 phosphorylation.
Both NHEJ and HR repair are impaired in cells
when thedamage-inducedH2B-Ub isprevented
(Moyal et al. 2011). The HR defect was traced to
a defect in DNA end resection and could be res-
cued by experimentally inducing chromatin re-
laxation. Reduced NHEJ is associated with less
XRCC4 and KU80 at the break in the absence of
H2B-Ub.
In addition to modulating H2B-Ub, a sec-
ond mechanism by which ATM relaxes chro-
matin to promote repair is through phos-
phorylation of KAP1 (Ziv et al. 2006). KAP1 is
a transcriptional corepressor that works with
histone methyltransferase and histone deacety-
lase complexes to promote chromatin compac-
tion. ATM-dependent KAP1 phosphorylation
disrupts an interaction between KAP1 and the
CHD3 nucleosome remodeler thereby promot-
ing chromatin relaxation (Goodarzi et al. 2011).
As a result, ATM is particularly important for
repair of DSBs that occur in heterochromatin
(Goodarzi et al. 2008a; Noon et al. 2010).
In addition to the examples of local chroma-
tin changes described here, there are changes in
other histone modifications regulated by DDR
kinases such as an ATM-dependent increase in
H2A-Ub that inhibits transcription near DSBs
(Shanbhag et al. 2010). There are also changes in
thebindingof chromatinproteins and the abun-
dance of histone variants. Understanding how
the DDR kinases regulate the local chromatin
environment to promote repair of other types
of DNA lesions, such as those encountered by
elongating replication forks, will also be impor-
tant. Some of the mechanisms may be similar.
For example, gH2AX spreads away from stalled
forks similarly to the spreading observed at
DSBs (Sirbu et al. 2011). However, other mech-
anismsmaybeunique, adding to the complexity
of the chromatin response to DNA damage.
DDR KINASES FACILITATE REPAIR BY
CREATING AN OPTIMAL CELLULAR
ENVIRONMENT
In addition to promoting DNA repair through
direct regulation of repair proteins and changes
in the chromatin near the DNAdamage site, the
DDR also facilitates repair through more global
changes in the cellular environment (Fig. 4).
The most obvious example of this mechanism
is the checkpoint activity of the DDR kinases,
which halts the cell cycle providing time to
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repair the DNAdamage before DNA replication
or mitosis. Checkpoint-dependent changes in
cyclin-dependent kinase (CDK) activities also
influence DNA repair more directly because
many repair proteins are CDK substrates. A sec-
ond example is the numerous DDR kinase-de-
pendent changes in gene expression that are
largely mediated through regulation of p53. In
addition to inducing cell cycle arrest and apo-
ptosis, these transcriptional changes can alter
the levels of DNA repair proteins, as well as the
nucleotides and histones needed for completing
repair synthesis and restoring chromatin.
Furthermore, results from functional geno-
mic screens suggest a much broader regulation
of cellular physiology by the DDR. For example,
proteomic screens for ATM and ATR substrates
and genetic screens for new DDR factors based
on the level of ATM/ATR activity in undamaged
cells identified proteins involved in a wide vari-
ety of cellular functions including intracellular
protein trafficking, cellular immunity, and RNA
metabolism (Matsuoka et al. 2007; Lovejoy et al.
2009; Paulsen et al. 2009; Bansbach and Cortez
2011). In many cases, the connection between
these processes and the DDR kinases is likely to
promote a cellular environment conducive to
DNA repair.
Nuclear Organization and Chromosome
Movements Facilitate DNA Repair
One of the important DDR kinase-dependent
changes important for repair is regulation of
nuclear organization. The nucleus is a highly
organized organelle with compartments devot-
ed to specific functions. A long-standing ques-
tion is whether DNA repair occurs equally well
anywhere within the nucleus or whether there
are specific repair centers (Misteli and Souto-
glou 2009). Recent studies on DSB repair in
yeast suggest that repair centers exist and indi-
cate that DDR-dependent changes in chromo-
some mobility promote HR repair.
Observations of DSBs marked with fluores-
cent proteins revealed that unrepairable DSBs
move to the nuclear periphery and cells with
two DSBs merge them into a single repair fo-
cus (Nagai et al. 2008; Oza et al. 2009). More
recently, the Rothstein and Gasser groups have
shown increased chromosomal mobility with-
in the yeast nucleus because of a DSB (Dion et
al. 2012;Mine-Hattab and Rothstein 2012). The
increased movement depends on the Mec1ATR
kinase, resection of the DNA end, and the
RAD51 recombinase. Intriguingly, the Roth-
stein study also showed that the dynamics of
unbroken, nonhomologous chromosomes is
also increased in the presence of a DSB, sug-
gesting that DDR kinases regulate global nu-
clear architecture (Mine-Hattab and Rothstein
2012).
The end-result of the increased chromo-
some mobility is an increase in repair efficiency.
Likely this results from an increase in the ability
of the RAD51-coated DNA end to find a ho-
mologous sequence. Flexibility of the RAD51-
coated DNA fiber is important for an efficient
homology search (Forget and Kowalczykowski
2012). It is also possible that the movement to
or away from a specific nuclear location pro-
motes repair. For example, movement out of a
region containing heterochromatin or the nu-
cleolus might increase repair efficiency.
Whether similar changes in chromosome
dynamics occur in higher eukaryotes is less
clear. Several studies indicate that most DNA
ends are largely immobile in mammalian cells
(Nelms et al. 1998; Kruhlak et al. 2006; Souto-
glou et al. 2007; Jakob et al. 2009). However,
deprotected telomere ends have increased mo-
bility compared with protected telomeres (Di-
mitrova et al. 2008). This increased mobility
Chromosome
mobility
Cell cycle
DDR
kinases
RNR
NTP
dNTP
RNA
metabolism
Gene
expression
Figure 4. DDR kinases regulate several aspects of nu-
clear and cellular physiology to provide an environ-
ment conducive for successful DNA repair.
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depends on both ATM and 53BP1 and these
ends are repaired through NHEJ. ATM and
53BP1 also control antigen receptor diversifi-
cation, and chromosome movement may be
needed especially in the context of long-range
joining during class switch recombination
(Nussenzweig andNussenzweig 2010).DSBs in-
duced by a particles are also mobile (Aten et al.
2004). Furthermore, breaks in heterochromatin
in Drosophila cells cause an expansion of the
heterochromatin domain followed by move-
ment of the repair focus outside of the hetero-
chromatin (Chiolo et al. 2011). These changes
in heterochromatin are dependent on the DDR
kinases and seem to be important after the re-
section step but before the RAD51-dependent
homology search for HR repair (Chiolo et al.
2011). Thus, at least in some circumstances
the increased mobility of broken chromo-
somes within the nucleus does occur in meta-
zoan cells.
The mechanism by which the DDR pro-
motes increased chromosome mobility is not
known. One clue might be found in the recent
observation thatDNAattachments to the nucle-
ar pore are regulated by the DDR (Bermejo et al.
2011). In this yeast study, the authors found that
DDR kinase modification of nucleoporins re-
leases the interaction between tethered chromo-
somes and the pore. Another possible mecha-
nism could involve phosphorylation of KAP1,
which is observed throughout the nucleus.
KAP1 binds the heterochromatin protein HP1
and as mentioned earlier, KAP1 phosphoryla-
tion is important for the repair of breaks in het-
erochromatin (Goodarzi et al. 2008b). Finally,
DSB recruitment of chromatin remodeling fac-
tors such as INO80 and histone variants such as
H2A.Z may be important to promote the in-
crease in mobility (Kalocsay et al. 2009; Neu-
mann et al. 2012). Discovering the mechanisms
by which the DDR kinases regulate chromo-
some dynamics will provide important infor-
mation about nuclear architecture and how
chromosomal domains are maintained. In ad-
dition, these studies have significant implica-
tions for the mechanisms driving chromosomal
translocations and rearrangements that cause
cancer.
Control of Cellular Nucleotide Levels
for DNA Repair
Perhaps the best-documented example of how
the DDR kinases create a cellular environment
conducive for repair is through the regulation
of nucleotide metabolism. In yeast, the intracel-
lular concentration of dNTPs increases in re-
sponse to DNA damage, whereas in mammali-
an cells increased production may be more
localized (Chabes et al. 2003; Hakansson et al.
2006b). Higher concentrations of dNTPs cause
an increase inmutation frequency (Chabes et al.
2003).Not surprisingly,maintaining anoptimal
balance of cellular dNTPs is a process strictly
controlled atmultiple levels by theDDRkinases.
The rate-limiting step in dNTP production
is catalyzed by ribonucleotide reductase (RNR)
(Nordlund and Reichard 2006). RNR contains
two subunits, R1 and R2, encoded by multiple
genes in most organisms. DDR kinases regulate
RNR at almost every conceivable level. The tran-
scriptional regulation of RNR subunits was one
of the first documented functions of the DDR
(Elledge et al. 1993). In human cells, a DDR
kinase- and p53-dependent pathway induces
expression of the catalytic RNR subunit p53R2
after prolonged exposure to DNA damage (Ta-
naka et al. 2000).
In addition to RNR gene expression, the
DDR kinases directly regulate the stability of
RNR subunits. For example, ATM phosphory-
lation of p53R2 increases its stability (Chang et
al. 2008). Furthermore, ATR signaling inhibits
Cyclin F-dependent R2 degradation, whichmay
be a rapid way of increasing functional RNR
enzyme levels (D’Angiolella et al. 2012).
The ATR pathway also controls the localiza-
tion of the RNR subunits. In yeast, one of the
RNR subunits is exported to the cytoplasm after
damage to form an active RNR enzyme (Yao
et al. 2003). In mammalian cells, RNR subunits
may actually be recruited directly to sites of
DNA damage to ensure dNTP production right
where it is most needed (Niida et al. 2010).
Finally, in budding and fission yeast, small
protein inhibitors of RNR includingDif1, Sml1,
and Spd1 are regulated by DDR kinases. Dif1
and Spd1 control the localization of RNR sub-
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units by regulating nuclear import (Liu et al.
2003; Lee et al. 2008) whereas Sml1 and Spd1
are direct inhibitors of RNR activity (Zhao et al.
1998; Hakansson et al. 2006a). The proteolysis
of all three of these proteins is under control of
the DDR pathway (Zhao et al. 2001; Liu et al.
2003; Lee et al. 2008; Wu and Huang 2008).
Thus, the DDR kinases control the timely
and appropriate production of dNTPs for DNA
repair through transcriptional, posttranscrip-
tional, and localization mechanisms targeting
RNR. The importance of this pathway to create
an optimal cellular environment for repair and
replication is illustrated by the observation that,
in budding yeast, the lethality associated with
deleting Mec1ATR can be rescued by increasing
RNR activity (Desany et al. 1998; Zhao et al.
1998). Whether ATR regulation of RNR func-
tion is equally important in human cells is un-
known.
CONCLUDING REMARKS
The basic DNA repair machinery is often suffi-
cient to reconstitute simple repair reactions in
vitro on naked DNA substrates. However, effi-
cient repair often requires regulation by the
DNA damage response. The DDR kinases di-
rectly modify repair proteins, change chromatin
structure around the DNA lesion, and regulate
nuclear and cellular environments. Failures at
any of these levels cause genome instability and
disease. Not surprisingly, the list of DDR kinase
substrates is long andour understanding of their
regulation is incomplete. Fortunately, new tools
for discovery in multiple systems promise to
rapidlymoveus toward an intimate understand-
ing of mechanism. This knowledge may help in
the design of cancer therapeutic opportunities
based on manipulation of the DNA damage re-
sponse, epigenetic therapies, and combinations
with existing radiation and chemotherapies that
work primarily by damaging DNA.
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